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i	
Pseudomonas	aeruginosa	is	a	metabolically	versatile	environmental	bacterium	that	grows	in	 extremely	 diverse	 habitats—from	 sea	water	 to	 jet	 fuel—and	 is	 able	 to	 infect	 a	 large	variety	 of	 organisms.	 It	 is	 a	 significant	 cause	 of	 human	 disease	 and	 is	 one	 of	 the	most	frequent	 healthcare-associated	 infections.	 P.	 aeruginosa	 uses	 a	 sophisticated	 gene	regulatory	network	to	adapt	its	growth	strategy	to	these	diverse	environmental	niches	and	the	 fluctuating	 conditions	 it	 encounters	 therein.	 The	 las	 and	 rhl	 “quorum	 sensing”	 (QS)	intercellular	 communication	 systems	 play	 integral	 roles	 in	 this	 regulatory	 network	and	control	the	expression	of	factors	important	to	the	bacterium’s	ecological	fitness,	including	many	 secreted	 factors	 involved	 in	 nutrient	 acquisition,	 microbial	 competition,	 and	virulence.	 These	 QS	 systems	 use	 diffusible	 acyl-homoserine	 lactone	 (AHL)	 signalling	molecules	to	infer	environmental	parameters,	including	bacterial	population	density,	and	to	coordinate	behaviour	across	bacterial	communities.	
This	dissertation	describes	an	 investigation	 into	 the	 relationship	between	QS	 and	 small	molecule	 primary	metabolism,	 using	metabolomic	methods	 based	 on	 nuclear	magnetic	resonance	 spectroscopy	 and	 mass	 spectrometry.	 Analysis	 of	 extracellular	 metabolic	profiles	(the	bacteria’s	“metabolic	footprint”)	established	that	QS	can	modulate	the	uptake	and	excretion	of	primary	metabolites	and	that	this	effect	was	strongest	during	the	transition	from	exponential	to	stationary	phase	cell	growth.	Analysis	of	the	cellular	metabolome	and	proteome	 demonstrated	 that	 QS	 affected	most	major	 branches	 of	 primary	metabolism,	notably	 central	 carbon	metabolism,	 amino	 acid	metabolism	 and	 fatty	 acid	metabolism.	These	data	indicate	that	QS	repressed	acetogenesis	and	the	oxidative	C02-evolving	portion	of	the	TCA	cycle,	while	inducing	the	glyoxylate	bypass	and	arginine	fermentation.	QS	also	induced	changes	to	fatty	acid	pools	associated	with	lower	membrane	fluidity	and	higher	chemical	 stability.	 Elevated	 levels	 of	 stress-associated	 polyamines	 were	 detected	 in	 QS	mutants,	 which	 may	 be	 a	 consequence	 of	 a	 lack	 of	 QS-dependent	 adaptations.	 These	findings	 suggest	 that	 wild-type	 QS	 directs	 metabolic	 adaptations	 to	 stationary	 phase	stressors,	including	oxidative	stress.	
Previous	work,	including	several	transcriptomic	studies,	has	suggested	that	QS	can	play	a	role	in	primary	metabolism.	However,	there	has	been	no	previous	study	of	the	global	impact	of	AHL	QS	on	the	metabolome	of	P.	aeruginosa.	Research	presented	here	demonstrates	that	QS	induces	a	global	readjustment	in	the	primary	metabolism	and	provides	insight	into	QS-dependent	metabolic	changes	during	stationary-phase	adaptation.		
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Chapter	1 		Introduction	
1.1 Pseudomonas	aeruginosa	
1.1.1 General	background	and	characteristics	
Pseudomonas	aeruginosa	is	a	Gram-negative	bacillus	with	unipolar	motility,	about	1-5	µm	long	and	0.5-1.0	µm	wide.	It	is	the	type	species	of	the	Pseudomonas	genus	and	is	a	member	of	 the	 fluorescent	 pseudomonad	 subgenus,	 which	 includes	 P.	 fluorescens,	 P.	 putida,	 P.	
chlororaphis,	P.	aureofaciens,	P.	cichorii	and	P.	syringae.	The	name	Pseudomonas	was	given	by	Walter	Migula	of	the	Karlsruhe	Institute	in	Germany	at	the	end	of	the	19th	Century,	and	seems	to	have	been	derived	from	the	Greek	pseudo	(“false”)	and	either	monas	(“unit”)	or	the	nanoflagellate	Monas,	i.e.	false	unit	or	false	Monas	(Migula	1900;	Palleroni	2010).	The	name	
aeruginosa	 (Latin—“full	 of	 verdigris”)	was	 given	 to	 the	 species	 earlier	 by	 the	 German	biologist	Joseph	Schröter	in	reference	to	the	blue-green	colour	of	colonies	grown	on	certain	media.	Schröter	noted	that	these	colonies	could	be	propagated	to	form	new	colonies	of	the	same	colour	and	hence	of	the	same	bacteria,	a	key	step	in	the	development	of	Robert	Koch’s	pure-culture	 techniques	 (Schröter	 1872).	 P.	 aeruginosa	 has	 subsequently	 attracted	research	 interest	 for	 production	 of	 coloured	 dyes,	 as	 a	 source	 of	 antimicrobials,	 its	environmental	and	metabolic	versatility,	as	a	human	pathogen,	and	as	a	model	organism	in	fields	including	bacterial	antibiotic	resistance,	biofilm	formation	and	bacterial	intercellular	signalling.	
P.	aeruginosa	is	one	of	the	most	prevalent	inhabitants	of	oligotrophic—that	is,	low	nutrient	content—	aquatic	ecosystems	and	as	such	is	likely	among	the	most	abundant	organisms	on	Earth.	P.	aeruginosa	has	low	nutrient	requirements—it	can	survive	in	deionized	or	distilled	water—but	 is	also	successful	 in	high	nutrient	environments	such	as	sewage.	 Its	optimal	growth	temperature	in	rich	growth	media	is	37˚C,	but	grows	at	temperatures	up	to	42˚C.	Although	it	is	principally	considered	a	soil	and	water	bacterium	it	is	one	of	most	versatile	bacteria	in	terms	of	its	range	of	habitats,	having	been	isolated	from	environments	as	diverse	as	 plant	 rhizospheres,	 dolphin	 gastric	 juice,	 disinfectant	 solutions	 and	 jet	 plane	 fuel	
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(Costerton	and	Anwar	1994;	Grosso-Becerra	et	al.	2014).	 Important	 to	 its	persistence	 in	natural	 and	 artificial	 environments	 as	 well	 as	 chronic	 infections	 is	 its	 ability	 to	 form	biofilms—communities	 of	 bacteria	 encased	 in	 complex	 polysaccharides,	 rendering	 the	bacteria	resistant	 to	removal	by	mechanical	means,	detergents,	disinfectants,	antibiotics,	disinfectants,	immune	response	or	predation	by	protozoa.	It	is	able	to	infect	a	wide	variety	of	 host	 organisms	 including	 nematodes,	 insects,	 many	 vertebrate	 species	 and	 plants	(Mahajan-Miklos	et	al.	2000).		
1.1.2 Genomic	complexity	and	metabolic	versatility	
The	 first	complete	P.	aeruginosa	genome	to	be	sequenced	was	that	of	 the	wound	 isolate	strain	 PAO1,	 published	 in	 2000	 (Stover	 et	 al.	 2000).	 This	 revealed	 a	 6.3	 Mbp	 circular	chromosome	encoding	~5,570	predicted	coding	sequences,	large	for	a	bacteria	and	similar	in	 coding	 capacity	 to	 that	 of	 simple	 eukaryotes	 such	 as	 Saccharomyces	 cerevisiae	(Kulasekara	and	Lory	2004).	Almost	10%	of	genes	appear	to	encode	regulatory	functions	including	 24	 sigma	 factors,	 434	 transcriptional	 regulators	 and	 many	 environmental	sensors,	an	unusually	high	proportion	compared	with	other	bacteria	(cf.	~5.8%	in	E.	coli,	5.3%	in	B.	 subtilis).	This	includes	a	remarkable	number	of	 two-component	system	(TCS)	proteins	comprised	of	55	sensor-kinases,	89	response	regulators	and	14	sensor-response	regulator	hybrids	 (cf.	 39	 response	 regulators	 in	E.	 coli	 K-12)	(Stover	 et	 al.	 2000;	Ashby	2004).	A	disproportionate	150	genes	are	predicted	to	encode	Outer	Membrane	Proteins,	including	factors	involved	in	environmental	sensing,	adhesion,	motility,	antibiotic	efflux	and	secretion	of	virulence	factors.	Almost	300	genes	encode	cytoplasmic	membrane	transport	systems,	of	which	around	two	thirds	are	predicted	to	be	involved	in	uptake	of	nutrients	and	other	 small	molecules.	 These	 features	 reflect	 the	 remarkable	 ability	 of	P.	 aeruginosa	 to	adapt	to	diverse	environmental	and	nutritional	challenges.		
The	genome	also	contains	a	large	number	of	genes	involved	in	the	catabolism	and	transport	of	organic	compounds.	P.	aeruginosa	possesses	a	highly	branched	respiratory	chain	with	at	least	17	respiratory	dehydrogenases	predicted	to	feed	electrons	into	the	quinone	pool	and	five	 terminal	oxidases.	The	differing	properties	of	 these	 terminal	oxidases,	 such	as	 their	affinity	 for	 oxygen	 and	 resistance	 to	 stresses	 like	 cyanide	 and	 reactive	 oxygen	 species	presumably	allow	aerobic	respiration	to	be	adapted	to	various	oxygen	concentrations	and	environmental	 	 stresses	 (Arai	 2011).	 The	 bacterium	 also	 possesses	 a	 complete	denitrification	pathway,	 allowing	 growth	under	 anaerobic	 conditions	 in	 the	presence	of	nitrate	 or	 nitrite	 (Zumft	 1997).	 In	 the	 absence	 of	 both	molecular	 oxygen	 and	 nitrogen	
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oxides,	 P.	 aeruginosa	 can	 still	 grow—slowly—by	 anaerobic	 fermentation	 of	 arginine	 to	ornithine	through	the	arginine	deiminase	pathway	(Lüthi	et	al.	1990).	P.	aeruginosa	appears	to	be	microaerophilic	as	 it	actively	generates	a	microaerobic	environment	in	response	to	high	aeration	by	forming	a	polysaccharide	cell	capsule	and	by	reducing	the	oxygen	transfer	rate	to	the	liquid	phase	via	the	production	of	biosurfactants	such	as	rhamnolipids	(Sabra	et	al.	2002).	
Advances	in	DNA	sequencing	technologies	since	2000	have	led	to	the	complete	genomes	of	over	 80	 clinical	 and	 environmental	 P.	 aeruginosa	 isolates	 being	 published	 via	 the	Pseudomonas	Genome	Database	(Winsor	et	al.	2009).	Genome	sizes	vary	between	5.5	and	7.5	Mbp.	The	core	genome	of	P.	aeruginosa	is	defined	as	those	genes	present	in	nearly	all	strains,	irrespective	of	origin	(environmental	or	clinical	isolates)	and	constitutes	~90%	of	the	total	genome	of	PAO1.	The	core	genome	is	highly	conserved	relative	to	those	of	other	bacterial	 pathogens	 such	 as	 Escherichia	 coli	 and	 other	 Pseudomonas	 species,	 with	interclonal	 sequence	 diversity	 of	 0.5–0.7%	 (Kung	 et	 al.	 2010;	 Klockgether	 et	 al.	 2011;	Grosso-Becerra	et	al.	2014).	The	core	genome	includes	the	vast	majority	of	known	virulence	factors:	approximately	97%	of	known	virulence	 factors	were	 found	to	be	conserved	 in	a	study	 of	 18	 strains	 (Wolfgang	 et	 al.	 2003).	Moreover,	 it	 appears	 that	 clinically-isolated	strains	do	not	constitute	a	distinct	subpopulation	of	P.	aeruginosa	and	that	environmental	isolates	 of	 diverse	 origins	 can	 be	 pathogenic	 (Grosso-Becerra	 et	 al.	 2014).	 This	 again	underscores	the	adaptability	of	this	bacterium.	
1.1.3 Human	disease	
Although	P.	aeruginosa	has	been	noted	to	infect	humans	since	the	19th	century,	these	were	considered	rare	cases	and	its	importance	as	a	major	cause	of	disease	was	not	recognised	until	the	mid-20th	century	(Botzenhart	and	Döring	1993).	It	is	still	principally	considered	a	saprophyte—growing	on	dead	or	decaying	matter—though	it	has	come	to	be	regarded	as	a	consummate	and	common	opportunistic	pathogen.	That	is,	though	it	frequently	colonises	healthy	individuals,	it	typically	only	causes	disease	in	the	immunocompromised.	In	humans,	it	 can	 colonise	 virtually	 any	mucosal	 surface	 and	 invade	most	 tissues.	 It	 is	 carried	by	 a	relatively	 small	 proportion	 of	 the	 healthy	 human	 population	 (2–10%),	 but	 50–60%	 of	hospitalised	patients	are	colonised	(Cholley	et	al.	2008).		
The	major	 forms	 of	 P.	 aeruginosa	 infection	 are	 i)	 bacteraemia	 in	 immunocompromised	patients,	 ii)	 pneumonia	 in	 cystic	 fibrosis	 (CF)	patients,	 iii)	 community-acquired	 ear	 and	pneumonia	infections,	and	iv)	hospital	outbreaks	associated	with	contaminated	reagents	or	
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medical	devices	(Fujitani	et	al.	2011).	Although	P.	aeruginosa	rarely	infects	healthy	tissue,	there	are	 few	tissues	 that	 it	cannot	 infect	 if	host	defences	are	compromised	by	 immune	deficiency	 (immunosuppression,	 neutropenia),	 or	 the	 breach	 of	 a	 physical	 barrier	 to	infection	(skin,	mucous	membrane).	 It	 is	one	of	 the	most	common	healthcare	associated	infections	(HAIs).	Using	data	collected	in	the	USA	between	2011	and	2104,	the	US	Centers	for	Disease	Control	and	Prevention	(CDC)	found	that	P.	aeruginosa	was	the	second	most	frequently	 reported	 pathogen	 for	 ventilator-associated	 pneumonia	 (16.5%),	 third	 for	catheter-associated	urinary	tract	infection	(10.5%)	and	sixth	across	all	HAIs	(7.3%	of	all	reports)	(Weiner	et	al.	2016).	People	at	particular	risk	from	P.	aeruginosa	infection	include	those	with	cystic	fibrosis	(CF),	acquired	immune	deficiency	syndrome	(AIDS;	50%	mortality	attributable	 to	 P.	 aeruginosa	 infection),	 severe	 burns	 (60%	 attributable	 mortality),	neutropenic	 cancer	 patients	 (30%	 attributable	 mortality),	 and	 patients	 with	 medical	implants	 (38%	 attributable	 mortality	 for	 ventilator-associated	 pneumonia	 in	 intubated	patients)	(Mendelson	et	al.	1994;	Laing	1999;	Gales	et	al.	2001).	P.	aeruginosa	may	account	for	 an	 increasing	disease	burden	 in	 coming	years	as	 vulnerable	populations	 expand:	 for	example	 aging	 populations	 are	 at	 greater	 risk	 of	 infection	 due	 to	 higher	 rates	 of	 co-morbidities	such	as	diabetes	mellitus	and	structural	lung	disease,	the	presence	of	invasive	medical	devices	and	age-related	decline	in	immune	function	(Pappas	et	al.	2009).	
The	capacity	of	P.	aeruginosa	to	infect	diverse	organisms	and	cause	such	a	range	of	diseases	is	coupled	to	its	arsenal	of	virulence	factors;	these	include	proteinaceous	virulence	factors	such	as	elastase,	exotoxin	A	and	haemolytic	phospholipase	C	(all	secreted	via	 type	I	or	II	secretion	systems),	which	facilitate	P.	aeruginosa	epithelial	invasion	by	breaking	down	the	epithelial	 glycocalyx	 (a	 protective	 layer	 of	 glycoproteins)	 and	 plasma	 membranes,	 the	cytotoxic	proteins	ExoY,	ExoS,	ExoT	and	ExoU,	which	upon	cell	contact	are	injected	directly	into	 the	 host	 cell	 cytoplasm	 via	 the	 syringe-like	 type	 III	 secretion	 system,	 and	 small	molecule	 secondary	 metabolites	 such	 as	 hydrogen	 cyanide	 and	 pyocyanin,	 which	 play	pleiotropic	roles	in	pathogenesis	(e.g.	pyocyanin	has	been	reported	to	depress	host	immune	response	and	induce	apoptosis	in	neutrophils).	In	fact,	it	has	been	reported	that	267	genes	(approximately	5%	of	 the	 genome)	 encode	known	or	putative	 virulence	 factor	products	(Gallagher	 and	 Manoil	 2001).	 Expression	 of	 these	 virulence	 factors	 is	 typically	 not	constitutive,	but	rather	controlled	by	a	complex	gene	regulatory	network	and	induced	in	response	to	environmental	cues	including	iron	availability	and	bacterial	cell-density.		
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1.2 Quorum	sensing		
1.2.1 Discovery	and	the	archetypal	system	
Many	 bacterial	 species	 synthesise	 signalling	 molecules	 whose	 accumulation	 in	 the	environment	 is	 detected	 by	 specific	 cell-associated	 protein	 receptors;	 since	 the	 signal-producing	 cells	 are	 themselves	 signal	 receivers,	 these	 signals	 have	 been	 dubbed	“autoinducers”.	In	reference	to	the	concept	that	these	processes	are	only	productive	when	performed	 by	 a	 sufficiently	 large	 number	 of	 spatially	 localised	 cells,	 describing	 such	 a	``minimal	 behavioural	 unit	 as	 a	 quorum	 of	 bacteria'',	 Fuqua	 et	 al.	 introduced	 the	 term	quorum	 sensing	 (QS)	 to	 describe	 the	 role	 of	 autoinducer	 signalling	 in	 cell	 density-responsive	regulation	(Fuqua	et	al.	1994).		
	
Figure	1.1	The	Vibrio	fischeri	LuxI/LuxR	QS	system.		3OC6-HSL	(diamonds)	is	produced	by	the	enzymatic	activity	of	the	LuxI	signal	synthase.	3OC6-HSL	can	diffuse	across	the	cell	membranes.	At	high	cell	densities,	binding	of	3OC6-HSL	to	LuxR	induces	transcription	 of	 the	 luxICDABEG	 operon,	 forming	 a	 positive	 feedback	 loop	 and	 leading	 to	chemiluminescence.		The	first	QS	system	described	is	the	archetypal	LuxI/LuxR	system	of	the	bioluminescent	marine	bacterium	Vibrio	fischeri	(Nealson	et	al.	1970;	Eberhard	1972).	V.	fischeri	exists	as	a	free-living	saprophyte,	a	commensal	in	the	guts	of	marine	mammals	and	as	a	mutualistic	symbiont	 in	 the	 light	 organs	 of	 squid	 and	 fish	 species;	 it	 is	 in	 this	 last	 niche	 that	 the	
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LuxI/LuxR	 system	 performs	 the	 archetypal	 quorum	 sensing	 function,	 linking	bioluminescence	to	bacterial	cell	density.	The	best-characterised		V.	fischeri		bioluminescent	symbiosis	 is	 that	 with	 the	 Hawaiian	 bobtail	 squid,	 Euprymna	 scolopes.	 This	 provides	 a	captivating	illustration	of	AHL-signalling	coordinating	the	behaviour	of	bacteria	with	their	eukaryotic	host.	E.	scolopes	is	a	small	nocturnal	predator	(weighing	up	to	2.7	g)	that	hunts	in	shallow	reef	flats.	The	squid	use	sophisticated	light	organ	apparatus—including	reflective	tissue,	a	lens,	yellow	filters	and	an	ink-sac	shutter	mechanism—to	direct	and	manipulate	the	light	produced	by	V.	fischeri	to	match	falling	moon	and	starlight,	thereby	masking	their	silhouettes	 from	 predators	 below	 (Montgomery	 and	 McFall-Ngai	 1998;	 Jones	 and	Nishiguchi	2004).	The	bacteria	seem	to	benefit	from	an	advantageous	growth	environment	in	the	light	organ,	which	provides	amino	acids	and	proteins	to	the	bacteria	(Graf	and	Ruby	1998).	
Key	 to	 this	symbiosis	 is	 the	 ability	 of	 the	bacteria	 to	 control	 their	bioluminescence	 as	a	function	of	their	population	density.	Each	dawn,	the	squid	vent	their	light	organs	of	>95%	of	their	V.	fischeri	monocultures	(Lee	and	Ruby	1994);	the	remaining	V.	fischeri	population	then	recovers	to	high	numbers	over	the	course	of	the	day	(approximately	107	to	108	in	an	adult's	light	organ).	The	constitutively	expressed	autoinducer	synthase	LuxI	catalyses	the	formation	of	N-(3-oxohexanoyl)-L-homoserine	lactone	(3OC6-HSL)	from	N-3-oxohexanoyl-ACP	(acyl	carrier	protein)	and	S-adenosylmethionine	(SAM)	(Schaefer	et	al.	1996;	Val	and	Cronan	 1998);	 these	 AHLs	 diffuse	 freely	 across	 the	 cell	 membranes,	 so	 that	 extra-	 and	intracellular	 concentrations	 equilibrate	 (Kaplan	 and	 Greenberg	 1985).	 Hence,	 as	 the	 V.	
fischeri	population	expands	over	the	course	of	the	day,	the	increasing	V.	fischeri	population	density	in	the	squid	light	organ	is	mirrored	by	increasing	concentrations	of	AHL.	At	dusk,	the	concentration	of	AHL	exceeds	a	threshold	concentration	such	that	their	specific	binding	to	 the	 V.	 fischeri	 cytoplasmic	 LuxR	 receptor	 protein,	 induces	 its	 binding	 to	 a	 specific	palindromic	recognition	sequence	(lux	box)	in	the	luxICDABEG	luciferase	operon,	activating	transcription	 and	 initiating	 bioluminescence	 (Figure	 1.1).	 Since	 this	 induced	 operon	includes	 luxI,	a	positive	feedback	loop	is	formed.	Such	positive	feedback	synchronises	QS	activity	 across	 bacterial	 populations	 and	 is	 a	 hallmark	 of	 QS	 regulatory	 networks.	 In	addition	 to	population	density,	 the	 lux	 system	 responds	 to	multiple	 additional	 variables	including	 nutritional	 cues	 and	 the	 signal	 mass	 transfer	 properties	 in	 the	 light	 organ.	Nonetheless,	by	linking	bioluminescence	to	AHL	concentration,	this	archetypal	QS	system	enables	 the	 bacteria	 to	 avoid	 committing	metabolic	 resources	 to	 futile	 light	production	during	daylight	hours.	
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As	in	many	other	bacteria,	V.	fischeri	has	a	second	AHL	signalling	system,	comprised	of	the	AI	synthase	AinS	and	the	receptor	protein	LuxN.	The	ainS/luxN	system	is	activated	at	lower	cell	 densities	 than	 the	 luxIR	 system	and	 is	 required	 for	host	 colonisation,	apparently	by	regulating	phenotypes	 such	 as	motility	as	V.	 fischeri	 reaches	deeper	 into	 the	 light	 organ	crypt	 tissues.	 In	 addition	 to	 downregulating	 expression	 of	 flagella,	 AinS/LuxN	autoinduction	also	 regulates	 a	number	of	 genes	with	metabolic	 functions,	 such	as	 folate	metabolism,	 histidine	 metabolism,	 polysaccharide	 biosynthesis	 and	 iron	 acquisition,	suggesting	that	these	may	be	important	for	successful	colonisation	(Lupp	and	Ruby	2005).	The	two	signal	systems	are	linked	by	the	transcriptional	regulator	LitR,	which	is	activated	by	LuxN:AHL	and	is	required	for	LuxIR	signalling.	This	network	architecture	enables	the	sequential	regulation	of	a	number	of	phenotypes	at	different	stages	of	colonisation.	
Since	the	discovery	of	the	lux	system	of	V.	fischeri,	QS	systems	using	several	distinct	signals	have	been	identified	in	a	large	number	of	bacteria.	For	example,	while	quorum	sensing	in	almost	 all	Gram-negative	bacteria	 is	mediated	by	AHL	 systems	analogous	 the	 V.	 fischeri	LuxI/LuxR	system,	Gram-positive	bacteria	use	 autoinducer	peptides	(AIPs)	 (Waters	and	Bassler	2005).	P.	aeruginosa	produces	two	AHL	signals,	N-3-oxododecanoyl-L-homoserine	lactone	(3OC12-HSL,	or	OdDHL)	and	N-butanoyl-L-homoserine	lactone	(C4-HSL,	or	BHL)	(Figure	1.2).	
	
Figure	 1.2 AHL	 quorum	 sensing	 signals	 produced	 by	 Vibrio	 fischeri	 (3OC6-HSL)	 and	
Pseudomonas	aeruginosa	(C4-HSL	and	3OC12-HSL).			
Introduction	
	
8	
	
Figure	1.3	Quinolone	autoinducers	produced	by	P.	aeruginosa.	The	2-alkyl-4-quinolone	(AQ)	signal	molecules	2-heptyl-3-hydroxy-4-quinolone	(PQS)	and	2-heptyl-4-quinolone	(HHQ).	
1.2.2 Interconnected	QS	systems	in	P.	aeruginosa	
	
Figure	1.4	P.	aeruginosa	AHL-	and	AQ-dependent	QS	regulatory	circuits.	The	quorum	sensing	circuitry	of	P.	aeruginosa	has	been	subject	to	intensive	study	over	the	past	 three	 decades.	 Two	 complete	 classical	 N-acyl-homoserine	 lactone	 (AHL)	 quorum	sensing	systems	have	been	described,	lasR-lasI	and	rhlI-rhlR.	The	las	system	consists	of	the	AHL	 synthase	LasI,	which	 generates	N-3-oxo-L-dodecanoyl-homoserine	 lactone	 (3OC12-
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HSL,	 or	 OdDHL),	 and	 the	 signal	 receptor	 LasR,	 which	 binds	 3OC12-HSL	 (Gambello	 and	Iglewski	1991;	Passador	et	al.	1993;	Pearson	et	al.	1994).	The	rhl	system	consists	of	the	AHL	synthase	RhlI,	which	produces	N-butanoyl-L-homoserine	lactone	(C4-HSL,	or	BHL),	and	the	signal	receptor	RhlR,	which	binds	C4-HSL	(Ochsner	et	al.	1994;	Ochsner	and	Reiser	1995;	Pearson	et	al.	1995).	The	R-proteins	form	transcriptional	activator	complexes	upon	binding	their	cognate	signal	molecules;	these	activate	transcription	through	the	binding	of	~20	bp	palindromic	DNA	sequences	upstream	of	target	genes	known	as	las	or	rhl	boxes	(Whiteley	and	Greenberg	2001).	Importantly,	the	R-proteins	show	high	specificity	for	their	cognate	ligands:	LasR	is	not	activated	by	C4-HSL	and	3OC12-HSL	only	activates	RhlR	to	low	levels	(Pearson	et	al.	1997).	In	addition	to	the	LasR	and	RhlR	signal	receptors,	the	orphan	receptor	QscR	responds	to	3OC12-HSL	and	regulates	its	own	set	of	genes	in	addition	to	repressing	many	las-	and	rhl-regulated	genes	(Lee	et	al.	2006;	Lequette	et	al.	2006).	
This	 picture	 of	 AHL-mediated	 QS	 in	 P.	 aeruginosa	 is	 further	 complicated	 by	 a	 third	 QS	system,	 the	 PQS	 system	 based	 on	 2-alkyl-4-quinolones	 (AQs)	 (Diggle	 et	 al.	 2007).	
Pseudomonas	aeruginosa	produces	over	fifty	different	AQs,	though	the	best	studied	for	their	signalling	 function	 are	 the	 2-heptyl-3-hydroxy-4-quinolone	 (Pseudomonas	 quinolone	signal,	PQS)	and	4-hydroxy-2-heptyl-quinoline	(HHQ)	(Déziel	et	al.	2004;	Lépine	et	al.	2004)	(Figure	 1.3).	 Synthesis	 of	 PQS	 proceeds	 from	 anthranilate,	 which	 is	 converted	 by	 the	
pqsABCD	gene	products	to	4-hydroxy-2-heptyl-quinoline	(HHQ),	the	immediate	precursor	of	 PQS	 (Déziel	 et	 al.	 2004).	 HHQ	 is	 exported	 from	 the	 cell	 and	 is	 taken	 up	 by	 adjacent	bacterial	cells	where	it	is	converted	to	PQS	by	PqsH.	PQS	regulates	its	own	production	by	driving	the	expression	of	pqsABCDE	via	PqsR	(MvfR)	and	that	of	other	target	genes	via	PqsE	(Déziel	et	al.	2004;	Diggle	et	al.	2006;	Hazan	et	al.	2010).	PqsE	also	represses	expression	of	the	pqsABCDE	operon,	forming	a	negative	feedback	loop	(Rampioni	et	al.	2010).	
As	per	the	V.	fischeri	lux	system,	at	low	cell	density	autoinducers	are	synthesized	at	basal	levels	 and	 diffuse	 into	 the	 extracellular	 space;	 as	 population	 cell	 density	 increases	 the	autoinducer	 concentration	 rises	 and,	 above	 a	 critical	 threshold,	 the	 formation	 of	 R-protein:signal-molecule	complexes	activates	target	gene	expression.	The	core	QS	circuits	are	 modulated	 by	 a	 plethora	 of	 additional	 regulatory	 factors,	 for	 example	 at	 low	 cell	densities	 AHL	 synthesis	 is	 repressed	 by	 the	 QS	 negative	 regulators	 RsmA	 and	 QscR.	Negative	feedback	loops	balance	positive	feedback	mechanisms	at	high	cell	densities,	for	example	the	las	system	induces	expression	of	RsaL,	which	represses	its	own	expression	and	that	of	LasI	(Rampioni	et	al.	2007).		
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The	regulatory	networks	of	the	three	QS	systems	are	highly	interconnected:	the	las	system	sits	atop	the	regulatory	hierarchy	and	regulates	both	the	rhl	and	PQS	systems,	the	rhl	system	regulates	the	PQS	system,	and	the	PQS	system	in	turn	can	regulate	the	rhl	system	(Figure	1.4).	This	leads	to	a	degree	of	co-dependence,	for	example	expression	of	RhlR-controlled	genes	is	delayed	in	a	lasR	mutant,	however	each	system	can	also	be	independently	activated,	for	example	activation	of	the	rhl	and	PQS	systems	is	delayed	rather	that	fully	abrogated	in	a	
lasR	mutant	(Dekimpe	and	Déziel	2009).	The	presence	of	three	QS	systems	seems	to	enable	finely	tuned	gene	expression	responses	to	complex	environmental	cues.	This	is	illustrated	by	the	dense	connections	between	the	QS	circuitry	and	a	complex	global	regulatory	network	involving	the	sigma	factors	RpoS	and	RpoN,	the	global	regulators	GacA,	DksA,	MvaT	and	Vfr,	as	well	as	the	LuxR-type	regulators	QscR	and	VqsR	(Juhas	et	al.	2005;	Schuster	and	Peter	Greenberg	2006).	These	add	context-dependence	to	the	QS	regulons,	for	example	growth	phase	and	nutrient	availability	have	important	co-regulatory	roles	and	QS	signals	alone	are	insufficient	for	expression	of	some	QS-regulated	genes	(Diggle	et	al.	2002;	Schuster	et	al.	2003).	
1.2.3 P.	aeruginosa	AHL	QS	regulons	and	their	global	regulatory	
context		
Both	 the	 las	 and	 rhl	 systems	 were	 discovered	 via	 screens	 for	 regulators	 of	 secreted	virulence	 factors.	 LasR	was	 identified	 in	 a	 screen	 of	 positive	 regulators	 of	 extracellular	elastase	activity	conferred	by	expression	of	LasB,	a	metalloprotease	with	broad	substrate	specificity	 including	 elastin,	 collagen,	 immunoglobins,	 transferrin	 and	 complement	components	 (Gambello	 and	 Iglewski	 1991).	 Similarly,	 the	 RhlR	 gene	 was	 identified	 by	genetic	 complementation	of	 a	 strain	deficient	 in	 expression	of	 rhamnolipids,	 rhamnose-containing	 glycolipid	 biosurfactants	 with	 roles	 in	 motility,	 biofilm	 architecture,	antimicrobial	defence	against	predators	and	lysis	of	eukaryotic	immune	cells	(Ochsner	et	al.	1994;	Cosson	et	al.	2002;	Boles	et	al.	2005;	Soberón-Chávez	et	al.	2005;	Jensen	et	al.	2007;	Alhede	et	al.	2009).	Subsequent	research	revealed	that	the	las	system	was	responsible	for	upregulating	expression	of	a	range	of	virulence	 factors	 in	addition	 to	elastase,	 including	LasA	protease,	alkaline	protease	and	exotoxin	A	(Toder	et	al.	1991;	Gambello	et	al.	1993).	Similarly,	the	rhl	system	was	found	to	upregulate	an	overlapping	but	distinct	set	of	factors	including	 elastase,	 alkaline	 protease,	 the	 stationary	 sigma	 factor	 RpoS	 and	 secondary	metabolites	pyocyanin	and	cyanide	(Brint	and	Ohman	1995;	Winson	et	al.	1995;	Latifi	et	al.	1996).	
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The	 development	 of	 high-density	 DNA	 microarray	 techniques	 facilitated	 more	comprehensive	analyses	of	AHL	regulation:	 in	2003,	 three	groups	used	 this	approach	 to	assess	AHL-dependent	gene	regulation	in	a	lasI	rhlI	mutant	(Hentzer	et	al.	2003;	Schuster	et	al.	2003;	Wagner	et	al.	2003).	Schuster	et	al.,	2003	and	Wagner	et	al.,	2003	each	found	that	over	300	genes	responded	to	AHLs,	while	Hentzer	et	al.	2003	 identified	163	genes,	using	more	stringent	criteria	and	different	growth	conditions.	Only	102,	or	about	20%	of	these	AHL-regulated	genes	were	modulated	in	all	three	studies	and	comprise	what	has	been	called	a	“general”	or	“core”	AHL	QS	regulon	(Schuster	and	Peter	Greenberg	2006).	The	most	prevalent	functional	class	in	this	core	QS	regulon	is	secreted	factors,	consistent	with	earlier	studies.	However,	80%	of	the	core	regulon	gene	functions	were	assigned	to	other	classes	including	a	substantial	(~20%)	fraction	with	primary	metabolic	functions,	indicating	that	AHL	 QS	 induces	 broader	 physiological	 changes	 than	 previously	 understood.	 The	dependence	 of	 the	 QS	 regulon	 on	 growth	 conditions	 is	 consistent	 with	 studies	demonstrating	that	the	core	QS	circuits	are	embedded	within	a	larger	network	of	regulators	that	 	 integrates	 and	 responds	 to	 multiple	 environmental	 signals	 (Schuster	 and	 Peter	Greenberg	2006;	Coggan	and	Wolfgang	2012;	Balasubramanian	et	al.	2013).		Key	regulators	with	direct	regulatory	links	with	QS	include	Vfr,	RelA,	RpoS	and	the	GacAS/RsmAZ	system	(Figure	1.5).		
Introduction	
	
12	
	
Figure	1.5	Regulatory	context	of	P.	aeruginosa	QS	systems—a	simplified	schematic.	One	of	the	mechanisms	by	which	P.	aeruginosa	senses	environmental	cues	is	via	so-called	two-component	systems	(TCS).	The	GacSA	proteins	comprise	one	such	system	that	controls	a	 switch	 between	 phenotypes	 associated	 with	 acute	 and	 chronic	 infection,	 including	virulence	 factors,	 secondary	 metabolites	 and	 biofilm	 formation	 (Coggan	 and	 Wolfgang	2012).	 	Phosphorylated	GacA	upregulates	the	transcription	of	the	small	regulatory	RNAs	RsmY	and	RsmZ,	which	bind	and	sequester	 the	regulatory	protein	RsmA	(Heurlier	et	al.	2004;	Kay	et	al.	2006;	Brencic	et	al.	2009).	RsmA	represses	AHL	QS,	while	inducing	factors	such	as	type	III	secretion	and	type	IV	pili	formation	(Pessi	et	al.	2001).	RsmA	also	regulate	several	 QS	 controlled	 factors	 including	 synthesis	 of	 hydrogen	 cyanide,	 pyocyanin	 and	rhamnolipids.	 Several	 host-associated	 environmental	 cues—including	 host-cell	 contact,	low	calcium	and	chemoattractants	such	as	phosphatidylethanolamine—result	in	elevated	levels	 of	 the	 alarmone	 cAMP	 in	 P.	 aeruginosa,	 mediated	 in	 part	 by	 activation	 of	 CyaB	adenylate	 cyclase	by	 the	Chp	 chemosensory	 system.	This	 information	 is	 fed	 into	 the	QS	regulon	 via	 the	 CRP	 (cyclic	 AMP	 receptor	 protein)	 homologue	 Vfr	 (virulence	 factor	regulator),	which	induces	LasR	transcription	in	response	to	elevated	levels	of	cAMP	via	a	CRP-binding	sequence	in	the	lasR	promoter	region	(Albus	et	al.	1997;	Wolfgang	et	al.	2003).	Vfr	induces	cAMP-dependent	expression	of	a	number	of	virulence	factors	including	flagella	
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(involved	 in	motility	and	attachment	to	host	cells),	and	 type	 II	and	 III	 secretion	systems	(responsible	for	delivery	of	virulence	factors	to	host	cells).		
Stress	response	signals	feed	into	the	QS	regulatory	network	via	the	RelA-mediated	stringent	response	and	the	stationary	phase	sigma	factor	and	general	stress	response	regulator,	RpoS.	RelA	catalyses	the	synthesis	of	the	alarmone	guanosine	3’,5’-bispyrophosphate	(ppGpp)	in	response	 to	 amino	 acid	 starvation	 or	 depletion	 of	 energy-sources	 and	 induces	 AHL	production	as	well	as	expression	of	LasR,	RhlR	and	RpoS	(Van	Delden	et	al.	2001).	In	E.	coli,	RpoS	 is	 important	 in	 regulating	 responses	 to	 heat	 shock,	 nutrient	 limitation,	 osmotic	pressure	and	oxidative	stress	(Loewen	et	al.	1998).	The	role	of	RpoS	in	P.	aeruginosa	is	less	clear	but	seems	to	be	comparable:	disruption	of	the	P.	aeruginosa	PAO1	rpoS	gene	increases	stationary	 phase	 sensitivity	 of	 the	 bacterium	 to	 heat	 stress,	 acid	 stress,	 osmotic	 stress,	oxidative	 stress	 and	organic	 solvents	(Jørgensen	et	 al.	 1999;	 Suh	et	al.	 1999).	The	RpoS	regulon	 in	 P.	 aeruginosa	 also	 includes	 many	 genes	 not	 obviously	 involved	 in	 stress	responses,	such	as	genes	involved	in	chemotaxis	(Schuster	et	al.	2004b).	The	QS	and	RpoS	systems	tune	each	other’s	activities;	RpoS	upregulates	expression	of	LasR	and	RhlR,	and	the	
rhl	 system	 in	 turn	 induces	 expression	 of	 RpoS	 (Latifi	 et	 al.	 1996;	Whiteley	 et	 al.	 2000;	Schuster	et	al.	2004b).	This	interconnection	is	illustrated	by	the	observation	that	the	RpoS	regulon	includes	40%	of	the	AHL	QS	core	regulon,	many	genes	of	which	appear	to	be	directly	regulated	by	RpoS	(Schuster	et	al.	2004b).		
The	 PQS	 system	 plays	 a	 complex	 role	 in	 this	 network,	 serving	 both	 as	 an	 intercellular	signalling	system	in	its	own	right	and	also	responding	directly	to	iron	availability,	a	major	regulator	of	virulence.	AQs,	 including	PQS,	regulate	multiple	virulence	 factors	and	genes	involved	in	iron	acquisition,	including	pyoverdine	and	pyochelin.	PQS	itself	chelates	and	its	activity	is	modified	by	Iron(III)	(Bredenbruch	et	al.	2006;	Diggle	et	al.	2007;	Hazan	et	al.	2010).	
1.2.4 Metabolic	strategies	and	evolutionary	stability 
The	 preponderance	 of	 virulence	 factors	 amongst	 las-	 and	 rhl-regulated	 genes	 in	 early	studies	indicated	that	these	AHL	QS	systems	are	global	regulators	of	virulence.	This	lead	to	the	 proposal	 that	 regulation	 of	 virulence	 traits	 by	 QS	 could	 enable	 communities	 of	 P.	
aeruginosa	 to	 mount	 a	 concerted	 attack	 on	 a	 host	 in	 response	 to	 bacterial	 population	density	or	other	environmental	or	nutritional	cues	(Passador	et	al.	1993).	The	intercellular	communication	 and	positive	 feedback	mechanisms	 of	 QS	would	 synchronise	 behaviour,	thereby	 avoiding	 the	 premature	 triggering	 of	 a	 strong	 host	 immune	 response	 until	
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conditions	 favour	 a	 coordinated	 switch	 to	 virulence.	 The	 importance	 of	 AHL	 QS	 to	 P.	
aeruginosa	virulence	has	been	demonstrated	in	a	number	of	animal	models,	 in	which	QS	mutants	are	attenuated	in	their	virulence	(Smith	and	Iglewski	2003).	However,	QS	systems	are	frequently	inactivated	by	mutation	in	P.	aeruginosa	isolates	from	chronic	infections	and	other	environments,	demonstrating	that	QS	is	an	unstable	trait	in	some	contexts	(Cabrol	et	al.	2003;	Dénervaud	et	al.	2004;	Salunkhe	et	al.	2005;	Heurlier	et	al.	2006).		
Although	 bacterial	 population	 density	 is	 a	 key	 variable	 determining	 the	 state	 of	 QS	systems—evoked	by	the	term	quorum—such	signalling	occurs	in	diverse	and	sometimes	complex	 environments	 in	 which	 other	 variables,	 such	 as	 mass	 transfer	 rates,	 can	 play	significant	or	even	dominant	roles.	This	was	highlighted	by	(Redfield	2002),	who	proposed	that	QS	systems	may	serve	to	assess	the	rate	at	which	secreted	molecules	move	away	from	the	 producing	 cell—“Diffusion	 Sensing”	 DS—and	 not	 necessarily	 serve	 any	 social	 or	cooperative	function.	In	the	DS	hypothesis,	AHL	concentrations	serve	as	proxies	for	the	fates	of	 more	 metabolically	 expensive	 exoproducts,	 such	 as	 secreted	 enzymes,	 whose	concentrations	 are	 determined	 by	 similar	 environmental	 parameters.	 Both	 QS	 and	 DS	models	are	supported	by	empirical	evidence	and	different	parameters	likely	dominate	in	different	physical	environments	(West	et	al.	2012).		
QS	controls	the	production	of	both	“public”	goods	(i.e.	secreted	factors	that	provide	benefits	to	a	local	neighbourhood	of	cells)	and	“private”	goods	(i.e.	“non-shared”	cellular	factors	of	benefit	only	to	the	producing	cell).	The	benefit	of	such	public	goods	often	increases	with	cell	density	and	QS	allows	bacteria	to	tune	gene	expression	accordingly	(Darch	et	al.	2012;	Pai	et	 al.	 2012).	 However,	 co-operative	 individuals	 can	 be	 vulnerable	 to	 competitive	exploitation	by	non-co-operative	 ‘cheats’	 that	 reap	 the	 rewards	of	public	 goods	without	contributing	to	their	costs.	Thus	under	conditions	requiring	quorum	sensing	induction	of	extracellular	 proteases	 for	 growth,	 QS	 “signal-blind”	 cheater	mutants—typically	 lacking	LasR	 function—have	 a	 competitive	 advantage	 over	wild-type	 cells	 (Sandoz	 et	 al.	 2007).	Nonetheless,	correlation	between	signal	concentration	and	cheater	frequency	means	that	QS	 can	 stabilise	 co-operative	 production	 of	 public	 goods	 in	 mixed	 populations	 of	 co-operators	and	cheats,	by	allowing	individuals	to	display	“general	reciprocity”,	that	is	to	“co-operate	when	surrounded	by	co-operators”	(Pfeiffer	et	al.	2005;	Allen	et	al.	2016;	Bruger	and	Waters	2016).		
The	cost	of	producing	public	goods	is	a	function	of	the	specific	nutritional	context	and	the	AHL	 QS	 regulatory	 network	 integrates	 such	 information	 when	 coordinating	 metabolic	strategies.	 Under	 growth-rate	 limiting	 concentrations	 of	 macronutrients,	 expression	 of	
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AHL-controlled	 extracellular	 enzymes	 and	 secondary	 metabolites	 is	 unrelated	 to	 cell	density	 and	 instead	depends	on	whether	 the	 limiting	nutrient	 is	 a	 building	block	of	 the	secreted	products,	a	strategy	termed	“metabolic	prudence”	(Xavier	et	al.	2011;	Mellbye	and	Schuster	2014).		
The	evolutionary	stability	of	co-operativity	is	also	influenced	by	QS	regulation	of	private	goods.	 Growth	 on	 adenosine	 requires	 LasR-dependent	 expression	 of	 the	 cytoplasmic	enzyme	nucleoside	hydrolase	gene	(nuh)	(Heurlier	et	al.	2005).	Mutants	in	lasR	are	rapidly	eliminated	from	adenosine-enriched	medium	when	co-cultured	with	wild-type	bacteria,	i.e.	QS	regulation	of	a	private	good	penalizes	the	appearance	of	“social	cheats”	(Dandekar	et	al.	2012).		
There	is	growing	evidence	that	AHL	QS	may	coordinate	a	variety	of	additional	metabolic	strategies,	 including	 stress	 responses.	Working	with	 Burkholderia	 spp.,	 Goo	 et	 al.	 2012	showed	that	QS-dependent	production	of	excreted	oxalate	counteracts	ammonia-mediated	alkaline	 toxicity	 and	 is	 required	 for	 stationary	 phase	 survival	 (Goo	 et	 al.	 2012).	 One	interpretation	of	these	findings	is	that	QS	regulation	allows	the	bacterium	to	“anticipate”	stationary	phase	alkaline	toxicity.	Similarly,	AHL	QS	acts	as	a	“metabolic	brake”	in	the	rice	pathogen	 Burkholderia	 glumae,	 down-regulating	 glucose	 uptake,	 substrate	 level	 and	oxidative	phosphorylation,	and	de	novo	nucleotide	biosynthesis	as	the	bacterial	population	density	increases	(An	et	al.	2014).	It	is	argued	that	this	QS-regulated	slowing	may	serve	to	maintain	metabolic	homeostasis	under	crowded	conditions.		
1.3 Metabolomics	and	analysis	of	metabolic	
perturbations		
Metabolomics	refers	to	the	measurement	of	the	complement	of	small	molecule	metabolites	(the	metabolome)	of	an	organism,	tissue,	cell	or	biofluid,	in	a	broad	and	comprehensive	way	(Oldiges	 and	 Takors	 2005).	 Metabolism	 is	 context	 dependent:	 data	 from	metabolomics	experiments	can	be	used	to	characterize	the	impact	of	changes	in	a	biological	system	(e.g.	a	gene	 mutation	 in	 a	 metabolic	 pathway)	 and	 its	 environment	 (e.g.	 the	 available	 carbon	source)	upon	the	concentrations	and	fluxes	of	metabolites.		
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1.3.1 Considerations	regarding	sampling	protocols		
The	 protocols	 used	 for	 sampling	 cell	 cultures	 can	 have	 a	 large	 impact	 on	metabolomic	investigations.	 Two	 key	 aspects	 of	 the	 sampling	process	must	 be	 addressed	 in	 order	 to	ensure	that	measured	metabolite	concentrations	are	representative	of	in	vivo	metabolism:	i)	metabolic	reactions	should	be	arrested—“quenched”—efficiently,	ii)	metabolites	should	be	extracted	efficiently,	with	minimal	bias	and	leakage	from	the	cell.	Quenching/extraction	protocols	 may	 include	 addition	 of	 solvents,	 acids,	 application	 of	 high	 temperatures	 to	denature	 enzymes,	 or	 cold	 temperatures	 to	 slow	 chemical	 reactions.	 Hot	 and	 cold	quenching	can	both	result	in	artifacts	including	cellular	leakage,	however	cold	quenching	with	isotonic	saline	and	a	single	wash	step	has	been	found	to	result	in	low	contamination	from	the	supernatant	and	minimal	leakage	of	metabolites	from	the	cell	(Bolten	et	al.	2007).	The	 duration	 of	 the	 sampling	protocol	 is	 also	 an	 important	 factor:	 the	 turnover	 rate	 of	metabolites	 inside	 a	 cell—approximately	 equal	 to	 the	 concentration	 of	 the	 metabolite	divided	by	the	flux	through	the	pathway	of	which	it	is	a	member—can	be	less	than	1	second,	even	for	metabolites	present	in	mM	concentrations;	wash	steps	are	often	used	to	reduce	the	contamination	of	cellular	fractions	with	extracellular	metabolites	but	come	at	the	cost	of	additional	processing	time	and	so	increased	risk	that	metabolite	concentrations	will	depart	from	in	vivo	levels	through	metabolic	turnover	and	cellular	leakage.	Of	the	many	possible	extraction	methods,	methanol-cholorform	extraction	is	a	common	choice	because	it	results	in	i)	high	recovery	of	a	wide	range	of	metabolites	in	either	the	aqueous	or	organic	phases,	ii)	 high	 efficiency	 in	 inactivating	 enzymes,	 thereby	 minimising	 interconversion	 of	metabolites,	iii)	low	rates	of	degradation	of	metabolites	(cf	extraction	methods	using	high	temperature	or	extremes	of	pH)	(Belle	et	al.	2002;	Maharjan	and	Ferenci	2003;	Canelas	et	al.	2009).	
1.3.2 The	extracellular	metabolome	
Microorganisms	 secrete	 a	 large	 number	 of	 metabolites	 into	 their	 environment:	 these	include	 products	 of	 primary	 (e.g.	 uracil	 and	 xanthine,	 alcohols	 from	 fermentation)	 and	secondary	 metabolism	 (e.g.	 P.	 aeruginosa	 secretes	 phenazine,	 lipid	 and	 amino	 acid	secondary	metabolites).	These	activities	are	a	reflection	of	(intra-)	cellular	metabolism.	In	contrast	to	intracellular	metabolites,	secreted	metabolites	are	diluted	in	the	extracellular	space,	where	the	concentrations	of	metabolic	enzymes	are	also	much	lower:	the	turnover	rates	 of	 secreted	 metabolites	 are	 therefore	 lower	 and	 so	 can	 be	 accurately	 measured	without	 the	 added	 complications	 of	 quenching	 metabolism.	 This	 approach,	 by	 which	
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samples	of	culture	media	are	analysed	by	a	metabolomic	technique,	 is	termed	metabolic	footprinting	(Kell	et	al.	2005).	Such	methods	have	demonstrated	that	the	extracellular	(or	exo-)	metabolome,	in	reflecting	metabolite	uptake	from	and	secretion	into	the	extracellular	space,	can	be	used	to	investigate	perturbations	to	metabolism;	this	approach	has	been	used	to	 classify	 single-gene	 yeast	 mutants,	 investigate	 tryptophan	 metabolism	 in	 E.	 coli,	discriminate	between	the	modes	of	action	of	antifungal	compounds	and	examine	metabolic	adaptations	of	P.	aeruginosa	CF	lung	isolates	(Allen	et	al.	2003,	2004;	Kaderbhai	et	al.	2003;	Behrends	et	al.	2013).	Metabolomic	analysis	of	mammalian	biofluids	such	as	urine,	and	even	serum	and	plasma,	might	be	considered	equivalent	to	metabolic	footprinting;	such	analyses	have	of	course	been	used	widely	to	infer	the	metabolic	state	of	the	organism	in	question	(e.g.	in	the	case	of	diabetes)	(Atherton	et	al.	2006).	
1.3.3 Metabolomic	analysis	methods		
There	are	many	analytical	techniques	available	for	the	measurement	of	metabolites,	which	vary	in	their	sensitivities	to	different	classes	of	compounds,	their	detection	limits	and	their	capacity	 to	 resolve	 many	 compounds	 within	 complex	 mixtures.	 1H-nuclear	 magnetic	resonance	spectroscopy	(1H-NMR)	and	mass	spectroscopy	(MS)	are	the	most	widely	used	techniques	 in	 metabolomics.	 Datasets	 generated	 by	 metabolomics	 experiments	 contain	many	variables	(often	several	hundred	or	more):	multivariate	statistical	methods,	such	as	principal	components	analysis	(PCA),	are	valuable	tools	for	the	interpretation	of	this	data.		
1H-NMR	is	robust,	rapid	and	non-destructive.	An	1H-NMR	spectrum	consists	of	a	series	of	peaks	corresponding	to	the	chemical	shifts	of	protons	in	differing	electronic	environments	(i.e.	in	different	positions	within	a	compound,	or	in	different	compounds).	Each	compound	gives	 rise	 to	 a	 unique	 pattern	 of	 chemical	 shifts.	 The	 chemical	 shift	 patterns	 of	 a	 large	number	 of	 biological	 molecules	 have	 been	 reported	 making	 metabolite	 identification	relatively	 straightforward.	 1H-NMR	 spectroscopy	 has	 proved	 to	 be	 a	 valuable	 tool	 in	metabolomic	analysis	of	biofluids	and	is	used	routinely	in	the	Department	of	Biochemistry	for	metabolic	profiling	(Pears	et	al.	2005;	Atherton	et	al.	2006).		
Mass	spectrometric	analysis	techniques	can	be	many	times	more	sensitive	compared	to	1H-NMR	analysis	and	are	often	combined	with	prior	chromatographic	separation	to	improved	
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resolution	 of	 metabolites	 in	 complex	 mixtures. 1 	The	 GC-MS	 instrument	 used	 for	experiments	described	 in	this	dissertation	(a	Thermo	Electron	TraceGC	 fitted	 to	a	Trace	DSQ	single	quadrupole	mass	spectrometer,	Thermo	Scientific,	USA)	offers	an	approximately	ten-fold	 increase	 in	 sensitivity	 over	 1H-NMR	 and	 GC	 separation	 facilitates	 metabolite	resolution;	over	1000	metabolites	have	been	detected	in	Arabidopsis	thaliana	extracts	by	GC-MS	 (Nikiforova	 et	 al.	 2005).	 The	 DSQ	 mass	 spectrometer	 uses	 electron	 impact	 (EI)	ionisation	 and	 so	 metabolite	 identification	 can	 be	 semi-automated	 by	 reference	 to	 EI	ionisation	 spectra,	 such	 as	 those	 available	 in	 the	 National	 Institute	 of	 Standards	 and	Technology	(NIST)	mass	spectral	reference	library.		
One	 disadvantage	 of	 GC-MS	 is	 that	 detection	 is	 limited	 to	 those	 metabolites	 that	 are	sufficiently	volatile	to	enter	the	GC	column,	or	those	that	can	be	chemically	derivatised	to	increase	 their	 volatility	 beyond	 that	 threshold.	 Liquid	 chromatography	 (LC)-MS	 is	 not	limited	in	this	regard	and	so	is	capable	of	detecting	a	complementary	range	of	metabolites.	The	 QTof-MicroTM	 LCMS	 (Waters,	 USA)	 instrument	 used	 in	 experiments	 described	 in	Chapter	 6	 is	 capable	 of	 metabolite	 identification	 by	 accurate	 mass	 and	 neutral	 loss	fragmentation.		
1.3.4 Multivariate	data	analysis		
The	 number	 of	 variables	 in	 a	 metabolomics	 datasets	 is	 often	 more	 than	 an	 order	 of	magnitude	greater	than	the	number	of	samples.	Multivariate	statistical	methods	consider	all	 variables	 simultaneously	 and	 resolve	 correlated	 variation,	 thereby	 reducing	 the	dimensionality	 of	 the	 dataset	 and	 facilitating	 its	 interpretation.	 Principle	 components	analysis	 (PCA)	 is	 an	 unsupervised	 method	 commonly	 used	 to	 summarize	 variation	 in	multivariate	data	by	representing	correlated	variation	using	only	a	few	dimensions	(PCA	components).	PCA	components	are	orthogonal	to	each	other	and	therefore	explain	different	correlated	variation.	The	first	PCA	component	represents	the	largest	proportion	of	the	total	variation	in	the	dataset	and	each	subsequent	component	explains	progressively	less.		
																																																													
1	1H-NMR	has	been	used	with	chromatographic	separation,	but	this	still	has	the	disadvantage	of	low	sensitivity	relative	to	MS,	as	well	as	currently	being	low	throughput,	and	is	therefore	little	used	in	metabolomics.  
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Projection	to	latent	structures	through	partial	least	squares	(PLS)	is	a	supervised	regression	extension	of	PCA,	in	which	PCA	components	are	adjusted	(rotated	in	X	variable	space)	to	maximise	 covariance	 between	 dependent	 (X)	 and	 independent	 “response”	 (Y)	 variable	matrices.	PLS	thus	refines	PCA	components	to	better	explain	Y	variables.	PLS	Discriminant	Analysis	 (PLS-DA)	 is	 an	 extension	 of	 PLS	 that	 regresses	 against	 class	membership	 (e.g.	sample	type).	In	PLS-DA,	membership	of	a	class	is	represented	by	a	Y	variable	for	which	1	=	membership,	0	=	non-membership.		
PCA	 and	 PLS	 models	 have	 associated	 parameters	 that	 describe	 how	 they	 relate	 to	 the	underlying	data.	In	PCA	and	PLS,	R2X	is	the	fraction	of	total	variation	in	the	X	matrix	that	is	explained	by	a	PCA/PLS	component,	 this	can	be	summed	over	several	components	 for	a	measure	of	the	variation	explained	by	a	model.	Q2	is	the	fraction	of	variation	in	the	Y	matrix	that	can	be	predicted	by	a	PLS	component,	as	calculated	by	internal	cross-validation	(ICV).	Thus	Q2	is	a	measure	of	the	predictive	ability	of	a	model	and	is	indicative	of	the	probability	of	 an	 observed	 trend	 being	 reproducible	 (0	 signifies	 no	 better	 than	 chance,	 1	 is	 the	theoretical	maximum).	Values	of	Q2	over	0.80	are	typically	considered	to	indicate	excellent	predictability,	while	less	than	0.40	indicates	that	the	model	is	not	robust.	
1.3.5 Multiple	comparison	procedures	
In	inferential	statistics	the	“null	hypothesis”	describes	the	default	position	that	there	is	no	relationship	 between	 select	 variables.	 The	 p-value	 is	 the	 probability,	 under	 the	 null	hypothesis,	 of	 obtaining	 a	 result	 equal	 to	 or	more	 extreme	 than	 that	 actually	 observed.	Experimenters	often	choose	to	reject	a	null	hypothesis	if	a	calculated	p-value	is	smaller	than	a	predetermined	(though	ultimately	arbitrary)	value	α;	if	a	p-value	is	calculated	correctly,	this	guarantees	that	the	probability	of	incorrectly	rejecting	a	true	null	hypothesis—a	"false	discovery",	 or	 type	 I	 error—is	 at	 most	 α.	 If	 a	 calculated	 p-value	 is	 greater	 than	 α,	 the	experimenter	accepts	the	null	hypothesis:	incorrect	acceptance	of	the	null	hypothesis	is	a	type	II	error	(a	“false	negative”).	The	probability	of	a	type	II	error	occuring	determines	the	statistical	power	of	a	study:	statistical	power	is	the	probability	that	a	statistical	discovery	is	identified	when	the	null	hypothesis	is	false.		
Metabolomic	analyses	typically	involve	testing	many	null	hypotheses	simultaneously.		 	
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Table	1.1	illustrates	how	the	outcomes	of	multiple	tests	can	be	classified	according	to	the	accuracy	of	each	decision	to	accept	or	reject	the	null	hypothesis.	When	m	hypotheses	are	tested,	 the	 probability	 of	 at	 least	 one	 type	 I	 error	 (V)	 at	 a	 given	 α	 is	! ×α .	 Multiple	comparison	procedures	(MCPs)	have	been	developed	to	control	the	type	I	error	rate.	For	example	 the	 popular	 Bonferroni	 correction	 controls	 the	 family	wise	 error	 rate	 (FWER),	which	 is	 the	probability	 of	one	 or	more	 type	 I	 errors	 occurring	 in	 a	 family	 of	 tests:	 the	Bonferroni	 correction	 is	 performed	 by	 rejecting	 hypotheses	 for	 which	$ ≤ &' ,	 thereby	controlling	 the	 FWER	at ≤ α 	(Dunn	 1958,	 1961).	 The	 Bonferroni	 correction	 thereby	achieves	 stringent	 control	 over	 false	discoveries,	 although	 it	 results	 in	 a	 corresponding	reduction	in	statistical	power	($/012 = 	1 − 6'7,	where	T	=	number	of	type	II	errors).	
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Table	1.1	Classification	of	outcomes	from	multiple	hypothesis	tests.	If	we	reject	or	accept	m	null	hypotheses	then	the	outcomes	can	be	classified	into	count	variables	according	to	the	following	table.	For	example	V	=	number	of	type	I	errors	(“false	discoveries”),	T	=	number	of	type	II	errors	(“false	negatives”).	
	 Null	hypothesis	accepted	 Null	hypothesis	rejected	 Total	Null	true	 U	 V	 m0	Alternative	true	 T	 S	 m1	Total	 W	 R	 m	
An	alternative	approach	is	to	control	the	proportion	of	type	I	errors	amongst	all	rejected	null	
hypotheses,	termed	the	false	discovery	rate	(FDR).	By	controlling	for	FDR	rather	than	the	FWER,	the	statistical	power	of	the	analysis	can	be	increased.	Moreover,	controlling	the	FDR	is	experimentally	adaptable,	intuitive	and	scalable:	adaptable	because	alpha	can	be	varied	to	 make	 the	 procedure	 more	 or	 less	 conservative;	 intuitive	 and	 scalable	 because	 the	experimenter	 learns	 what	 proportion	 of	 all	 statistical	 discoveries	 are	 likely	 to	 be	 false	discoveries	 and	 can	 control	 the	 cost	 of	 further	 investigation	 accordingly.	Benjamini	and	Hochberg	(1995)	proposed	the	first	means	of	controlling	the	FDR,	using	a	step-up	p-value	method:	 for	 null	 hypotheses	89,8;,⋯ ,8' ,	 with	 probabilities	=9,=9,⋯ , =' ,	 i)	 find	>? ,	 the	largest	>	such	that	=@ ≤ @'A,	ii)	reject	null	hypotheses	89,8;,⋯ ,8@ .	This	controls	the	FDR	when	defined	as	the	expected	proportion	of	false	discoveries	among	all	rejected	hypotheses	times	 the	probability	 of	rejecting	at	 least	 one	hypothesis:	FDR = C DEF GH > 0KPr(H > 0).	Importantly,	Pr(R > 0)	is	close	to	1	for	many	relevant	datasets,	 including	those	analysed	using	this	method	in	this	dissertation.	The	Benjamini-Hochberg	step-up	procedure	controls	the	FDR	when	the	tests	are	independent	and	also	under	quite	general	conditions	of	positive	dependency	(Benjamini	and	Yekutieli	2001).	However,	like	the	Bonferroni	correction,	the	statistical	 power	 of	 the	 Benjamini	 and	 Hochberg	 procedure	 typically	 decreases	 as	 m	increases.	
A	 variation	on	 the	FDR	approach	 that	scales	well	 to	 large	 values	of	m	was	proposed	by	(Storey	2002).	This	approach	exploits	the	fact	that	for	studies	with	larger	values	of	m	we	have	more	information	about	the	distribution	of	p-values	and	can	use	this	to	estimate	the	number	of	true	null	hypotheses	(!P).	If	each	test	is	independent,	then	each	p-value	comes	from	 the	 null	 distribution	 (i.e.	 uniform[0,1])	 with	 probability	 QP ≡ 'S' 	and	 from	 the	alternative	distribution	with	probability	Q9 ≡ 1 − QP .	 Larger	p-values	 are	more	 likely	 to	
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have	come	from	the	null	distribution,	so	we	can	conservatively	estimate	QP	by	calculating	the	ratio	of	 the	observed	number	of	p-values	greater	 than	a	threshold	T	and	 the	number	expected	to	greater	than	T	if	all	p-values	were	from	the	null	distribution,	i.e.	QUP(T) = #{XYZ[}(9][)'.	This	approach	is	conservative	regardless	of	the	chosen	value	of	T.	However,	estimates	of	QP	using	low	values	of	T	are	biased	by	inclusion	of	alternative	distribution	whereas	higher	values	of	T	result	in	greater	variance	in	QUP	due	to	smaller	sample	sizes:	this	variance-bias	tradeoff	can	be	addressed	by	estimating	QPusing	a	bootstrap	approach	(Storey	et	al.	2004).	The	 Storey	method	 controls	 what	 has	 been	 termed	 the	 positive	 FDR	 (pFDR),	 a	 slightly	modified	version	of	the	FDR,	defined	as	pFDR = C DEF GH > 0K	and	also	allows	calculation	of	a	pFDR	analogue	of	the	p-value,	termed	the	q-value,	which	is	the	minimum	pFDR	at	which	the	 test	 is	 called	 significant.	This	 amounts	 to	 an	 intuitive	means	of	 controlling	 the	 false	discovery	rate	while	maintaining	statistical	power	for	studies	with	large	numbers	of	tests.		
1.4 Aims	of	the	present	work	
AHL	QS	systems	can	infer	and	integrate	valuable	information	about	a	bacterium’s	physical,	social	and	intracellular	environments.	Bacteria	use	this	information	to	coordinate	a	variety	of	 adaptive	growth	strategies	and	there	 is	 growing	 evidence	 that	 this	may	 involve	 close	coupling	between	AHL	QS	and	primary	metabolism.	Several	AHL-dependent	perturbations	to	P.	aeruginosa’s	primary	metabolism	have	been	identified	including	genes	in	the	“core”	QS	regulon,	but	it	is	difficult	to	draw	conclusions	without	measuring	the	metabolites	involved.	
The	 primary	 thesis	 motivating	 the	 present	 work	 is	 that	 the	 primary	 metabolism	 of	 P.	
aeruginosa	 is	tightly	coupled	to	its	AHL	QS	systems	and	that	a	metabolomic	analysis	will	provide	insight	into	a	relationship	overlooked	by	other	approaches.	The	approaches	taken	in	 investigating	 these	 relationships—metabolomic	 and	 proteomic—are	 hypothesis-generating,	in	that	they	provide	complex	multivariate	data	collected	with	the	expectation	that	they	will	stimulate	the	post-hoc	formulation	and	testing	of	hypotheses.	Nonetheless,	some	broad	hypotheses	can	be	stated	at	the	outset:	i)	the	las,	rhl	and	PQS	systems	convey	different	information	about	the	cellular	environment	and	regulate	distinct	regulons,	they	will	 therefore	 coordinate	 distinctive	 metabolic	 transformations;	 ii)	 the	 information	conveyed	 by	 QS	 systems	 relates	 to	 population	 density	 and	 associated	 environmental	stressors	 and	 so	 the	 effects	 of	 QS	 on	 metabolism	 will	 include	 adaptation	 to	 such	environments,	for	example	adaptations	to	stationary	phase	stresses.		
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Brief	descriptions	of	objectives	and	approaches	taken	to	investigate	these	relationships	are	outlined	below:	
Chapter	3	
• Validate	metabolic	footprinting	for	studying	QS,	including	determining	whether	QS	mutants	have	measurable	and	distinct	effects	on	primary	metabolism.		
• Investigate	 whether	 the	 metabolic	 impact	 of	 the	 antibiotic	 azithromycin	 is	consistent	with	inhibition	of	QS.	
Chapter	4	
• Analyse	 the	 temporal	 dynamics	 of	 AHL	 QS	 systems	 in	 batch	 culture,	 using	measurement	of	AHLs,	QS-regulated	transcripts	and	metabolic	footprinting.	
• Correlate	QS	system	activity	with	effects	on	metabolic	footprints.	
• Perform	 a	 targeted	 analysis	 of	 early	 post-exponential	 changes	 to	 primary	metabolism	by	measurement	of	cellular	small	molecule	metabolites	and	the	cellular	proteome.	
Chapter	5	
• Focused	analysis	of	the	impact	of	AHL	QS	on	fatty	acid	metabolism.	
Chapter	6	
• Focused	analysis	of	the	impact	of	AHL	QS	on	amino	acid	and	polyamine	metabolism.	
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Chapter	2 		Methods	
2.1 Chemicals,	solutions,	growth	media	
Table	2.1	Growth	media,	solutions.	
a	 Individual	 components	 were	 added	 from	 sterile	 components	 to	 the	 final	 indicated	 amounts.	 b	Solution	was	prepared	 fresh	and	dissolved	at	below	37	 °C	 in	order	 to	minimise	 the	 formation	of	cyanate	ions	from	urea	(which	react	with	primary	amines,	thereby	rendering	them	unavailable	for	reaction	with	iTRAQ	reagents).	c	Prepared	from	HPLC-grade	reagents.	Medium/Solution	 Composition	(per	litre	unless	otherwise	stated)	Growth	media	 	Luria	Broth	(LB)	 10	g	Tryptone	(Duchefa	Biochemie)		 5	g	NaCl	(Riedel-de	Haen)		 5	g	Yeast	extract	(Duchefa	Biochemie)	Luria	Broth	agar	 LB,	15	g	Bacto	Agar	AGS	a	 5	g	L-alanine	(>=98	%,	Fluka)		 5	g	NaCl	(Riedel-de	Haen)		 3	g	Potassium	phosphate	dibasic	(Sigma)		 1	mL	7.5	mM	ZnCl2		 1	mL	100	mM	CaCl2		 1	mL	5	mM	FeCl3		 10	mL	1	M	MgSO4		 10	mL	50	%	glycerol		 (adjust	to	pH	7.0	with	HCl	or	NaOH)	AGSY	a	 5	g	L-alanine	(>=98	%,	Fluka)		 5	g	NaCl	(Riedel-de	Haen)		 3	g	Potassium	phosphate	dibasic	(Sigma)		 3	g	Yeast	extract	(Duchefa	Biochemie)		 1	mL	7.5	mM	ZnCl2		 1	mL	100	mM	CaCl2		 1	mL	5	mM	FeCl3	
Methods	
26	
Medium/Solution	 Composition	(per	litre	unless	otherwise	stated)		 10	mL	1	M	MgSO4		 10	mL	50	%	glycerol		 (adjust	to	pH	7.0	with	HCl	or	NaOH)	Glycerol	stocks	 700	µl	culture		 300	µl	50	%	glycerol	PBS	 Phosphate	Buffered	Saline	tablets	(Oxoid),	pH	7.3.		 Final	concentration	g/l:	8	g	sodium	chloride,	0.2	g	potassium	chloride,	1.15	g	disodium	hydrogen	phosphate,	0.2	g	potassium	dihydrogen	phosphate	iTRAQ	 	CHAPS	lysis	buffer	 8	M	urea	hydrochloride,	4	%	(w/w)	CHAPS,	5	mM	magnesium	acetate,	10	mM	Tris	pH	8.0,	2	´	Roche	Complete	Mini	protease	inhibitor	Cocktail	tablets	(Roche),	1	mM	PMSF	iTRAQ	labelling	buﬀerb	 8	M	urea,	25	mM	triethylammonium	bicarbonate	(TEAB),	2	%	(v/v)	Triton	X-100,	0.1	%	(w/v)	SDS,	pH	8.5	Trypsin	for	iTRAQ	 200	µg/mL	solutions	were	prepared	fresh,	by	adding	100	µL	50	mM	TEAB	to	one	vial	of	sequencing	grade	Trypsin	(Promega)	SCX	buﬀer	Ac	 20	%	acetonitrile	(ACN)	and	10	mM	KH2PO4-H3PO4	(pH	2.7)	SCX	buﬀer	Bc	 1	M	KCl,	20	%	ACN	and	10	mM	KH2PO4-H3PO4	(pH	2.7)	RP	solvent	Ac	 0.1	%	(v/v)	Formic	acid,	5	%	ACN	RP	solvent	Bc	 0.1%	(v/v)	Formic	acid,	95	%	ACN		 	
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2.2 Bacterial	strains	and	growth	conditions.		
The	bacterial	strains,	plasmids	and	bacteriophage	used	in	this	study	are	listed	in	Table	2.2.	Experiments	 in	 Chapter	 3	were	 conducted	 using	wild-type	 PAO1	 (PAO1BI	 in	 Table	 2.2)	generously	provided	by	Barbara	Iglewski	(University	of	Rochester,	New	York),	PDO100	(a	
rhlI::Tn501-2	derivative	of	PAO1)	and	PAO-JP1	(a	lasI::Tet	derivative	of	PAO1)	and	MP551	(a	 pqsR::ISphoA/hah-Tc	 derivative	 of	 PAO1),	 a	 gift	 from	 Colin	 Manoil	 (University	 of	Washington	Center	for	Genome	Sciences,	Seattle,	USA).		
Experiments	in	0,	Chapter	5	and	Chapter	6	were	performed	using	wild-type	PAO1	(PAO1JM	Table	2.2)	and	a	 lasI	rhlI	mutant	derived	from	this	strain	(PAO1	ΔlasI::GmR	ΔrhlI::TetR	in	Table	2.2).	This	lasI	rhlI	mutant	was	constructed	“fresh”	using	previously	described	suicide	plasmids	(Beatson	et	al.	2002).	This	resulted	in	a	 lasI	rhlI	mutant	strain	with	insertional	inactivations	of	both	the	lasI	and	rhlI	signal	synthase	genes.	QS	mutants	of	P.	aeruginosa	are	known	to	accumulate	secondary	mutations	in	other	global	regulators,	e.g.,	vfr	or	algR.	To	ensure	that	the	double	mutant	was	otherwise	isogenic	with	the	wild-type	progenitor	and	to	reduce	the	possibility	of	unlinked	accrued	secondary	mutations	being	responsible	for	the	observed	metabotype(s),	 the	 relevant	markers	were	 transduced	 into	 a	 wild-type	 strain	using	bacteriophage	φPA3	as	described	by	(Monson	et	al.	2011)).		
Bacterial	 cultures	 were	 grown	 in	 alanine-glycerol-salts	 (AGS)	 (Chapter	 3)	 or	 alanine-glycerol-	salts	medium	supplemented	with	yeast	extract	(AGSY	medium,	Chapter	4,	Chapter	5	and	Chapter	6).	Specific	growth	rates	were	calculated	by	 linear	regression	 in	R	3.1	 (R	Development	 Core	 Team	 2008)	 by	 fitting	 log-transformed	 optical	 density	 at	 600	 nm	(OD600)	 data	 during	 the	 exponential	 portion	 of	 growth	 from	 0	 h	 to	 3	 h.	 Analysis	 of	covariance	(ANCOVA)	was	used	to	test	for	significant	differences	in	growth	rates.		
Planktonic	cell	cultures	were	prepared	by	washing	cells	from	overnight	cultures	in	fresh	medium,	 resuspending	 them	 to	 an	 OD600	 of	 0.05	 in	 50	 mL	 fresh	 medium,	 and	 then	incubating	them	in	500	mL	conical	flasks	at	37°C	with	vigorous	aeration	in	an	orbital	shaker	(300	rpm).		
Complementation	 assays	were	performed	using	synthetic	AHLs	(kindly	provided	by	Drs	James	Hodgkinson	and	David	Spring,	Department	of	Chemistry,	University	of	Cambridge,	United	 Kingdom).	 OdDHL	and	 BHL	were	 dissolved	 in	 dimethyl	 sulphoxide	 (DMSO)	 and	added	to	growth	media	at	final	concentrations	of	15	µM	and	10	µM,	respectively.	An	equal	volume	of	DMSO	was	added	to	both	AHL-complemented	and	non-complemented	cultures.		
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Table	2.2	Bacterial	strains,	plasmids	and	bacteriophage.	Identifier	 Relevant	genotype	or	phenotype	a	 Reference	or	source	
P.	aeruginosa	strains	
	 	
PAO1BI	 Wild-type	PAO1	from	laboratory	of	Barbara	Iglewski	(University	of	Rochester,	New	York)	 (Holloway	1969)	PAO-JP1	 A	lasI::Tet	derivative	of	PAO1		 (Pearson	et	al.	1997)	PDO100	 A	rhlI::Tn501-2	derivative	of	PAO1	 (Brint	and	Ohman	1995)	MP551	 A	pqsR::ISphoA/hah-Tc	derivative	of	PAO1		 (Gallagher	et	al.	2002)	PAO1JM	 Wild-type	PAO1	from	laboratory	of	John	S.	Mattick	(University	of	Queensland,	Australia)	 (Beatson	et	al.	2002)	PAO1	ΔlasI::	GmR	 PAO1	with	Gm	cartridge	inserted	into	unique	EcoRI	site	of	lasI	 This	study	PAO1	ΔrhlI::	TetR	 PAO1	with	Tc	cartridge	inserted	into	unique	EcoRI	site	of	rhlI	 This	study	PAO1	ΔlasI::GmR	ΔrhlI::TetR	 Double	mutant	generated	by	using	φPA3	to	transduce	(first)	the	TetR	marker	from	PAO1	ΔlasI::TetR,	and	(second)	the	GmR	marker	from	PAO1	ΔrhlI::GmR	to	PA01	 This	study	
E.	coli	strains	
	 	
S17-1	 thi	pro	hsdR	recA	chr::RP4-2	 (Farinha	and	Kropinski	1990)	JM109	 F´	traD36	proA+B+	lacIq	Δ(lacZ)M15/	Δ(lac-proAB)	glnV44	e14-	
gyrA96	recA1	relA1	endA1	thi	hsdR17	 (Swift	et	al.	1997)		
Plasmids	
	 	
pSB219.8A	 pRIC380	carrying	lasI::Gm	on	SpeI	fragment	from	pSB222.7A	 (Beatson	et	al.	2002)	pSB224.12B	 pRIC380	carrying	rhlI::Tc	on	SpeI	fragment	from	pSB224.8A	 (Beatson	et	al.	2002)	pSB536	 BHL	biosensor	 (Swift	et	al.	1997)	
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pSB1075	 OdDHL	biosensor	 (Winson	et	al.	1998)	pQF50	 Broad-host-range	transcriptional	fusion	vector;	Cbr	lacZ	incP	 (Farinha	and	Kropinski	1990)	pβ01	 pQF50	derivative	containing	lasB-lacZ	transcriptional	fusion	 (Ikeda	et	al.	2001)	pβ02	 pQF50	derivative	containing	rhlA-lacZ	transcriptional	fusion	 (Ikeda	et	al.	2001)	
Bacteriophage	
	 	
φPA3	 P.	aeruginosa	generalized	transducing	phage	 (Monson	et	al.	2011)	
a	Antibiotic	resistance	abbreviations:	Tc,	tetracycline;	Gm,	gentamicin
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2.3 AHL	bioassays	
The	biosensors	were	calibrated	using	standard	curves	of	synthetic	AHL	standards	in	fresh	growth	medium	and	responded	linearly	in	the	ranges	0.03-1	µM	for	BHL/JM109(pSB536)	and	0.1-3	µM	for	OdDHL/JM109(pSB1075).	Synthetic	OdDHL	and	BHL	(kindly	provided	by	Drs	 James	 Hodgkinson	 and	 David	 Spring,	 Department	 of	 Chemistry,	 University	 of	Cambridge,	 United	 Kingdom)	 were	 used	 to	 generate	 standard	 curves.	 Neither	 reporter	strain	generated	detectable	signal	in	response	to	their	noncognate	AHL.	
Sample	preparation:	Two	mL	samples	were	collected	from	bacterial	cultures	using	sterile	serological	pipettes	“Stripettes”	(Corning	Costar,	New	York,	USA).	Cells	and	cell	debris	were	removed	by	centrifugation	(6,000	×	g,	20	min,	4°C).	A	1.5-mL	aliquot	of	the	upper	part	of	the	 supernatant	 was	 ﬁltered	 (0.2-μm	 pore	 size)	 (Sartorius	 Minisart	 Sterile	 EO	 ﬁlters;	Sartorius	 AG,	 Göttingen,	 Germany),	 and	 1	mL	 of	 this	 aliquot	 was	 snap	 frozen	 in	 liquid	nitrogen	and	stored	at	-80°C.	
To	 quantify	 BHL,	 Escherichia	 coli	 JM109(pSB536)	 was	 grown	 overnight	 at	 37°C	 with	shaking	 in	LB	broth	 containing	50	μg/mL	 carbenicillin.	This	 overnight	 culture	was	 then	subcultured	into	LB	with	a	1:10	dilution.	Once	the	subculture	had	grown	to	an	OD600	of	0.5,	100	μl	was	transferred	to	a	96-well	sterile	white	opaque	microtiter	plate	(Greiner	Bio-One,	Germany)	containing	100	μl	sterile	supernatant	from	the	test	culture.	The	microtiter	plate	was	incubated	statically	at	30°C,	and	bioluminescence	readings	were	taken	after	3	h	using	a	luminometer	(Lucy1;	Anthos	Labtec	Instruments,	Austria).	The	same	protocol	was	used	to	monitor	OdDHL	with	the	following	modiﬁcations:	E.	coli	 JM109	(pSB1075)	was	grown	overnight	at	30°C	with	10	μg/mL	tetracycline	(Winson	et	al.	1998),	the	microtiter	plate	was	incubated	at	30°C,	and	bioluminescence	readings	were	taken	after	4	h	of	incubation.	
2.4 β-galactosidase	assays	
Transcriptional	activity	from	the	lasB	and	rhlA	promoters	was	assayed	using	promoter-lacZ	fusions.	The	plasmids	pQF50,	pβ01,	and	pβ02	(Table	2.2)	(kindly	supplied	by	Junichi	Kato,	Graduate	 School	 of	 Advanced	 Sciences	 of	 Matter,	 Hiroshima	 University,	 Japan)	 were	introduced	into	P.	aeruginosa	by	the	protocol	of	Choi	et	al.	(Choi	et	al.	2006).	Cultures	were	
Methods	
	
31	
grown	 in	50	mL	AGSY	medium	 (containing	250	µg/mL	 carbenicillin)	 at	 37°C	with	 good	aeration	(shaking	at	250	rpm).	β-Galactosidase	activity	was	measured	by	the	protocol	of	Ramsay	 et	 al	 (Ramsay	 2013).	 The	 ﬂuorogenic	 substrate	 4-methylumbelliferyl-β-D-galactoside	 (catalogue	 no.	 M1095;	 Melford)	 was	 used	 at	 a	 ﬁnal	 concentration	 of	 0.25	mg/mL.	 Fluorescence	was	measured	using	 a	 SpectraMax	Gemini	XPS	ﬂuorescence	plate	reader	(Molecular	Devices,	Sunnyvale,	CA)	as	follows:	360	nm	excitation;	450	nm	emission;	cutoff	435	nm;	reading	every	30	s	for	20	min	at	37°C.	β-Galactosidase	activity	was	calculated	as	 relative	 ﬂuorescence	 units	 (RFU)	 per	 second	 and	 normalized	 to	 the	 OD600	 of	 the	corresponding	sample.	
2.5 pH	measurements	
The	pH	of	culture	supernatants	was	measured	with	a	S20	SevenEasyTM	pH	meter	(Mettler-Toledo,	 Columbus,	 OH,	 United	 States),	 calibrated	 at	 the	 appropriate	 temperature	 with	standard	 solutions	 (pH	 7,	 4,	 and	 10)	 and	 according	 to	 the	manufacturer’s	 instructions.	Calibration	was	carried	out	before	and	after	the	experiments,	and	in	no	case	did	the	pH	of	the	calibration	solutions	differ	significantly	(0.05	U).	
2.6 	1H-NMR	spectroscopy	of	extracellular	
metabolites—“metabolic	footprints”	
Sample	preparation:	Two	mL	samples	were	collected	from	bacterial	cultures	using	sterile	serological	pipettes	“Stripettes”	(Corning	Costar,	New	York,	USA).	Cells	and	cell	debris	were	removed	by	centrifugation	(6,000	×	g,	20	min,	4°C).	A	1.5-mL	aliquot	of	the	upper	part	of	the	 supernatant	 was	 ﬁltered	 (0.2-μm	 pore	 size)	 (Sartorius	 Minisart	 Sterile	 EO	 ﬁlters;	Sartorius	AG,	Göttingen,	Germany)	and	snap	frozen	in	liquid	nitrogen.	One	mL	of	this	aliquot	was	dried	overnight	in	a	Speed	Vac	(Savant)	and	then	stored	at	-80°C.		
Dried	samples	were	reconstituted	in	600	μl	D2O	buffered	with	sodium	phosphate	(pH	7.0,	0.24	M)	supplemented	with	1	mM	sodium	3-trimethylsilyl-2,2,3,3-	tetradeuteriopropionate	(TSP)	(Cambridge	Isotope	Laboratories	Inc.,	Andover,	MA)	and	then	transferred	to	5-mm-internal-diameter	NMR	tubes	for	analysis.	Samples	were	analysed	using	a	Bruker	Avance	II
	spectrometer	operating	at	500.13	MHz	for	the	1H	frequency	(Bruker,	Coventry,	United	
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Kingdom)	 equipped	 with	 a	 5	 mm	 broad-band	 inverse	 probe	 (Bruker).	 Spectra	 were	acquired	 using	 a	 conventional	 solvent	 suppression	 pulse	 sequence	 based	 on	 a	 one-dimensional	 (1D)	nuclear	Overhauser	spectroscopy	(NOESY)	pulse	sequence,	which	was	used	 to	 saturate	 the	 residual	 water	 1H	 signal	 (Atherton	 et	 al.	 2006).	 The	 solvent	suppression	pulse	was	applied	during	the	relaxation	delay	(2	s)	and	mixing	time	(150	ms).	The	spin-lattice	relaxation	time	(T1)	was	3	s.	A	total	of	128	transients	were	collected	into	32,768	data	points	over	a	spectral	width	of	16.0	ppm	at	300K.	Spectra	were	processed	using	Advanced	Chemistry	Development	(ACD)	SpecManager	1D	NMR	processor	(version	8;	ACD	Inc.,	 Toronto,	 Canada).	 Spectra	were	multiplied	by	 an	 exponential	window	 function	 and	then	 Fourier	 transformed	 from	 the	 time	 to	 frequency	 domain	 (line	 broadening	0.3	Hz).	Spectra	were	phased,	baseline	corrected,	and	referenced	to	the	TSP	singlet	at	0	ppm,	and	integrated	between	0.1	and	4.45	ppm	and	4.60	and	9.60	ppm	over	a	series	of	0.01	ppm	integral	regions	(thereby	excluding	the	TSP	and	H2O	resonances).	Each	spectral	region	was	normalized	 to	 the	 integral	 of	 the	TSP	 singlet	 at	0	ppm.	 Spectral	 peaks	were	 assigned	 to	metabolites	by	comparison	with	chemical	standards	and	with	resonances	reported	in	the	literature	(1D	and	2D	spectra),	including	data	available	in	the	Human	Metabolome	Database	(www.hmdb.ca)	and	Biological	Magnetic	Resonance	Data	Bank	(www.bmrb.wisc.edu).	
2.7 GC-MS	analysis	
2.7.1 Sample	preparation	
Cellular	metabolites	were	extracted	using	a	modified	version	of	the	methanol-chloroform	extraction	described	by	(Atherton	et	al.	2006).	A	volume	of	bacterial	culture	equivalent	to	2.9	×	1010	viable	cells	was	pelleted	by	centrifugation	(5,000	×	g,	5	min,	4°C),	washed	twice	with	10	mL	of	0.9%	NaCl,	snap	frozen	in	liquid	and	stored	at	-80°C.	Cell	pellets	were	then	resuspended	in	900	μl	of	a	2:1	(v/v)	mixture	of	methanol	and	chloroform.	The	cells	were	further	disrupted	by	tip	sonication	(24	×	2.5	s	bursts	on	ice).	Chloroform	(300	μl)	and	water	(300	μl)	were	added,	and	the	samples	were	mixed	by	vortexing	(30	s).	Insoluble	material	was	pelleted	by	centrifugation	(6,000	×	g,	20	min)	before	the	aliquots	of	the	aqueous	(top)	or	organic	(bottom)	fractions	were	removed	for	analysis.	
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2.7.2 Instrumentation	
GC-MS	analysis	was	performed	using	a	Thermo	TraceGC	Ultra	coupled	to	a	Thermo	Trace	DSQ	single	quadrupole	mass	spectrometer	(Thermo	Scientific,	Waltham,	MA).	An	AS	3000	autosampler	 (Thermo	 Scientific),	 was	 fitted	 to	 facilitate	 sample	 handling.	 Gas	chromatography:	the	injector	temperature	was	230	°C,	the	carrier	gas	was	Helium	(1.2	mL	min-1	constant	flow).	Mass	spectroscopy:	full	scan	mode,	3	scans	s-1	across	a	range	of	50-650	m/z.	
2.7.3 Analysis	of	metabolites	in	aqueous	phase	extracts	
The	aqueous	(top)	fraction	(300	μl)	of	the	samples	prepared	as	in	section	2.7.1	was	removed	by	 pipetting	 and	 dried	 overnight	 in	 a	 Speed	 Vac	 concentrator	 (Savant).	 Aliquots	 of	 the	aqueous	 phase	 of	 chloroform-methanol	 cell	 extracts	 were	 derivatised	 first	 with	methoxyamine	hydrochloride	in	pyridine	(30	μl,	20	mg	mL-1	solution,	17	h,	22°C)	and	then	with	N-methyl-N-(trimethylsilyl)trifluoroacetamide	(MSTFA)	(30	μl,	1	h,	22°C).	An	aliquot	(50	μl	volume)	of	the	derivatised	sample	was	added	to	50	μl	hexane	before	analysis.	GC-MS	analysis	was	performed	using	a	Thermo	Trace	GC	Ultra	gas	chromatograph	coupled	to	a	Thermo	 Trace	 DSQ	 single	 quadrupole	mass	 spectrometer	 (Thermo	 Scientific,	Waltham,	MA).	 One	 microliter	 of	 the	 derivatised	 sample	 was	 injected	 onto	 a	 5%-phenyl-	 95%-dimethylpolysiloxane	Zebron	column	(30	m	[length]	by	0.25	mm	[internal	diameter];	0.25	μm	 film	 thickness	 [df])	 (Phenomenex,	 Inc.,	 Torrance,	 CA).	 A	 35-min	 chromatography	method	was	used	with	an	initial	temperature	of	70°C,	ramped	to	130°C	(10°C	min-1),	then	to	230°C	(5°C	min-1),	and	finally	to	310°C	(20°C	min-1).		
2.7.4 Analysis	of	fatty	acids	in	organic	phase	extracts	
Aliquots	 of	 the	 organic	 phase	 of	 chloroform-methanol	 cell	 extracts	 were	 dissolved	 in	chloroform-methanol	(1:1;	500	μl	volume)	and	boron	trifluoride	in	methanol	(10%;	125	μl	volume)	and	heated	to	-80°C	for	90	min	(Morrison	and	Smith	1964;	Atherton	et	al.	2006).	Samples	were	vortexed	with	deionized	water	 (200	μl)	and	hexane	(400	μl).	The	organic	(top)	layer	was	removed,	dried,	and	reconstituted	in	100	μl	hexane	prior	to	analysis.	Two	microliters	 of	 derivatised	 sample	was	 injected	onto	 a	100%	polyethylene	 glycol	 Zebron	column	(30	m	by	0.25-mm-internal	diameter;	0.25	μm	df)	(Phenomenex,	Inc.,	Torrance,	CA).	
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Analytes	 were	 separated	 using	 a	 38	 min	 chromatography	 method	 with	 an	 initial	temperature	of	60°C,	ramped	to	150°C	(10°C	min-1),	and	finally	to	230°C	(4°C	min-1).		
2.7.5 GC-MS	data	processing	
All	GC-MS	data	was	processed	using	Qual	Browser	and	Quan	Browser	of	Xcalibur	version	2.0	(Thermo	Scientific,	USA).	The	peaks	were	individually	integrated	and	normalized	to	the	total	peak	area	for	each	spectrum.	Metabolites	were	identified	by	comparison	of	retention	times	and	MS	fragmentation	patterns	with	in-house	reference	data	and	libraries	available	in	the	National	Institute	of	Standards	and	Technology	(NIST)	Mass	Spectral	Search	Program	(version	2.0).	Commercially	available	mixed	FAME	standards	were	used	to	aid	assignment	of	FAMEs	(food	industry	FAME	mix;	Sigma-Aldrich,	United	Kingdom).		
2.8 LC-MS	analysis	
2.8.1 Sample	preparation	and	derivatisation	
Cellular	metabolites	were	extracted	using	a	modified	version	of	the	methanol-chloroform	extraction	described	by	(Atherton	et	al.	2006).	For	the	analyses	described	in	this	chapter	300	µL	of	the	aqueous	(top)	fraction	was	removed	by	pipetting	and	dried	overnight	in	a	Speed	Vac	concentrator	in	30	µL	aliquots	(Savant).	The	order	of	samples	was	randomized	before	 being	 reconstituted	 in	 100	 µL	 phosphate-buffered	 saline	 (PBS)	 containing	homoarginine,	methionine-d3,	and	homophenylalanine	as	internal	standards.	The	internal	standard	(HARG,	MET-d3	and	HPHE)	concentrations	provided	with	the	EZ:faast	kit	were	too	high,	saturating	the	MS	detector;	this	was	also	the	case	for	the	concentrations	of	some	analytes	 in	 the	 bacterial	 extracts.	 The	 internal	 standards	 and	 bacterial	 extracts	 were	therefore	 diluted	 100-fold	 to	 reduce	 their	 responses	 to	 within	 the	 linear	 range	 of	instrument.	 Analytes	were	 then	 separated	 from	matrix	 components	 and	 chloroformate-derivatised	using	the	EZ:faast	amino	acid	analysis	(AAA)	MS	kit	(Phenomenex,	Torrance,	CA,	USA).	The	EZ:faast	kit	consists	of	i)	a	solid	phase	extraction,	in	which	analytes	are	first	concentrated	 onto	 a	 cation	 exchange	 sorbent	 before	 wash	 and	 elution	 steps	 separate	analytes	from	proteins,	salts	and	other	matrix	components,	ii)	a	liquid	phase	derivatisation	step	 with	 n-propyl	 chloroformate	 and	 n-propanol,	 using	 picoline	 as	 a	 catalyst,	 which	converts	 carboxylic	 groups	 to	n-propyl	 esters	 and	 amine	 groups	 to	 n-propyl	 carbamate	
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esters,	 iii)	a	 liquid/liquid	aqueous/organic	extraction	step,	during	which	 the	derivatised	analytes	are	extracted	into	an	organic	phase.	The	removed	organic	phase	was	dried	under	N2.	 Chemical	 reference	 standards	 for	all	analytes	were	 supplied	by	Phenomenex,	 except	agmatine,	 putrescine,	 spermidine,	 spermine	 and	 cadaverine,	 which	 were	 supplied	 by	Sigma-Aldrich	(USA).	
2.8.2 Liquid	Chromatography	
Liquid	 chromatography	 was	 performed	 as	 described	 by	 Ubhi	 et	 al.	 (2013).	 Following	extraction	and	derivatisation	using	the	EZ:faast	kit,	dried-down	analytes	were	reconstituted	in	100	µL	of	a	1:2	(v/v)	mixture	containing	10	mM	ammonium	formate	in	water	and	10	mM	ammonium	formate	 in	methanol.	Analytes	were	separated	using	a	Waters	Acquity	UPLC	system	 (Waters,	 United	 Kingdom).	 Sample	 aliquots	 of	 5	 µL	 were	 injected	 onto	 a	Phenomenex	EZ:faast	AAA-MS	column	(250	mm	×	2.0	mm)	held	at	25	°C.	The	eluents	were	1	mM	ammonium	formate	(Buffer	A)	and	10	mM	ammonium	formate	in	methanol	(Buffer	B).	The	EZ:faast	chromatographic	method	was	shortened	by	reducing	both	 the	run	 time	from	 21	 to	 15	 min	 and	 the	 equilibration	 time	 from	 4–7	 min	 to	 2	 min	 with	 no	 loss	 of	resolution	or	sensitivity	(credit	due	to	Baljit	Ubhi).	Analytes	were	eluted	using	the	following	gradient:	0–11	min	from	68	to	83%	Buffer	B,	11–11.01	min	83	to	68%	Buffer	B	and	11.01–13.00	 68%	 Buffer	 B.	 A	 system	 re-equilibration	was	 performed	 for	 2	min	 prior	 to	 each	injection.	A	constant	eluent	flow	of	0.25	mL/min	was	used	throughout	the	analysis.	After	each	 injection,	 a	 strong	 needle	 wash	 (83:17	methanol:water)	 and	 a	 weak	 needle	 wash	(10:90	methanol:water)	cycle	were	used	to	eliminate	carry-over.	Amino	acid	and	polyamine	standards	in	a	mixture	were	used	 to	create	an	11-point	calibration	curve	and	run	at	 the	beginning	and	end	of	the	analysis	(with	concentrations	of	target	analyte	spanning	the	range	0.5	nM	to	50	µM).	A	quality	control	(QC)	sample	was	run	every	ten	injections	to	allow	the	assessment	 of	 system	 reproducibility.	 The	 QC	 sample	 consisted	 of	 the	 three	 internal	standards,	HARG,	MET-d3	and	HPHE,	diluted	1:100.	A	pooled	QC	(pQC)	sample	was	created	by	combining	10	µL	from	each	sample,	then	processing	this	pool	as	per	a	standard	sample.	Pooled	QC	sample	(5	µL)	was	 injected	after	every	block	of	 ten	samples.	Blank	 injections	were	included	following	every	5	samples	in	order	to	monitor	for	any	carryover	between	samples.	
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2.8.3 Mass	Spectrometry	
Mass	 spectrometric	 data	 were	 collected	 using	 a	 Waters	 Quattro	 Premier	 XE	 Triple	Quadrupole	 mass	 spectrometer	 equipped	 with	 an	 electrospray	 source	 used	 in	 positive	ionisation	mode	(Waters,	Manchester,	UK).	The	source	temperature	was	set	to	120°C	with	a	cone	gas	flow	of	50	l/h,	a	desolvation	temperature	of	350°C	and	a	desolvation	gas	flow	of	700	l/h.	A	capillary	voltage	of	1000	V	was	applied.	The	optimal	MS	tuning	conditions	(e.g.	cone	voltage)	 for	 each	 analyte	derivative	m/z	are	usually	different,	 requiring	 individual	tuning	in	positive	ionisation	mode.	The	parent	mass	was	detected	to	two	decimal	places	and	fragmented	using	a	collision	gas	at	optimised	collision	energy.	The	resulting	daughter	ions	were	then	observed	using	a	daughter	scan	experiment.	At	least	one	unique	daughter	ion	was	selected	for	quantification	of	each	amino	acid	and	another	as	a	qualifying	ion	to	confirm	identification.	 A	 multiple	 reaction	 monitoring	 (MRM)	 method	 was	 then	 created	 using	specific	transitions	for	each	analyte	and	its	unique	fragment(s)	to	allow	quantification	for	all	of	the	analytes	in	one	method.	A	scan	time	of	5	ms	with	an	inter-scan	delay	of	5	ms	was	used	for	all	the	analyses.	For	each	amino	acid	to	be	considered	quantitative	at	least	15	data	points	 across	 the	 peak	 were	 required.	 Analytes	 detected	 by	 MS	 were	 compared	 with	authentic	standards	for	confirmation.		
Optimisation	of	the	MS	method	for	amino	acid	and	polyamine	derivatives	resulted	in	the	parent	and	product	ions	shown	in	Table	1.	Structural	isomers	with	the	same	parent	mass,	such	as	leucine	and	isoleucine,	were	distinguished	using	different	product	masses	and/or	resolved	by	liquid	chromatography.		
2.8.4 LC-MS	data	processing	
Raw	data	were	processed	using	Waters	QuanLynx	software	version	4.1	(Waters,	Milford,	MA,	USA).	QuanLynx	was	employed	to	quantitate	the	data	using	response	values	of	target	analytes	and	homophenylalanine	from	the	calibration	curves.	QuanLynx	output	includes	the	retention	 time	 and	 area	 under	 each	 peak	 for	 each	 detected	 metabolite	 (corrected	 for	background	noise).	From	the	total	ion	chromatogram	(TIC),	extracted	ion	chromatograms	(XICs)	were	generated	for	each	analyte	derivative.	Responses	were	calculated	relative	to	the	homophenylalanine	internal	standard,	and	concentrations	were	calculated	from	mean-averaged	calibration	curves	of	each	analyte	according	to	the	following	equations.	Alanine	concentrations	were	extremely	high,	several-fold	higher	than	glutamate.	It	seems	probable	
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that	this	corresponds	to	carryover	from	the	growth	medium	and	so	alanine	was	excluded	from	further	analysis.	
HPHE-normalised	responses	(RN)	for	target	analytes	were	calculated	as	!" = $$%&',	where	R	is	the	baseline-subtracted	area	of	the	target	analyte	peak	and	RHPHE	is	the	area	of	the	HPHE	peak	(internal	standard).	For	each	target	analyte,	a	curve	was	fitted	by	linear	least-squares	regression	to	the	linear	portion	of	log10-transformed	RN	values	from	calibration	curves	(as	per	Figure	6.3):	()*+,(!") = /	 ×	 ()*+,(2) + 4.	This	was	then	used	to	estimate	measured	concentrations	of	target	analytes	(CM)	in	the	cell	extracts.	Estimated	cellular	concentrations	(CCell)	 of	 target	analytes	were	 estimated	using	25677 = 28 	×	 9:;9<=>>	×	"<=>>? ,	where	VEx	 is	 the	volume	of	the	cell	extract	analysed	(50	µL),	VCell	is	the	typical	volume	of	a	P.	aeruginosa	cell	(2.2	fL)	(Cohen	et	al.	2015),	NCells	is	the	number	of	cells	harvested	(2.9	×	1010	viable	cells).	This	estimate	assumes	100%	extraction	efficiency	into	the	aqueous	phase	and	constant	cell	volume.	
2.9 Metabolomics	data	analysis	
The	order	of	all	samples	was	randomized	prior	to	data	acquisition	by	1H-NMR,	GCMS	and	LCMS.	 Unpaired	 Student’s	 t	 tests	with	 no	 equal-variance	 assumption	 (“Welch’s	 unequal	variance	t	test”)	were	used	to	calculate	univariate	statistical	significance	(Welch	1947).	The	Benjamini-Hochberg	step-up	procedure	(α	=	0.1)	was	applied	to	control	the	false	discovery	rate	 for	all	metabolomics	data	and	was	 implemented	using	the	“p.adjust”	 function	in	R’s	“stats”	package	(Benjamini	and	Hochberg	1995;	R	Development	Core	Team	2008).		
Principal	component	analysis	(PCA)	and	partial	least	squares	analysis	(PLS)	was	performed	using	SIMCA-P	11.5	(Umetrics,	Umeå,	Sweden).	NMR	footprinting	data	was	Pareto	scaled	before	PCA	analysis:	each	variable	was	mean	centred	and	then	multiplied	by	1/Sk,	where	
Sk	 is	 the	 standard	 deviation	 of	 the	 variable.	 This	 scaling	 increases	 the	 contributions	 of	variables	with	 low	means	 to	 the	model,	without	 introducing	 excessive	 noise.	Metabolic	perturbations	 were	 identified	 by	 analysis	 of	 the	 corresponding	 loadings	 plots.	 The	robustness	of	all	PCA	models	was	assessed	using	R2	values	(i.e.,	 the	 fraction	of	variance	explained	 by	 the	 components).	 Where	 glog	 transformations	 were	 applied,	 this	 was	implemented	using	the	Bioconductor	“LMGene”	R-package	(Rocke	et	al.	2013).	
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2.10 iTRAQ	proteomics 
2.10.1 Sample	preparation 
Twelve	biological	samples	(2	genotypes	´	2	OD600	values	´	n	of	3)	and	4	pooled	standards	were	differentially	labelled	and	analysed	in	two	MS/MS	experiments	as	follows:	Cells	were	harvested	from	planktonic	bacterial	cultures	as	for	the	metabolomic	analyses,	but	with	the	following	 volumes:	 40	 mL	 at	 OD600	 1.5,	 13.33	 mL	 at	 OD600	 4.5.	 Cells	 were	 pelleted	 by	centrifugation	 (3220	 ´	 g,	 15	 min,	 4°C),	 washed	 in	 PBS	 (10	 mL,	 4°C),	 pelleted	 by	centrifugation	(3220	´ 	g,	15	min,	4	°C),	the	supernatant	carefully	removed	and	the	cell	pellet	snap	frozen	in	liquid	N2.	Pellets	were	 thawed	on	 ice	while	 they	were	simultaneously	resuspended	 in	CHAPS	 lysis	buffer	 (Table	 2.1).	 Cells	 were	 transferred	 to	 2	 mL	 microcentrifuge	 tubes	 and	 lysed	 by	sonication	(3	´	10	s,	MSE	microtip,	on	ice).	Cell	debris	and	insoluble	protein	was	pelleted	by	two	rounds	of	centrifugation	(the	supernatant	was	 transferred	 to	clean	 tubes	after	each	round):	1)	16,060	´	g,	10	min,	4°C,	2)	100,000	´	g,	1	hr,	4	°C.	Proteins	were	precipitated	in	acetone:	6	´	 supernatant	volume	of	acetone	at	4°C	was	added	and	proteins	precipitated	overnight	at	-20°C.	Precipitated	protein	was	pelleted	by	centrifugation	(3220	´	g,	20	min,	4°C)	and	the	acetone	decanted.	The	clean	protein	pellets	were	dissolved	in	200	µL	freshly	prepared	 iTRAQ	 labelling	 (Table	2.1).	 Sonication	was	used	 to	 improved	 resuspension	of	protein	 (2	´	 5	 s	 pulses,	 on	 ice)	 and	 the	protein	 solution	was	 clarified	by	 centrifugation	(16,060	´	g,	5	min,	10°C).	Protein	concentrations	were	measured	in	duplicate	using	the	BCA	Protein	Assay	Reagent	kit	(Pierce)	before	diluting	with	labelling	buffer	to	5	mg/mL.	Pooled	standard	 was	 prepared	 at	 this	 stage	 by	 combining	 equal	 volumes	 of	 all	 12	 biological	samples.	 The	 pooled	 standard	 was	 then	 divided	 into	 4	 aliquots	 that	 were	 prepared	 in	parallel	to	the	individual	biological	samples.	Protein	(100	µg,	20	µL)	from	each	sample	was	reduced,	 alkylated,	 digested	 and	 differentially	 labelled	 with	 8-plex	 iTRAQ	 reagents	 per	manufacturer’s	instructions	(Applied	Biosystems):		
1) Reduction:	 disulphide	 bonds	 were	 reduced	 by	 adding	 2	 µL	 tris-(2-carboxyethyl)phosphine	 (TCEP),	 vortex	 mixing,	 then	 incubating	 on	 a	 shaker	 at	room	temperature	for	1	hr.	
2) Alkylation:	 cysteine	 sulphydryls	 were	 blocked	 by	 adding	 1	 µL	 methyl	methanethiosulphonate	 (MMTS),	 vortex	mixing,	 then	 incubating	 on	 a	 shaker	 at	room	temperature	for	10	min.	
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3) Digestion:	samples	were	diluted	to	below	1	M	urea	(to	prevent	inhibition	of	trypsin)	by	diluting	samples	1:10	with	50	mM	TEAB	(i.e.	added	180	µL	50	mM	TEAB),	added	12.5	µL	200	µg/mL	Trypsin	in	50	mM	TEAB,	vortex	mixed,	and	incubated	for	1	hr	at	37°C.	The	trypsin	digestion	was	repeated	(adding	a	further	12.5	µL	200	µg/mL	Trypsin	in	50	mM	TEAB,	incubated	1	hr	at	37°C),	then	again	overnight	(12.5	µL	200	
µg/mL	Trypsin	in	50	mM	TEAB,	incubated	16	hr	at	37°C). 	
4) Labelling:	insoluble	parts	were	removed	by	centrifugation	(16,000	´	g,	5	min),	the	supernatant	 from	which	was	dried	 in	an	evacuated	centrifuge	(Eppendorf)	 then	resuspended	in	25	µL	1	M	TEAB	and	60	µL	isopropanol,	vortex	mixed	for	1	min,	transferred	to	 the	appropriate	 labelling	vial	 (Table	2.3),	vortex	mixed	 for	2	min,	incubated	 for	2	hr	shaking	at	room	temperature.	Residual	 iTRAQ	reagents	were	hydrolysed	by	adding	100	µL	H2O	and	incubating	at	room	temperature	on	a	shaker	for	2	hr.	Samples	were	then	pooled,	vortex	mixed,	and	dried	using	an	evacuated	centrifuge.		
Table	2.3	Experimental	design	for	iTRAQ	labelling.	
a	Pooled	Standard,	consisting	of	equal	parts	of	each	of	the	12	biological	samples	(OD600	label	does	not	apply	to	pooled	standards).	
OD600	 MS/MS	reporter	ion	113	 114	 115	 116	 117	 118	 119	 121	1.5	 ΔlasI	ΔrhlI	 PAO1	 ΔlasI	ΔrhlI	 PSa	 PAO1	 ΔlasI	ΔrhlI	 PSa	 PAO1	4.5	 ΔlasI	ΔrhlI	 PAO1	 ΔlasI	ΔrhlI	 PSa	 PAO1	 ΔlasI	ΔrhlI	 PSa	 PAO1	
Strong	cation-exchange	chromatography	of	iTRAQ-labelled	peptides 
iTRAQ-labelled	peptides	were	fractionated	by	cation-exchange	chromatography	(SCX)	on	a	PolySULFOETHYL	ATM	(poly[2-sulphoethyl	aspartamide]-silica)	column	(PolyLC,	Columbia,	MD;	2.1	´	200	mm,	5	µm,	300	Å)	using	BioLC	HPLC	system	(Dionex).	Immediately	before	sample	application,	BSA	digest	(40	µl	of	10	mg/mL	BSA	in	iTRAQ	labelling	buffer	added	to	280	µl	of	10	%	ACN,	50	mM	TEAB	and	digested	with	2.5	µg	trypsin	overnight)	was	run	to	test	the	separating	conditions	of	the	column	before	each	run.	The	iTRAQ-labelled	peptides	samples	were	resuspended	in	5	mL	of	SCX	buffer	A	and	pH	of	the	samples	adjusted	to	2.7	using	phosphoric	 acid	 (to	 increase	protonation	of	peptides	 for	 thus	 their	binding	 to	 the	column).	Samples	were	loaded	onto	the	column	and	washed	with	SCX	buffer	A	at	200	µl/min	
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for	1	hr,	to	remove	detergents	and	free	iTRAQ	reagents.	Peptides	were	eluted	using	a	70	min	linear	gradient	of	SCX	buffer	B	at	200	µL/min.	Sixty	fractions	were	collected	at	2	min	intervals	and	lyophilized	using	an	evacuated	centrifuge.	
Desalting	SCX	fractions 
Lyophilised	SCX	fractions	were	desalted	prior	to	MS	analysis	using	UltraMicro	Spin	Columns	(The	Nest	Group,	MA,	USA).	The	columns	were	conditioned	by	spinning	them	twice	with	100	µl	100	%	ACN	(1500	´	g,	1	min)	and	twice	with	100	µl	of	0.1	%	formic	acid	(1500	´	g,	1	min).	 SCX	 fractions	were	 resuspended	 in	0.1	%	 formic	 acid	 then	 loaded	onto	 a	 column,	washed	twice	with	100	µl	0.1	%	formic	acid	(1500	´ 	g,	1	min,	to	remove	salt).	Finally,	iTRAQ-labelled	peptides	were	eluted	in	100	µl	80	%	methanol	,	0.1	%	formic	acid	(1500	´	g,	1	min).	
LC-MS/MS	analysis	of	SCX	fractions 
	Cleaned	 and	 desalted	 SCX	 fractions	 were	 separated	 on	 an	 Ultimate	 nano-LC	 system	(Dionex)	coupled	to	a	QSTAR	XL	QTOF	mass	spectrometer	(Applied	Biosystems).	Prior	to	sample	 application,	 a	 phosphorylase	 b	 standard	 test	 was	 performed	 according	 to	 the	manufacturer’s	protocol	in	order	to	verify	chromatographic	conditions.	The	fractions	were	resuspended	in	HPLC-grade	water	with	0.1	%	(v/v)	formic	acid	loaded	onto	an	Acclaim	PA	C16	trap	column	(5	mm	x	300	µm	ID,	Dionex)	at	20	µl/min	using	a	FAMOS	autosampler	(Dionex).	The	trap	was	washed	for	25	min	with	RP	solvent	A	and	then	peptides	were	eluted	onto	a	PepMap	C18	analytical	column	(15	cm	×	75	µm	ID,	Dionex)	at	150	nL/min	with	265	min	gradient	of	0–95	%	RP	solvent	B	and	 ionized	via	2,000	V	applied	 to	a	distal	coated	PicoTip	electrospray	needle	(10	µm	tip	ID,	New	Objective).	The	QSTAR	XL	was	operated	in	Information-Dependent	Acquisition	(IDA)	mode	whereby	a	1	s	survey	scan	(m/z	400	to	1600)	was	used	to	select	2	precursor	ions	(highest	counts	per	second	with	charge	states	of	+2	or	+3	in	range	100-1580	m/z).	A	ten	minute	dynamic	exclusion	of	precursor	ions	with	the	repetitive	m/z	value	was	applied.	
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2.10.2 iTRAQ	data	processing	 
Peptide	identification 
	QSTAR	XL	raw	data	 files	(.wiff	 files)	resulting	 from	all	LC-MSMS	analyses	of	 the	 iTRAQ-labelled	 cation	 exchange	 fractions	 were	 converted	 using	 wiff2dta	 v.	 1.0.97	 software	(http://sourceforge.net/projects/protms/)	 into	 two	 types	 of	 text	 files	 (.txt	 files):	centroided	and	uncentroided	peak	lists.	Centroided	peak	lists	contained	the	m/z	value	and	ion	counts	corresponding	to	the	centre	of	every	ion	peak	which	was	present	in	each	product	ion	 spectrum.	 Uncentroided	 peak	 lists	 contained	 the	m/z	 values	 and	 ion	 counts	 for	 the	entire	peaks.	Next,	the	Mascot	v.	2.0.01	software	(Matrix	Science)	was	used	to	assign	peptide	sequences	to	product	ion	spectra	by	searching	the	centroided	peak	lists	against	the	MIPS	(Munich	Information	Center	for	Protein	Sequences)	Pseudomonas	aeruginosa	database.	The	following	 parameters	 of	 Mascot	 searches	 were	 used:	 trypsin	 specificity,	 one	 missed	cleavage,	 fixed	 iTRAQ-8plex	 (K),	 fixed	 iTRAQ-8plex	 (N-term),	 fixed	 MMTS	 (C),	 variable	oxidation	(M),	variable	iTRAQ-8plex	(Y),	ESI-QUAD-TOF	fragmentation,	2.0	Da	window	for	precursor	ion	mass	and	0.8	Da	for	fragment	ions.	Each	centroided	peak	list	was	searched	again	using	the	Mascot	algorithm	with	the	same	parameters	as	above	but	against	a	nonsense	version	of	the	relevant	sequence	database,	which	was	created	by	reversing	the	order	of	the	amino-acid	sequences	for	each	protein	so	that	the	C	termini	became	the	N	termini.	Database	reversal	 was	 achieved	 by	 using	 the	 fasta_flip.pl	 Perl	 script	 (Matrix	 Science).	 For	 every	proteomics	 experiment,	 a	 separate	 MySQL	 database	 (MySQL	 v.	 4.0;	 MySQL	 AB;	http://www.mysql.org)	 was	 created.	 Ultimately,	 the	 peptide	 identification	 and	 scoring	information	from	Mascot	output	files	(.dat	files)	were	transferred	to	the	relevant	MySQL	databases	using	the	xGAPP.pl	Perl	script	(Shadforth	et	al.	2006).	
Peptide	quantitation 
Based	on	the	uncentroided	peak	lists	generated,	the	xITRACKER.pl	Perl	script	(Shadforth	et	al.	2005)	was	used	to	calculate	the	areas	under	the	reporter	ion	peaks	in	every	product	ion	spectrum	 and	 to	 transfer	 this	 quantitation	 information	 into	 the	 appropriate	 MySQL	database.	 The	 areas	 under	 the	 peaks	 were	 calculated	 using	 trapezoid	 approximation,	corrected	for	isotope	impurities	(based	on	the	purity	correction	factors	supplied	with	every	iTRAQ	kit	by	its	manufacturer)	and	normalized	to	one	by	dividing	the	value	of	area	by	the	sum	of	all	reporter	ion	areas	in	a	MS/MS	spectrum.	
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Grouping	peptides	into	proteins 
Data	 was	 processed	 according	 to	 (Sadowski	 et	 al.	 2006).	 SQL	 scripts	 were	 used	 to	communicate	with	 the	 relevant	MySQL	database	 (4.5.1)	 in	order	 to	determine	 a	Mascot	score	threshold	application	and	limit	the	number	of	false	positive	identifications	in	the	final	results	table	to	a	maximum	of	1%.	This	was	performed	by	creating	the	tables	in	each	MySQL	database	containing	the	highest	scoring	version	of	every	peptide	identified	in	the	forward	and	reversed	sequence	database	searches.	Peptides	were	next	grouped	into	proteins	and	the	numbers	of	proteins	identified	from	the	forward	and	reversed	database	searches	using	different	peptide	Mascot	score	values	were	determined	(this	was	performed	separately	for	proteins	 identified	by	single	and	multiple	peptides).	The	 false	protein	 identification	rate	was	then	calculated	by	dividing	the	number	of	protein	 identifications	 from	the	reversed	database	 search	 by	 the	 number	 of	 identifications	 from	 the	 normal	database	 search	 and	multiplying	 it	by	100.	The	Mascot	score	 threshold	was	calculated	as	 the	 first	ratio	value	below	1%.	Next,	an	SQL	script	was	used	to:	(i)	apply	thresholds	for	peptide	identification	and	 peptide	 quantitation;	 (ii)	 link	 the	 identification	 information	 with	 the	 quantitation	information	about	each	single	peptide;	(iii)	to	group	peptides	into	proteins;	(iv)	quantitate	these	proteins.	Grouping	peptides	into	proteins	was	performed	as	follows:	in	cases	where	more	 than	 one	 peptide	 was	 assigned	 to	 a	 single	 MSMS	 spectrum,	 the	 highest	 scoring	assignment	was	chosen;	in	cases	where	more	than	one	MS/MS	spectrum	was	assigned	to	a	single	peptide,	only	the	highest	scoring	assignment	was	processed	and	for	the	calculation	of	Mascot	score	in	the	final	results	table.	For	peptide	identification,	the	threshold	that	was	applied	 was	 equal	 to	 the	 Mascot	 score	 threshold	 calculated	 above.	 This	 threshold	 was	applied	separately	to	proteins	identified	by	single	and	multiple	peptides.	Additionally,	the	requirement	of	at	least	one	unique	peptide	sequence	to	be	identified	per	protein	(unique	peptides	threshold)	was	applied	as	well	as	the	requirement	of	at	least	two	distinct	peptide	sequences	(distinct	peptides	threshold)	based	on	the	general	agreement	in	the	field	that	to	claim	the	presence	of	a	protein	in	a	sample,	the	detection	of	at	least	two	distinct	peptides	is	needed.		
For	protein	quantitation,	following	rules	were	applied:		
1. Intensity	 threshold:	 only	 MS/MS	 spectra	 of	 iTRAQ	 reporter	 ions	 with	 intensity	values	above	15	ion	counts	were	used	for	quantitation; 
2. Missing	value	threshold:	among	the	MS/MS	spectra	selected	for	quantitation,	the	maximum	intensity	of	only	one	iTRAQ	reporter	ion	was	permitted	to	fall	below	the	previously	mentioned	iTRAQ	reporter	ion	intensity	threshold; 
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3. Mascot	score	threshold:	only	MS/MS	spectra	assigned	to	a	protein	sequence	with	Mascot	 score	 20	 were	 used	 for	 protein	 quantitation;	 these	 included	 redundant	sequences	assigned	to	proteins	more	than	once;	 
4. Non-unique	 peptide	 threshold:	 which	 meant	 that	 all	 the	 homologous	 peptides	assigned	to	more	 than	one	protein	were	discarded	 from	the	quantitation	if	more	than	one	such	protein	was	listed	in	the	final	results	table.	 
For	quantitation	of	proteins,	the	arithmetic	average	and	percentage	standard	deviation	was	calculated	from	the	area	under	the	curve	of	normalized	iTRAQ	reporter	ions	in	all	spectra	assigned	to	a	single	protein.	The	final	lists	of	proteins	were	generated	as	Apro,	Bpro	and	ABpro	MySQL	tables	which	were	exported	into	text	files	for	differential	statistical	analysis	in	R.	Data	was	pre-filtered	 for	proteins	with	data	 for	at	 least	2	peptides.	The	number	of	proteins	detected	with	these	constraints	were	931	in	total,	870	at	OD1.5	and	700	at	OD4.5.	
Multiple	comparison	procedure	
Unpaired	Student’s	t	tests	with	no	equal-variance	assumption	(“Welch’s	unequal	variance	t	test”)	 were	 used	 to	 calculate	 univariate	 statistical	 significance	 (Welch	 1947).	 The	 false	discovery	 rate	 was	 controlled	 using	 the	 Bioconductor	 “q-value”	 R-package	 to	 estimate	Storey’s	q-values;	@,	was	estimated	using	the	automatic	“bootstrap”	method	and	validated	by	manual	 inspection	 of	plots	 of	A	versus	@B,(A)	and	p-value	 density	 histograms	 (Storey	2002;	Storey	et	al.	2004,	2015).	
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Chapter	3 		Pilot	study:	Use	of	metabolic	footprinting	to	assess	the	effects	of	Quorum	Sensing	and	azithromycin	
3.1 Introductory	comments	
Studying	the	dynamics	of	P.	aeruginosa	QS	and	metabolism	in	batch	culture	requires	the	analysis	of	bacterial	cultures	throughout	the	growth	curve.	Metabolic	footprinting	by	1H-NMR	has	the	potential	to	facilitate	such	analysis,	since	the	technique	requires	small	sample	volumes	and	minimal	sample	preparation.	This	chapter	describes	efforts	to	evaluate	 the	feasibility	 of	 such	 an	 approach.	 I	 investigate	 the	 range	 of	 exometabolites	 that	 can	 be	monitored	by	 1H-NMR	analysis	 and	whether	 these	metabolites	are	modulated	 in	strains	with	inactivating	transposon	insertions	in	the	QS	genes	lasI,	rhlI	and	pqsR.		
This	 study	 is	 extended	with	 an	 analysis	 of	 the	 impact	 of	 sub-MIC	 concentrations	 of	 the	macrolide	 antibiotic	 azithromycin	 (AZN)	 on	 the	 P.	 aeruginosa	 exometabolome.	 The	symptoms	of	CF	and	diffuse	panbronchiolitis	(DPB)	include	chronic	airflow	limitation	and	airway	 inflammation,	 rendering	 patients	 highly	 susceptible	 to	 chronic	 endobronchial	infection	 by	 P.	 aeruginosa.	 P.	 aeruginosa	 infection	 is	 associated	 with	 progressive	deterioration	 in	 lung	 function,	 and	 in	 a	 high	 proportion	 of	 cases	 eventually	 leads	 to	respiratory	 failure	 (Boucher	 2004).	 Aggressive	 antibiotic	 therapy	 fails	 to	 eradicate	 P.	
aeruginosa	infections	from	CF	and	DPB	patients	and	so	strategies	to	reduce	tissue	damage	and	slow	disease	progression	are	wanted.	AZN	 is	 thought	 to	 inhibit	bacterial	growth	by	blocking	the	peptide	exit	channel	of	23S	rRNA	 in	the	50S	ribosomal	subunit	and	several	clinical	studies	have	found	that	treatment	with	AZN	improves	clinical	parameters	of	DPB	and	 CF	 lung	 diseases	 (Hansen	 et	 al.	 2005;	 Marvig	 et	 al.	 2012).	 This	 is	 in	 apparent	contradiction	 with	 AZN	 acting	 via	 its	 established	 mechanism	 of	 inhibition	 of	 protein	synthesis	via	the	50S	ribosomal	subunit,	since	minimum	inhibitory	concentrations	(MIC)	of	AZN	 for	 clinical	 P.	 aeruginosa	 isolates	 are	 typically	 an	 order	 of	 magnitude	 higher	 than	clinically	achieved	sputum	concentrations:	Howe	and	Spencer	(Howe	and	Spencer	1997)	report	MICs	in	the	range	128	to	512	μg/mL;	Baumann	et	al.	(Baumann	et	al.	2004)	report	
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typical	sputum	concentrations	of	0.6	to	79.3	μg/mL.	Sub-MIC	concentrations	of	AZN	have	been	reported	to	inhibit	virulence	factor	expression,	motility	and	biofilm	formation	in	P.	
aeruginosa	 (Molinari	 et	 al.	 1993;	 Favre-Bonté	 et	 al.	 2003;	 Gillis	 and	 Iglewski	 2004;	Hoffmann	et	 al.	 2007;	Tsai	 et	 al.	 2009).	The	 association	of	 these	phenotypes	with	QS—especially	expression	of	secreted	virulence	factors—spurred	the	hypothesis	that	sub-MIC	AZN	may	act	by	inhibiting	QS	(Tateda	et	al.	2001;	Nalca	et	al.	2006;	Kai	et	al.	2009).	Indeed,	sub-MIC	AZN	inhibits	synthesis	of	AHLs	and	transcription	of	the	AHL	synthases	lasI	and	rhlI	(Tateda	 et	 al.	 2001;	 Kai	 et	 al.	 2009).	 A	 study	 combining	 transcriptomic	 and	 proteomic	analyses	found	that	2	μg/mL	AZN	affect	the	expression	of	8	out	of	77	genes	(10.4%)	of	the	“general	quorum	sensing	regulon”	(genes	that	have	been	identified	as	QS-regulated	in	three	recent	microarray	studies	of	P.	aeruginosa	quorum	sensing),	as	well	as	a	number	of	genes	involved	 in	protein	 synthesis	 (e.g.	 ribosomal	 subunits,	 initiation	and	elongation	 factors)	(Arevalo-Ferro	et	al.	2003;	Schuster	et	al.	2003;	Wagner	et	al.	2003;	Nalca	et	al.	2006).	These	authors	(Nalca	et	al.)	interpreted	their	data	as	being	in	support	of	the	hypothesis	that	AZN	interferes	 with	 QS.	 I	 investigate	 whether	 the	 metabolic	 footprints	 of	 AZN-treated	 P.	
aeruginosa	support	this	hypothesis.		
Aims	and	objectives:	First,	to	validate	metabolic	footprinting	for	studying	QS,	including	determining	 whether	 QS	 mutants	 have	 measurable	 and	 distinct	 effects	 on	 primary	metabolism.	 Second,	 to	 investigate	 whether	 the	 metabolic	 impact	 of	 the	 antibiotic	azithromycin	is	consistent	with	inhibition	of	QS.	The	power	of	statistical	analyses	to	detect	significant	 features	can	be	heavily	 influenced	by	the	choice	of	pre-processing	operations	and	their	parameters;	 In	the	course	of	 these	 experiments	 I	also	 identify	parameters	and	metrics	for	reliable	multivariate	analysis	of	1H-NMR	metabolic	footprinting	data.	
Part	of	this	work	has	been	published	in	an	original	research	article	in	PLOS	One	(Swatton	et	al.	2016).		 	
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3.2 Results	
3.2.1 Experimental	design	
Seven	culture	conditions	were	used,	each	with	four	biological	replicates,	as	outlined	in	Table	3.1.	Planktonic	cultures	of	the	bacteria	were	grown	in	AGS	to	stationary	phase	(18	h,	OD600	7.5),	 samples	 of	 the	 extracellular	 liquid	 medium	 were	 prepared	 by	 centrifugation	 and	filtration,	 then	 analysed	by	 1H-NMR	spectroscopy.	The	NMR	spectra	 contained	over	100	peaks,	 from	which	 19	metabolites	 spanning	 central	 carbon,	 amino	 acid	 and	 nucleotide	metabolism	were	identified	(Figure	3.1)	by	comparison	to	spectra	of	reference	compounds	and	Statistical	Total	Correlation	Spectroscopy	(STOCSY).		
	
Table	3.1	Experimental	design	for	1H-NMR	footprinting.		
N	 =	 number	 of	 biological	 replicates.	 †Two	 replicates	 of	 PAO1DlasI	 were	 lost	 during	 sample	preparation.	
Strain	 Genotype	 AZN	(µg/mL)	 N	PAO1BI	 PAO1	 0	 4	PAO-JP1	 PAO1DlasI	 0	 4†	PDO100	 PAO1DrhlI	 0	 4	MP551	 PAO1DpqsR	 0	 4	PAO1BI	 PAO1	 2	 4	PAO1BI	 PAO1	 8	 4	PAO1BI	 PAO1	 32	 4		
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Figure	3.1	Representative	1H-NMR	spectrum	of	PAO1	supernatant:	a	metabolic	``footprint''	
	
Table	3.2	Effect	of	data	pre-processing	on	class	discrimination	by	PCA.		Cohen’s	d	was	used	as	a	measure	of	 class	discrimination	 (effect	 size;	mean	difference	divided	by	standard	 deviation)	 and	 was	 calculated	 between	 wild-type	 and	 the	 “mean	 QS	 mutant”	 in	 PCA	component	space.	This	is	represented	in	the	table	relative	to	the	initial	pre-processing	method	used:	0.04	ppm	simple-buckets,	mean-centred.		
	 	 Simple-buckets	 Overlap-buckets	Scaling	 Noise	filter	 0.04	ppm	 0.01	ppm	 0.04	ppm	 0.01	ppm	Mean-centred	 0	 1	 1	 1	 1	Pareto	 0	 0.93	 0.94	 0.93	 0.94	Autoscaled	 0	 0.55	 0.59	 0.54	 0.59	Glog	 0	 0.66	 0.66	 0.64	 0.66	Mean-centred	 1	 1	 1	 1	 1.01	Pareto	 1	 0.96	 0.97	 0.95	 0.95	Autoscaled	 1	 1.02	 1.02	 0.67	 0.62	Glog	 1	 0.79	 0.8	 0.73	 0.74	
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Table	3.3	Univariate	effect	size:	number	of	features	called	significant	by	Student’s	t-test.	Significance	is	based	on	t-test	comparing	each	mutant	to	wild-type,	p<=0.05,	corrected	for	multiple	testing	 using	 the	 Benjamini	 and	 Hochberg	 step-up	 procedure.	 The	 number	 of	 features	 called	significant	was	then	averaged	across	the	three	wild-type	to	mutant	comparisons.	
	 	 Simple-buckets	 Overlap-buckets	Scaling	 Noise	filter	 0.04	ppm	 0.01	ppm	 0.04	ppm	 0.01	ppm	Mean-centred	 0	 35	 124	 73.7	 250.7	Mean-centred	 1	 41.7	 156	 52	 149	Glog	 0	 33	 117.7	 68.7	 243.3	Glog	 1	 47.7	 158	 51.3	 144.7	
	
3.2.2 Comparison	of	data-processing	methods	
Several	methods	were	investigated	for	i)	definition	of	x	variables,	ii)	scaling,	and	iii)	filtering	variables.	 The	 preprocessing	methods	 were	 evaluated	 according	 to	 the	 sensitivity	 with	which	 multivariate	 and	 univariate	 statistical	 tests	 could	 distinguish	 wild-type	 from	 QS	mutant	metabolic	footprints.	Principal	component	analysis	(PCA)	was	used	for	multivariate	analysis	 (MVA)	and	 the	metric	 for	sensitivity	was	Cohen’s	d	effect	size	(mean	difference	divided	by	standard	deviation)	between	wild-type	and	QS	mutants	in	principle	component	space	 (Table	3.2).	The	 effect	 of	 the	data	processing	methods	on	downstream	univariate	statistical	 analyses	 (UVA)	 was	 evaluated	 by	 examining	 the	 number	 of	 features	 called	significant	by	Student’s	t-test	(Table	2.3).		
Definition	of	x	variables	
“Simple-bucketing”	 was	 chosen	 as	 a	 starting	 point	 for	 its	 simplicity	 (ease	 of	implementation)	 and	 its	 established	 use	 in	metabolomics	 studies.	 This	method	 defines	dependent	variables	as	the	sum	of	spectral	intensity	within	fixed-width	intervals.	A	bucket	size	of	0.04	ppm	is	typical,	although	this	can	be	several	times	broader	than	some	metabolite	peaks	and	so	has	the	potential	to	confound	data-interpretation.		
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Reduction	of	bucket	width	from	0.04	ppm	to	0.01	ppm	had	very	little	effect	on	multivariate	effect	size	(Table	3.2).	However,	inspection	of	UVA	results	revealed	that	0.01	ppm	enabled	identification	of	significantly	modulated	peaks	that	were	missed	with	a	0.04	ppm	bucket	width:	these	were	typically	narrow	peaks,	whose	modulation	was	masked	by	adjacent	peaks	or	background	noise	when	0.04	ppm	buckets	were	used.		
A	concern	with	the	use	of	"simple-bucketing"	is	that	information	(signal:noise	ratio)	could	be	lost	where	peaks	are	arbitrarily	split	across	buckets.	An	alternative	"overlap-bucketing"	approach	was	tested	whereby	two	sets	of	buckets	were	defined,	the	second	set	offset	from	the	 1st	 by	 half	 a	 bucket	 width.	 This	 should	 increase	 the	 probability	 of	 a	 bucket	symmetrically	straddling	the	maximum	of	any	given	spectral	peak.	The	overlap-bucketing	method	resulted	in	similar	MVA	effect	sizes	as	simple-bucketing	for	unfiltered	datasets;	this	was	expected	since	for	every	bucket	with	increased	signal:noise	ratio,	buckets	may	also	be	created	with	lower	signal:noise	ratios.	However,	UVA	showed	that	even	after	correcting	for	multiple	 testing	 the	overlap-bucketing	method	 resulted	 in	a	 greater	number	of	 features	called	significant:	this	increase	was	proportionally	greater	with	a	0.04	ppm	bucket	width	(55	 to	 75)	 than	 for	 0.01	 ppm	 (203	 to	 240),	 consistent	 with	 reduced	 bucket	width	 and	overlap-bucketing	reducing	loss	of	information	from	the	same	sources.	
Scaling	
Mean	and	variance	of	dependent	variables	tend	to	be	highly	correlated	 in	metabolomics	datasets.	Higher	concentration	metabolites	can	therefore	dominate	multivariate	analyses,	obscuring	 valuable	 information	 regarding	 lower	 concentration	 metabolites.	 Variance-stabilising	transformations	can	be	used	to	counter	this,	for	example	autoscaling	(division	by	the	standard	deviation)	results	in	equal	variance	for	all	dependent	variables,	with	the	penalty	 that	 this	also	amplifies	noise.	Noise	 is	a	particular	concern	 in	bucketed	Fourier-transformed	NMR	(FT-NMR)	spectral	data,	which	has	a	background	of	high	frequency,	low	amplitude	noise.	Pareto	scaling	(division	by	the	square	root	of	the	standard	deviation)	is	often	used	 in	FT-NMR	preprocessing	 as	 a	 compromise	between	 stabilising	 variance	 and	dampening	noise.	Other	scaling	methods	have	been	developed	based	on	log-transformation	such	as	the	generalised	 logarithm	"glog"	 transformation.	Whereas the	 log	transformation	stabilises	the	variance	for	variables	with	high	but	not	those	with	low	or	zero	means,	the	glog	transformation	results	in	constant	variance	and	approximately	symmetric	errors	in	data	for	both	low	and	high	means.	The	glog	transformation	was	originally	developed	to	normalise	variance	in	microarray	expression	data	for	which	error	can	be	modelled	as	C = D + EFG +
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H, where C is the measured expression, E is the true expression and I and H are normally 
distributed error terms with mean 0 and variance JGK and JLK, respectively. Based on this 
two-component error model Durbin	et	al.,	(2002);	Huber	et	al.,	(2002)	and	Munson	(2001) 
independently developed the glog transformation to stabilise the variance in such data: glog(C, D, Q) = ln	 S(C − D) + U(C − D)2 + QW , where Q = JBGK JBLKX 	(Geller	 et	 al.	 2003). The	following	scaling	methods	were	selected	for	assessment:	mean-centred	(no-scaling),	Pareto,	autoscaling	and	glog.	
Mean-centering	resulted	in	the	highest	multivariate	effect	size,	followed	by	Pareto,	glog	and	autoscaling	(Table	3.2).	The	Student’s	t-statistic	is	scale-invariant	and	so	is	unaffected	by	UV	and	Pareto	scaling,	hence	only	mean-centred	and	glog	transformed	data	were	compared:	no	large	or	consistent	difference	was	observed	between	the	performance	of	mean-centering	or	glog	transformation	for	UVA	(Table	2.3).	 	
Noise	filtering	
Filtering	variables	based	on	their	noise	component	was	investigated	as	a	complementary	approach	to	scaling.	Excluding	noisy	variables	was	also	expected	to	reduce	the	loss	of	power	of	univariate	analyses	to	multiple	testing.	The	filtering	method	entailed:	1)	Calculating	the	mean	and	standard	deviation	of	background	noise	(these	parameters	were	constant	across	the	NMR	spectrum);	2)	Defining	the	limit	of	detection	"LOD"	as	the	mean	of	the	noise	plus	3	standard	deviations;	3)	Excluding	all	variables	for	which	fewer	than	4	samples	(the	number	of	 biological	 repeats)	had	a	magnitude	greater	 than	 the	LOD.	Noise	 filtering	 resulted	 in	increased	multivariate	effect	sizes,	with	the	greatest	increase	seen	for	autoscaled	data	(1.84	fold	for	0.01	ppm	buckets).	This	is	illustrated	in	the	plots	of	PCA	scores	in	Figure	3.2.	Overlap	bucketing	and	noise	filtering	interacted	with	unexpectedly	consequences:	the	improvement	on	effect	size	due	to	noise	filtering	was	largely	abrogated	by	overlap-bucketing.	With	regard	to	univariate	analysis,	noise	filtering	increased	the	number	of	features	called	significant	in	simple-bucketed	data,	while	the	opposite	was	true	for	overlap-bucketed	data.		
Metabolic	footprinting	pilot	study—QS	mutants	and	azithromycin	 
	
	 52	
	Plot	label	 Bucket	width	 Bucketing	method	 Noise	filtering	 Scaling	A,	B	 0.01	ppm	 Simple	 0	 Mean-centred	C,	D	 0.01	ppm	 Simple	 0	 Autoscaling	E,	F	 0.01	ppm	 Simple	 1	 Autoscaling	
Figure	3.2	Effect	of	noise-filtering	on	Principle	Components	Analysis	of	metabolic	footprints.	Subplots	represent	PCA	scores	(A,	C,	E)	and	loadings	(B,	D,	F)	illustrating	the	effect	of	noise-filtering.	All	data	was	mean-centred	and	processed	using	a	simple	bucket	method	with	a	bucket	width	of	0.01	ppm.	Autoscaling	(to	unit	variance)	was	applied	to	data	in	C-F.	A	noise	filtering	method	(described	in	the	body	text)	was	applied	to	data	in	E-F.			 	
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Conclusions	
The	 choice	 of	 data	 pre-processing	 steps	 had	 a	 large	 effect	 on	 the	 sensitivity	 of	 both	multivariate	and	univariate	analysis.	Bucket	widths	of	0.01	ppm	were	preferable	to	0.04	ppm.	Noise-filtering	improved	sensitivity	of	both	multivariate	and	univariate	analysis	and	facilitated	 interpretation	 of	 PCA	 loadings	 plots.	 Use	 of	 an	 overlap-bucketing	 method	revealed	 significantly	modulated	 features	 that	would	 otherwise	 have	 been	masked,	 but	mitigated	the	benefits	of	noise-filtering.	Since	no	single	combination	of	preprocessing	steps	outperformed	 all	 others	 in	 both	 multivariate	 and	 univariate	 analysis,	 the	 choice	 of	preprocessing	method	 depends	 on	 the	 relative	 importance	 of	multivariate	 analysis	 and	univariate	analysis.		
In	 the	 following	 study	 of	 P.	 aeruginosa	 QS	 mutants,	 multivariate	 analysis	 was	 used	 to	investigate	global	patterns	in	metabolic	metabolism,	while	univariate	analysis	was	used	to	investigate	 the	underlying	 features	of	 such	patterns.	By	 equalising	 variance,	 autoscaling	enables	a	more	 “global”	assessment	of	patterns	amongst	 variables	 (as	 illustrated	by	 the	loading	plots	in	Figure	3.2).	Since	noise-filtering	mitigated	the	loss	of	sensitivity	(effect	size)	due	 to	 amplification	 of	 noise,	 the	 following	 pre-processing	 procedure	 was	 chosen	 as	 a	compromise:	i)	0.01	ppm	simple-bucketing,	ii)	noise-filtering,	iii)	autoscaling.	
	
Figure	3.3	Principal	Components	Analysis	of	QS	mutant	metabolic	footprints.			
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Table	3.4	Extracellular	metabolites	differentially	regulated	in	1H-NMR	metabolic	footprints	of	
lasI,	rhlI	and	pqsR	mutants.		The	lasI,	rhlI	and	pqsR	mutants	show	similar	perturbations	in	their	metabolic	footprints,	with	similar	changes	to	their	amino	acid	and	fatty	acids	profiles	relative	to	wild-type	P.	aeruginosa.	Direction	of	modulation	indicated	in	the	table	is	relative	to	wild-type	PAO1	(Student’s	t-test,	p	<	0.05).	
	 Metabolites	Strain	 Up	 Down	
DlasI 
glycero-3-phosphocholine,	glycine,	isoleucine,	sarcosine	(N-methylglycine),	tryptophan,	tyrosine	 fatty	acids,	glutamine	
DrhlI 
formate,	glycero-3-phosphocholine,	glycine,	isoleucine,	sarcosine	(N-methylglycine),	trimethylamine,	tryptophan,	tyrosine	 fatty	acids,	glutamine	
DpqsR formate,	glycine,	isoleucine,	sarcosine	(N-methylglycine),	tyrosine	 fatty	acids,	glutamine		 	
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3.2.3 The	effects	of	las,	rhl	and	PQS	intercellular	signalling	can	be	
distinguished	by	1H-NMR	metabolic	footprinting	 
Comparison	of	1H-NMR	spectra	by	PCA	indicated	that	the	metabolic	footprints	of	the	three	signalling	mutants	deviated	from	the	wild-type	in	a	similar	manner:	each	mutant	could	be	distinguished	 from	the	wild-type	 in	 the	same	direction	 in	 the	 first	principal	component,	which	 accounted	 for	 36%	 of	 the	 variation	 in	 the	 dataset	 (Figure	 3.3).	 The	 lasI	 and	 rhlI	mutants	were	clearly	distinguished	from	each	other	and	the	pqsR	mutant	by	the	second	(R2	=	19%)	and	third	(R2	=	13%)	principal	components,	indicating	that	the	las	and	rhl	systems	have	pronounced	and	distinct	impacts	on	P.	aeruginosa	metabolism.	At	this	global	level	of	analysis,	the	pqsR	mutant	could	be	distinguished	from	the	other	strains	in	degree	rather	than	 quality	 of	 metabolic	 effect.	 The	 effect	 sizes	 of	 the	 lasI	 and	 rhlI	 mutants	 were	approximately	twice	that	of	the	pqsR	mutants	(Figure	3.3).	This	is	consistent	with	models	of	QS	networks	in	which	the	PQS	system	sits	under	the	AHL	systems,	though	it	is	important	to	 consider	 that	 these	 metabolic	 footprints	 represent	 only	 a	 portion	 of	 the	 complete	extracellular	metabolome	at	a	single	point	in	batch	culture.	
Student	t-tests	were	used	to	determine	which	1H-NMR	spectral	regions,	and	hence	which	metabolites,	 distinguished	the	mutants	 from	 the	wild-type.	After	 correction	 for	multiple	testing,	this	analysis	identified	60	spectral	regions	as	being	modulated	in	one	or	other	of	the	signalling	mutants	relative	to	the	wild-type	(Student's	t-test,	p<0.05);	of	these,	35	spectral	regions	were	assigned	to	10	metabolites	and	a	broad	fatty	acid	CH2	peak.	The	majority	of	the	60	modulated	spectral	regions	were	affected	similarly	in	all	three	QS	mutants	compared	to	wild-type:	glycine,	isoleucine,	sarcosine	(N-methylglycine)	and	tyrosine	were	at	higher	concentrations	in	the	QS	mutants,	whereas	the	signal	intensities	of	glutamine	and	the	broad	fatty	acid	peak	were	 lower	(Table	3.4).	This	suggests	 that	 the	various	QS	systems	share	control	of	a	core	set	of	metabolic	functions.	
A	smaller	number	of	metabolites	were	modulated	 in	only	a	subset	of	 the	QS	mutants:	 i)	trimethylamine	concentrations	were	elevated	in	the	rhlI	mutant	footprints	and	to	a	lesser	degree	in	the	las	mutant,	but	no	effect	was	detectable	in	pqsR	mutant	cultures,	ii)	there	was	a	higher	concentration	of	formate	in	the	rhlI	and	pqsR	mutants	but	not	in	the	las	mutant,	iii)	glycero-3-phosphocholine	concentrations	were	higher	in	the	las	and	rhl	mutants,	but	not	in	the	pqsR	mutant.	These	modulations	remained	specific	to	the	above	subsets	even	when	the	threshold	for	significance	was	decreased	from	p<=0.05	to	p<=0.3.		
In	addition	to	an	overall	decrease	in	the	concentration	of	fatty	acids	in	the	QS	mutants,	there	was	a	shift	in	the	profile	of	the	fatty	acid	peak	towards	lower	chemical	shift	(Figure	3.5).	
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Wild-type	spectra	had	a	peak	centred	at	1.30	ppm,	whereas	lasI	and	rhlI	mutants	had	peaks	centred	at	1.24	ppm.	The	pqsR	mutant	had	an	intermediate	phenotype,	showing	similarly	sized	peaks	centred	at	both	chemical	shifts.	These	metabolic	changes	indicate	the	 las,	rhl	and	 PQS	 systems	 have	 marked	 effects	 on	 the	 metabolic	 function	 of	 P.	 aeruginosa,	encompassing	fatty	acid	and	amino	acid	metabolism.		
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Figure	3.4	Distinct	clustering	of	signal	mutants	by	PLS-DA.	PLS-DA	 generated	 robust	 models	 separating	wild-type	 PAO1	 from	 lasI,	 rhlI	 and	 pqsR	 signalling	mutants.	 PAO1:	 black	 squares,	 DlasI:	 red	 dots,	 DrhlI:	 blue	 diamonds,	 DpqsR:	 green	 triangles.	Separation	of	each	mutant	from	wild-type	in	Principal	Component	1	of	each	model	was	found	to	be	significant	in	each	case	(Student’s	t-test):	lasI	(p=3.12-06), rhlI (p=2.20-16), pqsR (p=2.20-16).	
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Figure	3.5	1H-NMR	footprinting	indicates	QS-modulated	fatty	acid	metabolism.	The	broad	resonance	due	to	saturated	(CH2)n	groups	is	centred	at	lower	chemical	shift	in	the	lasI,	rhlI	and	pqsR	signalling	mutants,	indicating		a	shift	in	length	and/or	saturation	in	their	fatty	acids	profiles.	PAO1:	black,	DlasI:	red,	DrhlI:	blue,	DpqsR:	green.	
3.2.4 Metabolic	footprinting	indicates	that	sub-inhibitory	
azithromycin	has	a	QS-independent	mode	of	action	
Wild-type	P.	aeruginosa	was	grown	in	AGS	media	supplemented	with	2,	8	or	32	µg/mL	AZN.	Under	these	conditions	AZN	has	no	discernible	effect	on	the	growth	of	P.	aeruginosa,	though	the	 upper	 concentration	was	 chosen	 selected	 to	 be	within	 a	 factor	 of	 two	 of	 inhibitory	concentrations	(64	µg/mL	AZN	results	in	a	slight	growth	defect	in	AGS).	The	full	dataset,	consisting	of	all	seven	conditions	(Table	3.1),	was	re-processed	in	order	to	filter-out	peaks	due	to	AZN:	1H-NMR	spectral	peaks	due	to	azithromycin	were	first	identified	with	reference	to	spectra	of	pure	azithromycin	and	were	removed	prior	 to	processing	as	above.	A	PCA	model	was	built	to	compare	wild-type	P.	aeruginosa,	AZN-treatment	and	QS	mutants	(Figure	3.6A).	 The	 first	 principal	 component,	 accounting	 for	 40%	 of	 variation	 in	 the	 dataset,	separated	wild-type	samples	from	the	QS	mutants,	but	AZN-treated	co-clustered	with	wild-type	in	this	dimension.	Both	the	QS	mutants	and	the	AZN-treated	samples	showed	a	small	deviation	 away	 from	 the	 wild-type	 in	 the	 second	 principal	 component	 (R2=23%).	 The	majority	of	the	QS	effect	was	therefore	unrelated	to	that	of	azithromycin	treatment.	On	the	other	 hand,	 the	 largest	 discernible	 AZN	 effect	 in	 this	 model	 was	 correlated	 with	 QS	(detected	in	the	second	principal	component):	AZN	does	appear	to	affect	a	small	portion	of	QS-regulated	metabolites.		
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As	a	complementary	approach	to	addressing	this	relationship,	a	PLS	model	was	built	using	only	wild-type	samples,	treating	AZN	concentration	as	an	independent	(“Y”)	variable.	The	advantage	of	this	PLS	model	over	the	previous	PCA	is	that	the	PLS	model	focuses	on	AZN	effects,	whereas	these	may	be	obscured	in	the	PCA	by	the	much	larger	QS	effects.	Plotting	the	AZN	 concentration	of	 each	 sample	against	AZN	 concentrations	predicted	by	 the	PLS	model	resulted	in	a	linear	dose-response	curve	with	good	fit	(Figure	3.7,	R2	=	0.81).	Model	validation	by	bootstrapping	confirmed	that	this	was	a	robust	model	of	a	dose-dependent	effect	of	AZN-treatment.	This	reflects	that	higher	concentrations	of	AZN	result	in	a	greater	degree	of	modulation	of	 the	same	metabolites	as	 lower	AZN	doses,	consistent	with	AZN	acting	via	the	same	mechanism(s)	at	all	concentrations	tested.	
The	 AZN	 PLS	model	was	 then	 used	 to	 predict	 pseudo-concentrations	 of	 AZN	 of	 the	 QS	mutants,	a	measure	of	the	strength	of	AZN-like	effects	in	these	samples.	In	this	analysis,	the	QS	mutant	profiles	were	equivalent	to	intermediate	AZN	concentrations	(7-19	µg/mL	AZN,	Figure	3.7),	confirming	that	the	metabolic	impact	of	AZN-treatment	correlates	with	aspects	of	QS-inhibition.	PLS	coefficients	were	analysed	to	determine	the	proton	resonances	driving	the	 dose-dependent	 effect	 of	 AZN.	 Although	more	 than	 40	 spectral	 regions	 contributed	significantly	 (Student's	 t-test,	 p	 <	 0.05)	 to	 the	 separation	 of	 sample	 types,	 only	 a	 small	number	 could	 be	 confidently	 assigned	 to	 specific	 metabolites:	 these	 corresponded	 to	tyrosine	(increased	in	AZN	samples),	fatty	acids	(decreased	in	AZN	samples)	and	glutamine	(decreased	in	AZN	samples).		
Finally,	Student’s	t-tests	were	used	to	compare	the	metabolic	profiles	of	the	wild-type	to	each	of	the	QS	mutants	and	AZN	treatments	in	turn.	These	results	were	consistent	with	the	multivariate	analyses,	showing	similar	changes	to	concentrations	of	tyrosine,	fatty	acid	and	glutamate.	Notably,	the	8	and	32	µg/mL	AZN-treated	samples	also	showed	similar	changes	in	the	fatty	acid	peak	profile	as	the	QS	mutants	(Figure	3.8).	Concentrations	of	other	QS-modulated	metabolites,	 such	as	 tryptophan,	sarcosine	and	 formate,	were	not	affected	by	AZN	 treatment	(Figure	3.5).	 Several	 spectral	 peaks	were	 specifically	modulated	 in	AZN-treated	 samples	 (that	 is,	 not	modulated	 in	 QS	mutants),	 though	 none	 of	 these	 could	 be	confidently	assigned	to	specific	metabolites.		
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Figure	3.6	Effects	of	sub-MIC	azithromycin	apparent	in	1H-NMR	metabolic	footprints.		A)	PCA	plot	showing	separation	of	signalling	mutants	from	untreated	and	AZN-treated	PAO1	samples	along	component	1.	B)	PLS-DA	plot	 showing	separation	of	untreated	PAO1	 from	32	µg/mL	AZN-treated	PAO1	 samples.	 PAO1:	 black	 squares,	DlasI:	 red	 dots,	DrhlI:	 blue	 diamonds,	DpqsR:	 green	triangles,	2	µg/mL	AZN-treated	PAO1:	open	squares,	8	µg/mL	AZN-treated	PAO1:	open	diamonds,	32	µg/mL	AZN-treated	PAO1:	open	inverted	triangles.	
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Figure	 3.7	 Effect	 of	 azithromycin	 on	 P.	 aeruginosa	 metabolic	 footprint	 is	 orthogonal	 to	
quorum	sensing	mutants.		A	PLS	model	was	built	using	wild-type	PAO1	and	AZN-treated	samples,	with	AZN	concentration	as	the	Y	variable.	The	model	was	then	used	to	predict	AZN	concentrations	of	the	signalling	mutants	(coloured	 symbols).	 PAO1:	 black	 squares,	 DlasI:	 red	 dots,	 DrhlI:	 blue	 diamonds,	 DpqsR:	 green	triangles,	2	µg/mL	AZN-treated	PAO1:	open	squares,	8	µg/mL	AZN-treated	PAO1:	open	diamonds,	32	µg/mL	AZN-treated	PAO1:	open	inverted	triangles.		 	
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Figure	3.8	Exposure	to	azithromycin	modulates	the	1H-NMR	fatty	acid	(CH2)n	peak	to	lower	
chemical	shift.	The	1H-NMR	resonance	of	saturated	(CH2)n	groups	is	centred	at	lower	chemical	shift	in	AZN-treated	 PAO1,	 in	 a	 manner	 similar	 to	 that	 seen	 for	 the	 QS	 deficient	 lasI,	 rhlI	 and	 pqsR	mutants	(see	Figure	3.5).	PAO1:	black,	32	µg/mL	AZN-treated	PAO1:	purple.		 	
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Table	3.5	Extracellular	metabolites	differentially	regulated	in	QS	mutants	and	AZN-treated	P.	
aeruginosa.	Exposure	 of	 P.	 aeruginosa	 to	 sub-MIC	 concentrations	 of	 azithromycin	 perturbs	 extracellular	concentrations	of	amino	acids	—notably	aromatic	amino	acids—and	fatty	acids.	Direction	of	change	is	relative	to	untreated	wild-type	PAO1	(Student’s	t-test,	p	<	0.05).	
	 	 Metabolites	Strain	 AZN	(µg/mL)	 Up	 Down	PAO1	 32	 tyrosine	 fatty	acids,	glutamine	PAO1	 8	 tyrosine	 fatty	acids,	glutamine	
DlasI 0	 tyrosine,	tryptophan	 fatty	acids,	glutamine	
DrhlI 0	 sarcosine,	tyrosine,	tryptophan	 fatty	acids,	glutamine	
DpqsR 0	 formate,	tyrosine	 fatty	acids,	glutamine		 	
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3.3 Discussion		
The	present	study	found	that	mutants	in	the	las,	rhl	and	PQS	systems	each	had	a	significant	and	distinct	impact	on	metabolism,	including	changes	to	amino	acids	and	fatty	acids.	These	findings	also	validated	1H-NMR	footprinting	as	a	tool	for	monitoring	metabolic	effects	of	QS:	the	 low	 sample	 volume	 required	 and	 relative	 ease	 of	 data-processing	 would	make	 it	 a	convenient	choice	for	experiments	involving	profiling	large	numbers	of	conditions,	e.g.	for	example	monitoring	and	comparing	changes	throughout	the	growth	curve.	
Biosynthesis	of	AHL	and	PQS	signalling	molecules	branches	from	primary	metabolism	at	different	points.	The	homoserine	lactone	ring	of	AHLs	originates	from	SAM	and	the	acyl	side	chains	are	derived	from	fatty	acids	loaded	onto	acyl	carrier	protein	(ACP).	PQS	is	derived	from	anthranilate	(Heurlier	et	al.	2006).	The	major	metabolic	effects	of	 the	 lasI,	rhlI	and	
pqsR	mutations	were	similar,	suggesting	that	these	perturbations	were	due	to	co-regulation	of	common	functions	by	these	QS	systems,	rather	than	synthesis	of	signalling	molecules.	Moreover,	PQS	signalling	is	typically	activated	by	the	las	system	and	repressed	by	the	rhl	system;	 the	 similarity	 in	 the	 metabolic	 footprints	 of	 the	 lasI,	 rhlI	 and	 pqsR	 mutant	 is	consistent	with	the	 las	system	dominating	the	regulatory	hierarchy	under	the	conditions	tested.	 However,	 such	 interpretations	 come	 with	 the	 caveats	 that:	 i)	 only	 a	 portion	 of	metabolic	processes	are	represented	in	the	footprint;	ii)	samples	from	only	a	single	point	in	the	growth	curve	were	analysed,	but	the	expression	of	AHL-	and	AQ-regulated	genes	varies	significantly	 between	 different	 growth	 conditions	 and	 optical	 densities	 (Schuster	 et	 al.	2003;	 Déziel	 et	 al.	 2004);	 iii)	 the	 AHL	mutants	 used	 are	 “signal-null”	whereas	 the	pqsR	mutant	 is	 a	 form	 of	 “signal-blind”	 mutation,	 in	 which	 AQ	 signalling	 is	 expected	 to	 be	repressed	but	may	not	have	been	abolished.	
The	small	number	of	metabolites	identified	in	the	metabolic	footprints	limits	interpretation	of	specific	metabolic	phenotypes.	However,	the	data	does	suggest	several	lines	for	further	investigation.	The	broad	fatty	acid	peaks	observed	in	all	samples	were	smaller	(total	area	under	the	curve)	in	all	three	QS	mutants.	More	strikingly,	the	QS	mutants	showed	a	shift	in	distribution	of	intensity	between	higher	(1.30	ppm)	to	lower	(1.24	ppm)	chemical	shift.	This	could	reflect	a	variety	of	QS-related	activities	including	impacts	on	AHL	synthesis	(the	alkyl	chains	of	AHLs	are	synthesised	from	the	fatty	acid	pool),	energy	metabolism,	membrane	function	 and	 lipid	 metabolites	 such	 as	 rhamnolipids	 (biosurfactants	 proposed	 to	 be	involved	in	motility,	virulence	and	biofilms).	The	higher	levels	of	glycero-3-phosphocholine	observed	 in	 the	 lasI	 and	 rhlI	mutant	 samples	 further	 suggests	 alterations	 to	membrane	metabolism.	
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Changes	in	glutamine	concentration	could	reflect	changes	in	amino	acid	synthesis	or	of	its	use	in	amino	group	transfer,	for	example	as	donor	in	the	synthesis	of	nitrogen	containing	small	 molecule	 secondary	metabolites	 such	 as	 the	 phenazines	 (e.g.	 aminotransfer	 from	glutamine	 to	 chorismate	 in	 the	 synthesis	 of	 the	 phenazine	 precursor	 2-amino-4-deoxyisochorismate).	 Several	 amino	 acids	were	modulated	 in	 the	QS	mutants,	 this	may	reflect	 changes	 in	 the	 rate	 or	 type	 of	 QS-regulated	 protein	 and	 secondary	 metabolite	synthesis.		
In	a	second	line	of	investigation,	the	metabolic	effects	of	sub-inhibitory	concentrations	of	AZN	were	compared	to	those	of	the	three	QS	mutants.	The	major	metabolic	impact	of	AZN	was	closely	related	to	QS,	however	the	reverse	was	not	true:	the	major	portion	of	QS	effects	were	unrelated	to	those	of	AZN.	These	observations	contradict	the	proposed	role	of	AZN	as	a	 specific	 modulator	 of	 QS	 at	 low	 concentrations.	 The	 partial	 overlap	 of	 the	metabolic	profiles	of	AZN-treatment	and	QS	metabolic	profiles	may	simply	reflect	the	association	of	QS	with	stress-responses.	In	this	light,	it	would	be	interesting	to	explore	the	shift	in	fatty	acid	profile:	is	this	part	of	a	general	stress	response?	
The	present	study	was	primarily	intended	as	a	proof-of-principle	investigation	for	studying	QS	 by	 1H-NMR	 footprinting.	 The	 results	 suggest	 that	 several	 areas	 of	 metabolism	 are	perturbed	in	the	signal	mutants;	these	changes	could	be	probed	further	by	more	focused	metabolic	 profiling.	 Given	 the	 large	 perturbations	 observed	 and	 the	 small	 sample	 sizes	required	 for	 analysis,	 these	 footprinting	methods	could	be	useful	 for	 tracking	metabolic	profiles	through	the	growth	curve,	thereby	facilitating	the	study	of	temporal	relationships	between	QS	and	metabolism.	
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Chapter	4 		Metabolic	footprinting	and	open	profiling	of	QS	mutants		
4.1 Introductory	comments	
The	rhlI	and	lasI	mutants	studied	in	Chapter	3	had	highly	correlated	metabolic	footprints,	in	 keeping	 with	 our	 understanding	 of	 their	 regulatory	 interactions	 and	 overlapping	regulons.	Given	this	regulatory	integration,	I	chose	to	investigate	their	metabolic	influence	using	a	 lasI	 rhlI	double	mutant.	Using	 this	design,	 the	metabolic	 roles	 of	 the	 las	 and	rhl	systems	 can	 be	 revealed	 by	 comparison	 with	 the	 wild-type	 and	 by	 chemical	complementation	with	BHL	and	OdDHL.		
Aims	and	objectives:	To	characterise	QS	activity	and	the	associated	metabolic	activity	of	wild-type	 PAO1	 and	 a	 lasI	 rhlI	mutant	 in	 batch	 culture.	 QS	 activity	will	 be	 assessed	 by	measurement	of	i)	BHL	and	OdDHL	using	cellular	biosensor	assays,	ii)	the	transcriptional	activity	of	canonical	QS-regulated	promoters,	using	lacZ	transcriptional	fusion	assays.	The	global	 metabolic	 status	 of	 the	 bacteria	 will	 be	 assessed	 using	 i)	 1H-NMR	 metabolic	footprinting	at	hourly	intervals,	ii)	MSTFA-GCMS	analysis	of	aqueous	cell	extracts,	iii)	LCMS-based	analysis	of	the	cellular	proteome.	
Part	 of	 this	 work	 has	 been	 published	 as	 an	 original	 research	 article	 in	 the	 Journal	 of	Bacteriology	(Davenport	et	al.	2015).	Proteomic	analysis		was	performed	at	the	Cambridge	Centre	for	Proteomics	(CCP,	UK)	with	advice	and	assistance	from	Prof.		Kathryn	Lilley:	LC-MS	analysis	 and	 peptide	 identification	was	performed	 by	 Svenja	Hester;	 all	 other	 steps	including	sample	preparation,	 iTRAQ	labelling	and	data	analysis	was	performed	by	Peter	Davenport.		 	
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4.2 Results	
4.2.1 Generation	and	verification	of	a	lasI	rhlI	double	mutant		
Beatson	et	al.	(2002)	reported	that	mutations	in	lasI	and	rhlI	select	for	secondary	mutations	in	 vfr	 and	algR	 respectively,	 resulting	 in	 pleiotropic	 phenotypes	 including	 deficiency	 in	twitching	motility	(Beatson	et	al.	2002).	This	illustrates	the	importance	of	minimising	the	opportunity	 for	 selection	 of	 secondary	 mutations.	 In	 order	 to	 ensure	 that	 the	 lasI	 rhlI	mutant	 was	 otherwise	 isogenic	 with	 its	 wild-type	 progenitor	 a	 ‘fresh’	 mutant	 was	constructed	 using	 suicide	 plasmids.	 This	 was	 achieved	 first	 by	 generating	 lasI	 and	 rhlI	mutants	by	marker	exchange	as	described	in	(Beatson	et	al.	2002),	then	transducing	these	mutations	(separately)	into	a	wild-type	strain	to	generate	a	lasI	rhlI	mutant	with	insertional	inactivations	of	both	the	lasI	and	rhlI	signal	synthase	genes.		
4.2.2 Planktonic	growth	of	a	lasI	rhlI	mutant	
Cultures	 of	 the	 (phage-transduced)	 lasI	 rhlI	 mutant	 and	 its	 wild-type	 progenitor	 were	grown	aerobically	in	AGSY	growth	medium.	This	growth	medium	has	previously	been	used	to	 characterise	planktonic,	 colony	 and	biofilm	growth	of	P.	 aeruginosa,	providing	useful	reference	 data	 for	 the	 physiological	 state	 of	 the	 bacterium	 under	 these	 conditions	(Mikkelsen	et	al.	2007).	
The	 growth	 profile	 of	 the	 wild-type	 in	 AGSY	 exhibited	 no	 obvious	 lag	 phase	 and	 grew	exponentially	 (growth	 rate	 [µ]	 =	 1.12	 h-1)	 between	 0	 and	 3	 hours	 before	 decelerating	between	3	and	5	hours	(idiophase)	to	approximately	linear	growth,	which	continued	from	5	hours	until	the	end	of	observation	at	10	hours	(Figure	4.1).	Notably,	the	wild-type	cultures	turned	bright	green	between	3	and	5	hours,	indicative	of	accumulation	of	the	QS-regulated	exoproduct	pyocyanin,	whereas	 the	mutant	cultures	showed	no	such	colour	 change	and	remained	grey-brown	throughout.		
The	growth	of	 the	 lasI	 rhlI	mutant	matched	that	of	 the	wild-type	during	 the	exponential	phase	(0-3	h)	and	the	linear	phase	(5-10	h),	but	was	faster	during	the	intervening	2-hour	deceleration	phase	(3-5	h).	Consequently,	after	5	hours’	growth	the	mutant	had	reached	an	
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18%	higher	optical	density,	which	it	maintained	(+/-	5%)	for	the	remainder	of	observations	(Figure	4.2).2	
Viable	cell	counts	were	performed	at	3	and	6	hours’	growth	to	account	for	the	possibility	that	the	observed	differences	in	optical	density	were	due	to	differences	in	cell	morphology	or	other	optical	effects	distinct	from	growth	rate	per	se	(for	example	accumulation	of		cell	debris	or	cell	exoproducts)	(Figure	4.3).	At	3	h,	no	difference	was	observed,	whereas	at	6	h	cell	counts	for	the	mutant	were	15%	higher	than	for	the	wild-type	(P	≤	0.05,	Student’s	t	test),	 consistent	 with	 the	 mutant	 growing	 faster	 than	 the	 wild-type	 at	 the	 end	 of	 the	exponential	growth	phase.		
The	 growth	 advantage	 of	 the	 lasI	 rhlI	 mutant	 is	 limited	 to	 a	 short	 period	 during	 the	transition	from	exponential	to	stationary	phase	growth.	Previous	studies	in	rich	media	have	found	 that	 most	 genes	 in	 the	 las	 and	 rhl	 regulons	 are	 upregulated	 during	 this	 period	(Schuster	et	al.	2004a).			 	
																																																													
2	The	lasI	rhlI	mutant	had	a	higher	optical	density	than	the	wild-type	at	each	time	point	from	5	to	10	h	(P	≤	0.05	Student’s	t	test).	
Metabolic	Footprinting	and	Open	Profiling	of	QS	mutants	
	 70	
	
	
Figure	4.1	P.	aeruginosa	and	lasI	rhlI	mutant	growth	curves	and	AHL	profiles.		Growth	characteristics	of	wild-type	PAO1	and	a	lasI	rhlI	mutant	strain	of	P.	aeruginosa.	Growth	of	the	wild-type	 (filled	symbols)	and	mutant	 (open	symbols)	was	monitored	 in	AGSY	medium.	Samples	were	removed	at	 the	 indicated	 times	and	assayed	 for	OD600	(circles),	OdDHL	(triangles)	and	BHL	(squares).	No	significant	differences	in	optical	density	were	found	during	exponential	phase	growth	(1-3	hours,	p<=0.05,	Student’s	t-test	or	ANCOVA).	A	small	but	significant	difference	growth	between	the	wild-type	and	lasI	rhlI	mutant	is	apparent	following	a	deceleration	in	growth	between	3	and	4	hours:	this	was	assessed	by	Student’s	t	tests	(indicated	by	asterisks	in	(a),	*	p<=0.05,	**	P<=0.01)	and	by	ANCOVA	(p<=0.001,	Tukey’s	HSD,	considering	data	between	5	and	10	hours).	Error	bars	represent	standard	deviations	of	means.		
Metabolic	footprinting	and	open	profiling	of	QS	mutants	
71	
	
Figure	4.2	P.	aeruginosa	growth	curves	plotted	to	a	linear	scale.		Growth	of	wild-type	(filled	symbols)	and	lasI	rhlI	mutant	(open	symbols)	plotted	on	a	linear	optical	density	scale.	The	growth	rate	of	the	wild-type	decreases	relative	to	that	of	the	mutant	between	4	and	5	hours.				
	
Figure	4.3	Viable	cell	counts	of	wild-type	PAO1	(black	bars)	and	lasI	rhlI	mutant	(white	bars)	
sampled	at	three	and	six	hours’	growth.	Cultures	of	 the	 lasI	 rhlI	mutants	grew	to	higher	densities	of	viable	cells,	 consistent	with	optical	density	measurements	(see	Figure	4.1	and	Figure	4.2).	
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4.2.4 AHL	concentrations	during	planktonic	growth	
Canonical	QS-regulatory	functions	were	characterised	by	measuring	the	concentrations	of	AHL	signal	molecules	and	the	promoter	activities	of	the	QS-regulated	genes	lasB	and	rhlA.	This	data	provides	benchmarks	for	the	timing	of	AHL	signalling	activity	under	the	present	growth	conditions.	
The	concentrations	of	BHL	and	OdDHL	were	measured	using	E.	coli	biosensors	assays.	The	BHL	biosensor	strain	E.	coli	JM109(pSB536),	contains	the	Aeromonas	hydrophila	ahyR	gene	and	the	cognate	ahyI	gene	promoter	fused	to	the	luxCDABE	luminescence	operon	(Swift	et	al.	1997).	The	resulting	biosensor	luminesces	in	response	to	addition	of	exogenous	BHL.	The	OdDHL	biosensor	strain	 JM109(pSB1075)	contains	the	 lasRI’	 regulatory	region	of	P.	
aeruginosa	fused	to	luxCDABE	so	that	the	biosensor	expresses	the	luminescence	operon	in	response	 to	 OdDHL	 (Winson	 et	 al.	 1998).	 To	 provide	 quantitative	 analyses	 of	 AHL	concentrations	 in	culture	supernatant	 these	biosensor	assays	were	 first	calibrated	using	standard	curves	of	synthetic	AHL	standards	in	fresh	growth	medium.		
As	expected,	OdDHL	and	BHL	were	only	detected	in	wild-type	culture	supernatants	and	not	in	those	of	the	lasI	rhlI	mutant.	In	wild-type	culture	supernatants	OdDHL	peaked	after	4	h	growth	at	15	µM,	then	steadily	declined	to	below	0.1	µM	over	the	following	4	h	(Figure	4.1).	Similarly,	the	concentration	of	BHL	peaked	after	5	h	growth	at	11	µM,	then	decreased	to	below	0.1	µM.	 Such	drops	 in	AHL	 concentrations	 following	 exponential	growth	 in	batch	culture	have	been	linked	to	alkalization	of	the	growth	medium	and	consequent	lactonolysis	(Yates	 et	 al.	 2002).	Under	our	 growth	 conditions	 the	pH	of	 both	wild-type	 and	 lasI	 rhlI	mutant	culture	supernatants	 increased	from	pH	7.0	at	0	h	to	pH	8.4	at	10	h,	 sufficiently	alkaline	 to	 induce	 lactonolysis.	 These	 results	 indicate	 that	 AHL	 profiles	 in	 AGSY	 during	batch	culture	are	qualitatively	similar	to	those	in	other	rich	media,	including	LB.	
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Figure	4.4	Timing	of	AHL	QS-regulated	lasB	and	rhlA	promoter	activity.	Promoter	activity	was	measured	as	β-galactosidase	activity	encoded	by	pβ01	(the	PlasB	reporter)	and	pβ02	(the	PrhlA	reporter).	β-Galactosidase	activity	symbols:	black	bars,	P.	aeruginosa	PAO1	carrying	pβ01;	white	bars,	PAO1(pβ02);	stippled	bars,	lasI	rhlI	mutant	carrying	pβ01;	hatched	bars,	lasI	rhlI	mutant(pβ02).	Growth	curve	symbols:	ﬁlled	circles,	PAO1(pβ01);	ﬁlled	squares,	PAO1(pβ02);	open	circles,	lasI	rhlI	mutant(pβ01);	open	squares,	lasI	rhlI	mutant(pβ02).	
4.2.5 Activities	of	QS-responsive	promoters	
Quorum	sensing	is	a	transcriptional	regulatory	mechanism.	To	examine	the	dynamics	of	the	canonical	quorum	sensing	transcriptional	regulon,	I	measured	the	promoter	activity	of	lasB	and	rhlA,	genes	whose	expression	is	primarily	dependent	on	OdDHL	and	BHL,	respectively.	I	used	pQF50-based	lacZ	reporter	constructs:	pβ01	to	measure	PlasB	promoter	activity	and	pβ02	 to	 measure	 PrhlA	 activity	 (Farinha	 and	 Kropinski	 1990;	 Ikeda	 et	 al.	 2001).	 These	reporter	plasmids	were	transformed	into	the	wild-type	and	lasI	rhlI	mutant	and	grown	with	antibiotic	selection	for	plasmid	maintenance.	
In	the	wild-type,	PlasB	activity	increased	rapidly	between	4	and	6	h	growth	and	PrhlA	activity	increased	 rapidly	 between	 5	 and	 7	 h	 of	 growth	 (Figure	 4.4),	 consistent	 with	 the	accumulation	of	OdDHL	and	BHL,	respectively.	In	contrast	PlasB	and	PrhlA	promoter	activities	were	 negligible	 in	 the	 lasI	 rhlI	 mutant.	 Again,	 these	 results	 are	 qualitatively	 similar	 to	observations	in	other	rich	media	batch	growth	conditions.	
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Figure	4.5	Uptake	of	nutrients	and	secretion	of	secondary	metabolites	is	observable	in	1H-
NMR	spectra	of	bacterial	supernatants.		A	representative	1H-NMR	spectrum	of	 lasI	rhlI	mutant	culture	supernatant	sampled	after	7	hours	growth	is	displayed	at	two	scales:	the	full	spectrum	(0–8.5	ppm)	in	panel	A,	and	an	enlarged	portion	of	the	same	in	panel	B	([1]	=	glycerol,	[2]	=	acetate,	[3]	=	alanine,	[4]	=	TSP,	[5]	=	valine).	Panel	C	presents	sections	of	the	1H-NMR	spectra	(0.8-1.4	ppm)	of	spectra	of	wild-type	P.	aeruginosa	and	the	
lasI	rhlI	mutant,	illustrating	differerential	utilisation	and	excretion	of	metabolites	between	the	two	strains.		
4.2.6 NMR	Footprinting:	nutrient	uptake	and	acetate	overflow		
Experiments	described	in	Chapter	2	indicated	that	perturbation	of	QS	can	have	widespread	effects	 on	 central	metabolism.	 To	 understand	 how	 these	metabolic	 effects	 relate	 to	 the	timing	of	canonical	QS	functions,	the	exometabolomes	of	the	wild-type	and	lasI	rhlI	mutant	were	compared	at	hourly	 intervals	throughout	growth:	Cell-free	supernatants	 from	each	strain	were	collected	from	0-10	h	and	analysed	by	1H-NMR	spectrometry.		
As	per	data	presented	in	Chapter	3,	the	1H-NMR-visible	metabolic	profiles	of	the	two	strains	were	similar	early	in	growth,	then	diverged	as	the	cultures	aged.	Example	spectra	taken	at	1,	7	and	10	hr	growth	are	shown	in	Error!	Reference	source	not	found..	To	identify	latent	patterns	in	these	data,	I	used	Principal	Components	Analysis	(PCA)	(Kell	et	al.	2005).	This	revealed	that	the	“metabolic	footprints”	of	the	wild-type	and	QS	mutant	were	essentially	indistinguishable	 until	 5	 h	 of	 growth	 (Figure	 4.6),	 corresponding	 to	 peak	 AHL	concentrations	in	wild-type	cultures.	The	metabolic	footprints	of	the	two	strains	diverged	from	this	point	onwards,	 this	 is	particularly	evident	 in	principal	components	2	and	3	as	shown	in	Figure	4.6b	and	c.	
Inspection	of	the	PCA	loadings,	which	underlie	the	PCA	scores	shown	in	Figure	5,	revealed	that	this	divergence	between	hours	5	to	7	is	due	to	the	mutant	showing	i)	higher	uptake	of	nutrients	including	alanine,	glycerol	and	valine,	and	ii)	increased	production	of	extracellular	acetate	(Figure	4.7).	Considering	that	the	mutant	simultaneously	achieved	a	higher	growth	rate	than	wild-type	during	this	period,	this	suggests	that	the	QS	mutant	assimilated	carbon	more	efficiently.	The	las	and	rhl	systems	are	known	to	upregulate	the	expression	of	many	secreted	factors	in	early	stationary	phase	(Nouwens	et	al.	2003).	Lower	efﬁciency	of	carbon	assimilation	 by	 the	wild	 type	 could	 be	 explained	by	QS-dependent	 diversion	 of	 cellular	resources	towards	secreted	factors.	However,	this	would	account	for	differences	in	outputs	(re	growth	yield	and	acetogenesis)	and	would	not	prima	facie	explain	differences	in	inputs	
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(re	 uptake	 of	 nutrients).	 This	 suggests	 that	 AHL	QS	 induces	 a	 considerable	 rewiring	 of	central	metabolism	during	the	transition	to	stationary	phase	growth.	
	
Figure	4.6	1H-NMR	footprints	of	lasI	rhlI	mutant	diverge	from	wild-type	after	5	h	growth.		
1H-NMR	data	were	analysed	using	Principal	Components	Analysis.	Wild-type	(filled	symbols)	and	
lasI	rhlI	mutant	(open	symbols).		 	
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Figure	4.7	Differential	accumulation	and	depletion	of	metabolites	monitored	by	1H-NMR.		Wild-type	(filled	symbols)	and	lasI	rhlI	mutant	(open	symbols).	
4.2.7 Cellular	metabolite	profiling:	perturbations	to	central	
metabolism	
To	explore	the	cellular	basis	of	the	divergence	in	metabolic	footprints,	aqueous	fractions	of	methanol-chloroform	 cell	 extracts	were	 analysed	by	 GC-MS.	Metabolites	 in	 cell	 extracts	were	derivatised	using	MSFTA	prior	to	separation	and	analysis	by	GC-MS.	Bacterial	cultures	were	 grown	 as	 previously	 and	 samples	 were	 taken	 at	 ODs	 of	 1.5,	 2.5,	 4.5,	 and	 6.5,	corresponding	to	3h,	3h50,	5h30	and	7h40	for	the	wild-type	and	3h,	4h,	6h30	and	8h50	for	the	 lasI	 rhlI	mutant.	 The	 sampling	 points	were	 based	 on	 optical	 density	measurements	(rather	than	time)	to	account	for	differences	in	growth	rates	between	the	bacterial	strains	and	were	chosen	to	bracket	the	initial	point	of	divergence	in	the	metabolic	footprints,	which	occurred	at	an	OD	of	~3.		
Consistent	 with	 the	 footprinting	 data,	 the	 cellular	 metabolic	 profile	 of	 the	 mutant	 was	essentially	 identical	 to	 that	 of	 the	wild-type	 at	 early	 sampling	 points	 (OD	 1.5	 and	 2.5),	whereas	 by	 OD	 4.5	 the	 concentrations	 of	 one	 third	 of	 the	 90	 metabolite	 peaks	 were	
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perturbed	(Table	4.2).	Metabolites	from	all	major	domains	of	metabolism	were	modulated:	central	 carbon,	 amino	 acid,	 nucleic	 acid,	 fatty	 acid	 and	 membrane	 metabolism.	 Of	 the	metabolic	changes	identified,	the	following	themes	were	particularly	notable.	
Many	sugars	or	sugar-phosphates	were	perturbed	in	the	lasI	rhlI	mutant.	Notably,	citrate	and	malate	concentrations	were	both	higher	in	the	lasI	rhlI	mutant	at	OD	4.5	and	by	OD	6.5	other	tricarboxylic	acid	(TCA)	cycle	intermediates,	such	as	succinate	and	fumarate,	were	also	elevated	in	the	mutant.	The	TCA	cycle	is	a	central	hub	of	metabolism,	oxidizing	carbon	sources	and	providing	anabolic	precursors	for	biosynthesis.	Depletion	of	TCA	intermediates	in	 the	wild-type	may	be	due	 to	allocation	of	 cellular	 resources	 to	AHL-induced	 secreted	factors	and	also	help	explain	the	temporary	growth	deficit	relative	to	the	mutant.	Levels	of	sn-glycerol-3-phosphate	were	27-fold	higher	in	the	mutant	at	OD	4.5	and	3-fold	higher	at	OD6.5.	Differences	between	the	strains	in	rates	of	uptake	of	nutrients	such	as	alanine	and	glycerol	are	not	sufficient	to	account	the	differences	in	sn-glycerol-3-phosphate,	suggesting	there	is	a	bottleneck	in	glycerol	assimilation	in	the	lasI	rhlI	mutant,	especially	during	early	stationary	phase.	
The	 GC-MS	measurements	 also	 indicated	 that	 amino	 acid	 and	 polyamine	metabolism	 is	affected	in	the	mutant;	nine	of	twenty-two	amino	acid	metabolites	detected	were	perturbed	at	OD	4.5.	The	concentrations	of	the	aromatic	amino	acids	phenylalanine	and	tyrosine	were	higher	in	the	mutant	at	both	OD	4.5	and	6.5.	These	aromatic	amino	acids	share	precursors	from	 the	 shikimic	 acid	 pathway	 with	 QS-regulated	 factors	 including	 phenazines	 and	quinolones.	 There	 were	 several	 indicators	 of	 perturbed	 polyamine	 metabolism:	concentrations	 of	 putrescine	 (four-fold	 by	 OD4.5),	 arginine	 (two-fold	 by	 OD6.5)	 and	ornithine	(four-fold	by	OD6.5)	were	elvated	in	the	mutant.		
The	 concentrations	of	 several	metabolites	 involved	 in	AHL	metabolism	were	perturbed:	methionine,	adenine,	ribose	and	fatty	acids	are	all	linked	to	AHL	synthesis	or	degradation	(Heurlier	et	al.	2006).	Levels	of	adenine	and	methionine	in	the	mutant	were	60-70%	of	wild-type	 at	 OD4.5,	 whereas	 ribose	 concentrations	 were	 almost	 double	 wild-type	 levels.	Methionine,	adenine	and	ribose	are	 involved	 in	 the	synthesis	and	salvage	of	S-adenosyl-methionine	(SAM),	the	precursor	of	the	homoserine	lactone	ring	of	BHL	and	OdDHL.		
The	 concentrations	 of	 six	 out	 of	 the	 seven	 fatty	 acids	detected	 by	 GC-MS	analysis	were	perturbed	in	the	lasI	rhlI	mutant	relative	to	the	wild	type	at	OD	4.5	and/or	OD	6.5:	levels	of	2-hydroxypentanedioic	 were	 up	 to	 5-fold	 higher	 in	 the	 mutant,	 whereas	 levels	 of	 3-hydroxydecanoic	acid,	hexadecanoic	acid,	octadecanoic	acid,	nonanoic	acid	were	reduced	by	 at	 least	 50%.	 The	 concentration	 of	 a	 monounsaturated	 fatty	 acid	 that	 was	 not	
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unambiguously	 identified	was	also	lowered	 in	 the	mutant.	These	data	 indicate	that	 fatty	acid	metabolism	is	markedly	altered	in	the	lasI	rhlI	mutant	during	stationary	phase	growth.		
4.2.8 Cellular	proteomics		
Coverage	of	PAO1	proteome	
Differences	in	protein	abundance	in	the	wild-type	and	lasI	rhlI	mutant	were	measured	using	a	mass-spectrometric	iTRAQ	approach.	Bacterial	cultures	were	sampled	at	OD1.5	and	OD4.5	in	 order	 to	 straddle	 the	 divergence	 in	 cellular	metabolism	 identified	 by	 profiling	 small	molecules.	 In	 total	 931	proteins	were	 identified	 accounting	 for	17%	 of	 PseudoCAP	CDS	annotations	(Winsor	et	al.	2009).	This	 is	comparable	 in	coverage	 to	previous	proteomic	studies	of	P.	aeruginosa,	for	example	that	of	Arevalo-Ferro	et	al.,	who	detected	986	protein	spots	 in	 an	 “intracellular”	 fraction	 analysed	 by	 PAGE	 (Arevalo-Ferro	 et	 al.	 2003)3.	 The	coverage	of	the	proteome	showed	bias	according	to	protein	localisation.	Cytoplasmic	and	periplasmic	 proteins	 are	 overrepresented	 whereas	 membrane-associated	 proteins	 are	underrepresented	(Figure	4.8).	More	highly	expressed	proteins	such	as	ribosomal	subunits	were	better	represented	compared	with	proteins	with	typically	lower	or	condition-specific	expression	profiles	(Figure	4.9).		
Principal	Components	Analysis	 and	Principal	 Least	 Squares	 analysis	were	performed	 to	gauge	the	co-clustering	of	samples	and	to	identify	major	trends	in	the	data	(Figure	4.10).	The	major	trends	correlate	with	growth	phase	(Principal	Component	1)	and	the	genotypic	effect	is	evident	as	the	second	largest	trend	(Principal	Component	2).	This	was	supported	by	Principal	Least	Squares	analysis	using	genotype	and	optical	density	as	independent	(“Y”)	variables.	Univariate	analysis	of	proteins	expression	levels	yielded	similar	patterns	to	the	mulativariate	 analyses:	 This	 indicated	 that	 even	 at	 OD	 1.5,	 28%	 of	 proteins	 were	significantly	modulated	in	the	mutant	relative	to	the	wild-type	and	that	this	increased	to	52%	at	OD	4.5	(Table	4.1).	At	a	false	discovery	threshold	of	10%,	6	proteins	were	modulated	in	the	mutant	at	OD	1.5	and	96	proteins	at	OD	4.5.		
																																																													
3	The	number	of	gel-spots	is	an	overestimate	of	the	number	of	primary	protein	sequences	detected,	due	to	the	influence	of	post-translational	modifications	on	protein	mobility.	
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Figure	4.8	Cellular	distribution	of	proteins	detected	by	tandem	mass	spectrometry.		The	left	panel	illustrates	the	subcellular	localisation	of	proteins.	The	right	panel	illustrates	coverage	of	proteins	in	each	subcellular	local	by	this	study.	The	dotted	line	in	the	right-hand	panel	indicates	the	global	coverage	by	this	study	of	the	PAO1	proteome	(17%).		
	
Figure	4.9	Functional	distribution	of	proteins	detected	by	tandem	mass	spectrometry.		The	dotted	line	in	the	right-hand	panel	indicates	the	global	coverage	by	this	study	of	the	PAO1	proteome	(17%).		
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Figure	4.10	Multivariate	analyses	of	iTRAQ	proteomic	data.		Principal	Components	Analysis	(a)	and	Partial	Least	Squares	Discriminant	Analysis	(b)	illustrate	that	all	four	sample	types	cluster	with	no	outliers	and	that	growth	phase	is	the	largest	trend	in	the	data,	followed	by	genotype.			
Table	4.1	Total	numbers	of	proteins	significantly	modulated	in	the	lasI	rhlI	mutant	relative	to	
wild-type	PAO1.		Bracketed	figures	indicate	the	number	of	proteins	downregulated	in	the	mutant.	Student’s	t-tests	were	performed	to	calculate	p-values.	These	were	used	to	calculate	q-values	using	Storey’s	method	so	 as	 to	 control	 the	 overall	 False	 Discovery	 Rate.	 1− 	@B 0	 is	 Storey’s	 estimate	 of	 the	 portion	 of	significantly	modulated	proteins	(true	alternative	hypotheses)	(Storey	et	al.	2004). 	
	 Growth	phase	effect	Significance	test	 OD	1.5	 OD	4.5	
p	<=	0.01	 26	(11)	 60	(18)	
q	<=	0.05	 4	(1)	 59	(17)	
q	<=	0.1	 6	(3)	 96	(36)	1-@B0	 0.28	 0.52	
wild-type OD4.5
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Slowed	growth,	adaptations	to	oxygen	limitation	and	oxidative	stress	
The	most	striking	difference	between	the	two	strains	during	early	stationary	phase	(OD	4.5)	relates	to	mechanisms	of	protein	synthesis	and	degradation	(Table	4.3).	Of	the	60	proteins	upregulated	in	the	mutant	during	early	stationary	phase,	26	were	linked	to	these	functions,	including	 ribosomal	 proteins,	 elongation	 factors,	 initiation	 factors	 and	 ribosomal	 RNA	processing	 enzymes.	 Levels	 of	 both	 the	 core	 RNA	 polymerase	 beta’	 subunit	 and	 of	 the	exponential	 phase	 sigma	 factor	 RpoD	 were	 over	 40%	 higher	 in	 the	 mutant.	 Enzymes	involved	 in	 biosynthesis	 of	 purines	 (PurK)	 and	 pyrimidines	 (CTP	 synthase	 PyrG)	were	downregulated	in	the	wild-type.	These	changes	to	protein	expression	are	all	consistent	with	the	slower	growth	rate	of	the	wild-type.	
The	lasI	rhlI	mutant	also	showed	lower	expression	of	arginine	deiminase	(ArcA),	catalase	(KatA),	 nitrite	 reductase	 (NirS,	 cytochrome	 cd1)	 and	 azurin	 (a	 nitrite	 reductase	 redox	partner).	These	are	all	regulated	by	the	redox	regulator	Anr	and	are	induced	in	response	to	oxygen	 depletion	 (Trunk	 et	 al.	 2010).	 Arginine	 deiminase	 is	 essential	 for	 arginine	fermentation,	 which	 provides	 energy	 during	 the	 transition	 to	 anaerobiosis	 and	 also	contributes	 to	 longer	 term	anaerobic	survival	 (Schreiber	et	al.	2006;	Trunk	et	al.	2010).	Carbamoyl	 phosphate	 synthetase	 (CarB)	 and	 argininosuccinate	 lyase	 (ArgH)	 (which	catalyse	the	first	and	final	reactions	in	arginine	biosynthesis	from	glutamine,	respectively)	were	also	both	downregulated	in	the	wild-type,	suggesting	a	coordinated	downregulation	of	 arginine	 biosynthesis	 alongside	 induction	 of	 arginine	 fermentation.	 Nitrite	 reductase	catalyses	the	reduction	of	nitrite	to	nitric	oxide	(NO)	during	the	denitrification	pathway	and	is	also	important	in	protecting	against	nitrite-dependent	oxidative	damage	(Scoffield	and	Wu	2016).	Nitrite	reductase	expression	is	induced	under	microaerobic	conditions,	prior	to	other	enzymes	 involved	 in	denitrification	and	this	early	expression	may	be	 important	 in	preparing	 cells	 for	 full	 expression	of	 denitrification	pathways	upon	exposure	 to	nitrate,	nitrite	or	NO	(Alvarez-Ortega	and	Harwood	2007;	Kuroki	et	al.	2014).	In	addition	to	its	role	in	 detoxification	 of	 hydrogen	peroxide	 generated	during	 aerobic	 respiration,	 catalase	 is	induced	under	anaerobic	conditions	and	is	important	in	protecting	the	cell	from	the	toxic	effects	 of	 NO	 during	 anaerobic	 respiration	 (Su	 et	 al.	 2014).	 These	 patterns	 in	 protein	expression	are	consistent	with	a	QS-dependent	advance	in	growth	arrest	and	activation	of	adaptations	to	growth	in	oxygen-depleted	environments.	
Notably,	 the	 two	most	 highly	 upregulated	proteins	 in	 the	wild-type	 are	 involved	 in	 the	biosynthesis	of	the	siderophores	pyochelin	and	pyoverdine	(pyochelin	biosynthesis	protein	PchD	and	pyoverdine	biosynthesis	protein	PvdA).	Pyoverdine	has	previously	been	shown	
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to	be	induced	by	AHL	QS	(Brint	and	Ohman	1995;	Winson	et	al.	1995;	Hentzer	et	al.	2003).	Production	of	siderophores	is	regulated	in	response	to	as	oxidative	stress	as	well	as	iron	availability	 (Cornelis	 et	 al.	 2011).	 Low	availability	of	 iron	 can	 limit	 the	 function	of	 iron-containing	proteins,	some	of	which	are	provide	protective	functions	against	oxidative	stress	(e.g.	catalase).	Furthermore,	ROS	can	damage	such	iron	sulphur	centres.	On	the	other	hand,	higher	concentrations	of	unbound	iron	can	increase	oxidative	damage	by	generating	ROS	via	the	Fenton	reaction.	Increased	siderophore	biosynthesis	in	the	wild-type	again	points	towards	protection	against	oxidative	stress.	
Regulation	of	the	TCA	cycle	and	glyoxylate	shunt		
Several	enzymes	involved	in	central	carbon	metabolism	were	also	differentially	regulated	in	 the	 lasI	 rhlI	 mutant.	 The	 TCA	 cycle	 enzymes	 citrate	 synthase	 (GltA),	 succinate	dehydrogenase	(SdhA)	and	isocitrate	dehydrogenase	(Idh)	are	upregulated	in	the	mutant.	This	 is	 consistent	 with	 higher	 levels	 of	 TCA	 metabolites	 (citrate,	 succinate,	 fumarate,	malate)	observed	by	GC-MS	and	a	greater	flux	through	the	TCA	cycle.	In	contrast	isocitrate	lyase	 (AceA),	 which	 catalyses	 the	 first	 step	 in	 the	 glyoxylate	 shunt	 is	 downregulated.	Relative	flux	through	the	glyoxylate	shunt	and	the	oxidative	CO2-evolving	portion	of	the	TCA	cycle	 is	 controlled	 by	 competition	 between	 Idh	 and	 AceA	 for	 their	 common	 substrate	isocitrate.	The	ratio	of	AceA	to	Idh	levels	is	3-fold	higher	in	the	wild-type,	it	therefore	seems	that	while	the	TCA	cycle	as	a	whole	is	repressed	in	the	wild-type,	the	glyoxylate	shunt	is	activated.	The	glyoxylate	shunt	is	an	anaplerotic	pathway	that	bypasses	the	NADH/NADPH	and	CO2	producing	steps	of	the	TCA	cycle;	it	is	the	first	step	leading	to	gluconeogenesis	as	well	 as	 being	 used	 for	 assimilation	 of	 acetyl-CoA,	derived	 for	 example	 from	 acetate	 re-uptake	or	fatty	acid	degradation	(Cozzone	1998;	Martínez-Gómez	et	al.	2012).	Induction	of	the	glyoxylate	shunt	has	been	shown	to	be	important	under	conditions	of	oxidative	stress,	antibiotic	stress,	and	host	infection	(Dunn	et	al.	2009;	Ahn	et	al.	2016).	The	only	TCA	cycle	enzyme	to	be	downregulated	 in	 the	mutant	was	 fumarate	hydratase	(FumC1;	 to	25%	of	wild-type	levels).	FumC1	encodes	a	superoxide	resistant	fumarase	that	also	participates	in	mixed	 acid	 fermentation	 and	 anaerobic	 respiration.	 It	 belongs	 to	 the	 same	 operon	 as	superoxide	 dismutase	 SodA	 and	 its	 expression	 is	 induced	 in	 response	 to	 low	 iron	 or	oxidative	stress	(Polack	et	al.	1996;	Vinckx	et	al.	2011).	Interestingly,	FumC1	was	one	of	the	few	proteins	to	be	differentially	regulated	during	exponential	growth,	suggesting	it	may	be	part	of	an	early	metabolic	response	to	AHL	QS.	Levels	of	AceF,	a	subunit	of	the	pyruvate	dehydrogenase	complex,	were	30%	lower	in	the	mutant.	The	significance	of	this	is	unclear	
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but	is	likely	linked	to	restructured	fermentative	processes	and	acetate	metabolism,	since	the	mutant	generates	higher	levels	of	extreted	acetate.		
Interestingly	the	sigma	factor	RpoN	is	downregulated	by	over	90%	in	the	wild-type.	Early	work	identified	its	functions	in	regulating	nitrogen	assimilation,	motility	and	cell	adhesion,	however	 RpoN	 has	 subsequently	 been	 found	 to	 negatively	 regulate	 genes	 involved	 in	siderophore	biosynthesis,	the	glyoxylate	shunt	(aceA),	resistance	to	antibiotics	and	quorum	sensing	(Heurlier	et	al.	2003;	Viducic	et	al.	2007;	Hagins	et	al.	2010;	Damron	et	al.	2012).	Although	the	transcriptional	regulatory	mechanisms	of	RpoN	are	not	well	understood,	they	seem	 to	 depend	 on	 the	 stringent	 response	 via	 ppGpp	 concentrations,	 suggesting	 it	 is	involved	in	navigating	transitions	to	less	favourable	environmental	conditions	(Szalewska-Palasz	et	al.	2007).	The	present	data	suggests	that	RpoN	downregulation	plays	a	role	in	the	metabolic	response	to	QS	during	slowed	growth.	
4.3 Discussion	
For	P.	aeruginosa	grown	in	AGSY	medium,	deceleration	from	exponential	growth	occurred	between	3	and	5	h,	and	was	followed	by	consistent	linear	growth	from	5	h	to	10	h.	The	onset	of	linear	growth	(between	4	and	5	h)	coincided	with	accumulation	of	acetate	in	the	culture	supernatant;	given	that	high	concentrations	of	alanine	and	glycerol	remained	in	the	growth	medium	 at	 this	 time	 (>35	mM),	 this	 is	 consistent	with	 acetogenesis	 induced	 by	 oxygen	limitation	(Wolfe	2005).	Acetogenesis	occurs	when	the	influx	of	reduced	carbon	exceeds	the	catabolic	capacity	of	the	TCA	cycle	and	that	of	other	central	metabolic	pathways;	this	can	occur	when	oxygen	is	limited	or	with	high	concentrations	of	highly	assimilable	carbon.	Conversion	 of	 acetyl-CoA	 to	 acetate	 by	 phosphate	 acetyltransferase	 (PTA)	 and	 acetate	kinase	 (AK)	 yields	 ATP	 and	 recycles	 coenzyme	 A	 (CoASH),	 thereby	 relieving	 CoASH	bottlenecks	(e.g.	at	2-ketoglutarate	dehydrogenase)	and	supporting	faster	growth	rates	(El-Mansi	2004).	Acetogenesis	can	also	occur	via	the	pyruvate	oxidase	(PoxB),	which	catalyses	the	 oxidative	 carboxylation	 of	 pyruvate	 directly	 to	 acetate,	 reducing	 flavin	 adenine	dinucleotide	 and	 producing	 CO2.	 Like	 the	 PTA-AK	 pathway,	 PoxB	 activity	 seems	 to	 be	important	 under	 oxygen	 limiting	 conditions	 and	 may	 be	 particularly	 important	 under	microaerophilic	conditions	(Wolfe	2005).	Under	 the	present	growth	conditions,	 it	 seems	that	oxygen	supply	became	limiting	once	the	bacterial	population	reached	an	optical	density	of	~2	(3	h),	resulting	in	reduced	growth	rate	and	induction	of	acetogenic	overflow.		
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Metabolic	footprinting	indicated	that	the	metabolism	of	the	lasI	rhlI	mutant	diverged	from	the	wild-type	as	the	growth	rates	of	both	strains	slowed.	Moreover,	the	growth	of	the	wild-type	slowed	faster	than	that	of	the	lasI	rhlI	mutant	and	this	coincided	with	increased	activity	of	 the	 las	 and	 rhl	QS	 systems	 in	 the	wild-type	 strain,	 as	measured	by	 concentrations	of	OdDHL	and	BHL	and	by	 transcription	 from	 lasB	and	rhlA	promoters.	Consistent	with	 its	reduced	growth	 rate,	 levels	 of	 factors	 involved	 transcription,	 translation	 and	nucleotide	biosynthesis	were	depressed	in	the	wild-type.		
How	might	QS	slow	growth?	One	explanation	for	the	reduced	growth	rate	of	the	wild-type	is	QS-directed	allocation	of	biomass	and	energy	towards	biosynthesis	of	secreted	factors	That	QS-regulated	products	are	metabolically	costly	and	are	likely	to	impose	an	energetic	burden	 on	 the	 producer	 was	 illustrated	 by	 Sandoz	 et	 al.,	 who	 cocultured	 wild-type	 P.	
aeruginosa	 and	 a	 lasR	 mutant	 under	 conditions	 in	 which	 QS-dependent	 extracellular	proteases	are	required	for	growth	(Sandoz	et	al.	2007);	the	lasR	mutant	(which	could	exploit	the	secreted	proteases—“public	goods”	made	by	the	wild	type)	grew	approximately	60%	faster	 than	 its	wild-type	 counterpart.	 The	 redirection	of	metabolic	 resources	 away	 from	central	metabolism	and	toward	QS-dependent	biosynthesis	may,	in	part,	explain	why	the	wild	type	was	more	depleted	of	TCA	cycle	intermediates	compared	with	the	lasI	rhlI	mutant.		
However,	the	wild-type	displayed	patterns	of	metabolite	and	protein	levels	associated	with	not	just	slowed	growth,	but	adaptation	to	microaerobiosis,	suggesting	that	effects	of	QS	on	primary	metabolism	 beyond	 simple	diversion	 of	 biomass	 towards	 synthesis	 of	 secreted	products:	in	addition	to	TCA	cycle	intermediates	and	enzymes	being	downregulated	in	the	wild-type,	enzymes	responsible	 for	the	glyoxylate	shunt	and	arginine	fermentation	were	elevated.	Elevated	 levels	of	catalase	and	 the	siderophores	pyoverdine	and	pyochelin	are	also	linked	to	protection	from	oxidative	stress.	These	changes	are	typical	of	growth	under	oxygen	 limiting	conditions	and	 imply	 that	wild-type	QS	directs	precocious	adaptation	to	microaerobiosis.		
An	additional	consideration	 is	that	QS-mediated	changes	to	primary	metabolism	may	be	induced	via	manipulation	of	 the	cellular	environment:	 the	 las	and	rhl	 systems	positively	regulate	a	number	of	 factors	 that	 can	 influence	 cellular	 redox	 state	 and	oxidative	stress	including	 rhamnolipid	 surfactants,	 phenazine	 redox	 shuttles,	 siderophores	 and	 catalase.	For	 example	 work	 by	 Sabra	 et	 al.	 and	 Kim	 et	 al.	 demonstrated	 that	 P.	 aeruginosa	 can	manipulate	the	oxygen	transfer	rate	of	cultures	and	that	this	is	enhanced	by	iron	deficiency	(Sabra	et	al.	2002;	Kim	et	al.	2003).	Conversely	quorum	sensing	is	strongly	affected	by	both	oxygen	and	iron	concentrations	(Bollinger	et	al.	2001;	Kim	et	al.	2005).	It	therefore	seems	
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that	quorum	sensing	both	responds	to	and	in	turn	influences	oxidative	potential	within	the	cell,	 which	 could	 help	 explain	 many	 of	 the	 observed	 changes	 to	 primary	 metabolism	including	to	the	TCA	cycle,	glyoxylate	shunt	and	arginine	fermentation.		
In	summary,	analysis	of	cellular	metabolic	profiles	demonstrated	that	 the	mutant	differs	from	 the	 wild-type	 in	 most	 major	 domains	 of	 metabolism;	 the	 timing	 and	 diversity	 of	metabolites	affected	suggests	that	the	las	and	rhl	systems	are	involved	in	a	global	rewiring	of	metabolism	during	the	transition	from	exponential	to	stationary	phase	growth.		
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Table	4.2	Cellular	metabolic	profiles	recorded	by	MSFTA-GCMS.	Bacterial	cultures	were	sampled	at	OD600	1.5,	2.5,	4.5	and	6.5.	A	methanol-chloroform	extraction	was	used	to	isolate	metabolites	prior	to	being	derivatised	with	MSTFA	and	analysed	by	GCMS.	Data	is	ordered	by	p-value	at	OD600	4.5.	Asterisks	indicate	significant	differences	(*P<=0.05,	**	P<=0.01,	two-tailed	Student’s	t	test).	Multiple	MSFTA	derivatives	of	the	same	metabolite	are	indicated	by	Arabic	numerals	in	brackets.	ND	=	not	detected.	
Metabolite	 Fold	change	(lasI	rhlI	mutant	/	wild-type)	OD600	=	1.5	 OD600	=	2.5	 OD600	=	4.5	 OD600	=	6.5	Glycerophosphoric	acid	 1.3	 2.1	 27**	 3**	2-Hydroxypentanedioic	acid	 1.2	 1.9	 5.4**	 3.1**	3-Pyridinecarboxamide	(Nicotinamide)	 1.1	 1.2	 2.2**	 2.8**	Pentose-phosphate	 1.2	 1.1	 16.5**	 10.1**	Phenylalanine	(2)	 0.8	 0.6	 0.5**	 2.3	3-Hydroxydecanoic	acid	 0.9	 1.1	 0.3**	 0.1**	Trehalose	 1.3	 1.1	 4.3**	 ND	Hypoxanthine	(6-Hydroxypurine)	 1.2	 1.7	 2.4**	 2.5	Glutaric	acid	 1.2	 0.7	 0.4**	 1.2	Monosaccharide	 1.1	 1.1	 1.8**	 1.9**	Aromatic	 0.9	 1.1	 2.8**	 4.4*	Citric	acid	 0.9	 1.6	 2**	 2.7**	Fructose	6-phosphate	 1.1	 1.8	 2.8**	 2.9*	5-Aminopentanoic	acid	 1.1	 1	 3.5**	 6.5	Inositol	 1	 1.1	 1.6**	 1.6**	Citramalic	acid	 0.8	 0.8	 1.8**	 3.8**	Ribose	 1.2	 1.7	 1.9**	 2.5**	Methionine	 1.2	 0.7	 0.7**	 0.5**	Ribofuranose	 1.2	 1.1	 0.6**	 0.7*	Malic	acid	 0.8	 1.1	 1.6**	 1.3	Hexose-phosphate	 0.8	 1.8	 3.1**	 2.4*	Aspartic	acid	 1.2	 0.8	 0.6**	 0.8	Tyrosine	(1)	 1.3	 0.9	 0.6*	 0.8	Adenine	 1.1	 0.8	 0.6*	 0.7*	Hexose-phosphate	 0.9	 1.8	 2.7*	 2*	Glutamic	acid	 0.7	 0.7	 2*	 2.5	Pyrimidine	 1.5	 1.2	 1.7*	 1.9	
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Alkane	 1.2	 0.7	 0.6*	 0.5**	Putrescine	(2)	 0.8	 1.2	 4.3*	 5.9*	Phenylalanine	(1)	 1	 0.9	 0.5*	 1.9	Glucose	or	galactose	 1.8	 1.1	 0.7*	 0.5	Amino	acid	 1	 0.7	 1.4*	 1.2	Alkane	 1	 0.8	 0.5*	 0.5*	Long	chain	alcohol	 1.4	 0.8	 0.5*	 0.6**	Hexadecanoic	acid	 1.2	 0.7	 0.5*	 0.5**	N-acetylglutamic	acid	(1)	 0.9	 1.2	 1.9*	 1.9	Mono-unsaturated	fatty	acid	(1)	 1	 1	 0.5*	 0.5*	Hexose-phosphate	 1.2	 3.2	 2.9*	 4.3**	Tyrosine	(2)	 1	 0.7	 0.5*	 1.9	Alkane	 1	 0.7	 0.6	 0.4*	Alkane	 1.4	 0.6	 0.5	 ND	Aromatic	 0.8	 1	 0.7	 0.7	Octadecanol	 1.3	 0.5	 0.5	 0.6	Nonanoic	acid	 1.2	 0.8	 0.5	 0.7*	d-altro-2-Heptulose,	7-(dihydrogen	phosphate)	 1.2	 3.8	 3	 5.2**	Octadecanoic	acid	 1.3	 0.7	 0.5	 0.4**	Spermidine	 1	 1.2	 1.7	 3.5	Polyamine	 1	 1.3	 2.7	 4.8	5'-Adenylic	acid	(AMP)	 1.5	 0.8	 0.3	 0.1*	Putrescine	(1)	 0.6	 1.3	 6	 5.3	Lysine	 0.9	 0.6	 1.6	 3.3	1-Monopalmitoylglycerol	 1.4	 1.1	 0.6	 0.7*	Cysteine	 0.6	 0.5	 0.7	 0.6	Aromatic	 1.5	 0.7	 0.5	 0.3**	Succinate	 1.1	 1	 1.2	 1.4*	Octacosane	 1.3	 0.7	 0.5	 0.5*	Glycerol	 1	 0.9	 1.2	 1.2	Arginine	 1	 0.8	 1.4	 2.3**	Alkane	 1	 0.6	 0.5	 0.5**	Long	chain	alcohol	 1.3	 1	 1.5	 1.1	Fumaric	acid	 1.2	 1.1	 1.2	 1.4**	Adenosine	 1	 0.9	 0.7	 0.1	Threonine	(2)	 1.1	 1	 0.2	 1.1	
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N-acetyl	glucosamine	 1.1	 1	 1.2	 1	Alkane	 1.4	 0.6	 0.6	 0.5	Pyroglutamic	acid	 1.1	 1.1	 1.2	 0.9	5'-Uridylic	acid	(UMP)	 1.9	 1.4	 1.8	 3.2	Glucose	or	Galactose	 1.1	 1.2	 0.9	 1.4*	Pantothenic	acid	 0.9	 1.1	 1.3	 1.5*	Valine	 1.1	 1.1	 1.2	 2.3	Threonine	(1)	 1.3*	 1	 0.2	 0.8	Glucose	or	Galactose	 1.2	 1.3	 0.9	 2**	Glycine	 0.9	 1.1	 1.2	 1	Proline	 1.1	 0.8	 1.1	 0.9	Beta-alanine	 1	 1.1	 1.2	 0.4*	Alkane	 1.3	 0.6	 0.7	 ND	Ornithine	 0.8	 0.5	 0.6	 4*	Monosaccharide	 0.9	 0.9	 0.9	 ND	Tetradecanoic	acid	 1	 0.7	 0.8	 1	Glucose	or	Galactose	 2.2	 1.4	 0.9	 1.4*	4-Aminobutyric	acid	 1.1	 1	 0.9	 0.5	Ribofuranose	 1.7	 1.3	 1.3	 0.6	Uracil	 1.3	 1.2	 1	 1.1	
S-Methyl-5-thioadenosine	 1.5	 1.5	 0.9	 2.1	N-acetyl	glutamic	acid	(2)	 1.1	 1.1	 0.9	 0.7	Ethanol,	2-amino-	 0.7	 0.5	 0.9	 4.1	2-Glycerophosphoric	acid	 1	 1	 1	 1.1	Xanthine	 1	 1.3	 0.9	 6.9	Ethanethioic	acid	S-(3-methylbutyl)	ester	 1	 0.8	 1	 1.3	2-Methylbenzoic	acid	(o-Toluic	acid)	 0.8	 0.9	 1	 1.8	
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Table	4.3	Proteins	differentially	regulated	in	the	lasI	rhlI	mutant.		Protein	levels	were	measured	by	iTRAQ	MS.	Fold-change	was	calculated	as	wild-type/mutant.	P	values	were	calculated	by	Welch	t-tests	and	adjusted	to	Storey’s	q-values	to	control	the	false	discovery	rate.	Proteins	are	listed	where	q<=0.1.	…Cont.	PA	No.	 Gene	name	 Protein	description	 Fold-change	 p	value	 q	value		
Proteins	up-regulated	in	the	wild-type	compared	to	the	lasI	rhlI	mutant	at	OD	1.5	
	 	 	
PA1904	 phzF2	 probable	phenazine	biosynthesis	protein	 14.12	 4.07E-04	 0.044	PA0588	 	 conserved	hypothetical	protein	 3.98	 5.92E-05	 0.014	PA4470	 fumC1	 fumarate	hydratase	 3.54	 6.30E-04	 0.058		
Proteins	down-regulated	in	the	wild-type	compared	to	the	lasI	rhlI	mutant	at	OD	1.5	 	 	 	PA5316	 rpmB	 50S	ribosomal	protein	L28	 0.07	 1.77E-06	 0.001	PA4268	 rpsL	 30S	ribosomal	protein	S12	 0.24	 1.23E-04	 0.014	PA5555	 atpG	 ATP	synthase	gamma	chain	 0.4	 9.54E-05	 0.014		
Proteins	up-regulated	in	the	wild-type	compared	to	the	lasI	rhlI	mutant	at	OD	4.5	 	 	 	PA4228	 pchD	 pyochelin	biosynthesis	protein	PchD	 9.34	 6.30E-03	 0.039	PA2386	 pvdA	 L-ornithine	N5-oxygenase	 6.27	 1.45E-03	 0.032	PA0660	 	 hypothetical	protein	 4.77	 1.83E-03	 0.032	PA4470	 fumC1	 fumarate	hydratase	 4.09	 4.30E-03	 0.035	PA0519	 nirS	 nitrite	reductase	precursor	 3.83	 2.28E-04	 0.01	
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…Cont.	PA	No.	 Gene	name	 Protein	description	 Fold-change	 p	value	 q	value	PA2003	 bdhA	 3-hydroxybutyrate	dehydrogenase	 3.32	 3.70E-02	 0.099	PA0283	 sbp	 sulphate-binding	protein	precursor	 3.26	 2.38E-02	 0.086	PA3450	 lsfA	 1-Cys	peroxiredoxin	LsfA	 2.63	 1.02E-02	 0.051	PA4922	 azu	 azurin	precursor	 2.55	 2.99E-04	 0.011	PA0744	 	 probable	enoyl-CoA	hydratase/isomerase	 2.49	 3.86E-02	 0.099	PA4226	 pchE	 dihydroaeruginoic	acid	synthetase	 2.45	 1.61E-02	 0.067	PA1456	 cheY	 two-component	response	regulator	CheY	 2.34	 1.43E-02	 0.063	PA4495	 	 hypothetical	protein	 2.28	 2.44E-02	 0.087	PA2204	 	 probable	binding	protein	component	of	ABC	transporter	 2.15	 2.29E-02	 0.086	PA0139	 ahpC	 alkyl	hydroperoxide	reductase	subunit	C	 2.08	 2.18E-02	 0.084	PA1094	 fliD	 flagellar	capping	protein	FliD	 2.04	 8.55E-03	 0.046	PA5171	 arcA	 arginine	deiminase	 1.98	 9.09E-03	 0.048	PA0459	 	 probable	ClpA/B	protease	ATP	binding	subunit	 1.96	 1.82E-03	 0.032	PA3712	 	 hypothetical	protein	 1.94	 4.96E-03	 0.036	PA4461	 lptB	 Lipopolysaccharide	export	system	ATP-binding	protein	LptB	 1.82	 9.92E-03	 0.05	PA4236	 katA	 catalase	 1.78	 1.42E-02	 0.063	PA2634	 aceA	 isocitrate	lyase	AceA	 1.75	 2.85E-02	 0.096	PA1337	 ansB	 glutaminase-asparaginase	 1.73	 1.58E-02	 0.067	PA3440	 	 conserved	hypothetical	protein	 1.67	 1.53E-02	 0.066	PA4370	 icmP	 Insulin-cleaving	metalloproteinase	outer	membrane	protein	precursor	 1.63	 1.81E-02	 0.074	
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…Cont.	PA	No.	 Gene	name	 Protein	description	 Fold-change	 p	value	 q	value	PA3988	 lptE	 LPS-assembly	lipoprotein	LptE	 1.62	 3.68E-03	 0.035	PA3171	 ubiG	 3-demethylubiquinone-9	3-methyltransferase	 1.6	 8.20E-03	 0.045	PA5373	 betB	 betaine	aldehyde	dehydrogenase	 1.46	 1.10E-02	 0.054	PA2823	 	 conserved	hypothetical	protein	 1.45	 6.16E-03	 0.039	PA5016	 aceF	 dihydrolipoamide	acetyltransferase	 1.41	 5.39E-03	 0.036	PA0423	 pasP	 PasP	 1.39	 1.83E-02	 0.074	PA1292	 	 probable	3-mercaptopyruvate	sulphurtransferase	 1.38	 7.72E-03	 0.044	PA0546	 metK	 methionine	adenosyltransferase	 1.3	 1.40E-02	 0.063	PA5134	 ctpA	 carboxyl-terminal	processing	protease,	CtpA	 1.3	 1.34E-02	 0.063	PA4079	 	 probable	dehydrogenase	 1.26	 1.86E-03	 0.032	PA4971	 aspP	 adenosine	diphosphate	sugar	pyrophosphatase	 1.23	 3.49E-03	 0.035		
Proteins	down-regulated	in	the	wild-type	compared	to	the	lasI	rhlI	mutant	at	OD	4.5	 	 	 	PA5425	 purK	 phosphoribosylaminoimidazole	carboxylase	 0.04	 3.28E-03	 0.035	PA4566	 obg	 GTP-binding	protein	Obg	 0.06	 1.89E-04	 0.01	PA4462	 rpoN	 RNA	polymerase	sigma-54	factor	 0.08	 1.82E-03	 0.033	PA4433	 rplM	 50S	ribosomal	protein	L13	 0.16	 7.15E-05	 0.007	PA0025	 aroE	 shikimate	dehydrogenase	 0.21	 2.10E-03	 0.032	PA0140	 ahpF	 alkyl	hydroperoxide	reductase	subunit	F	 0.24	 1.40E-02	 0.063	PA4042	 xseB	 exodeoxyribonuclease	VII	small	subunit	 0.26	 3.09E-02	 0.094	
		
93		
…Cont.	PA	No.	 Gene	name	 Protein	description	 Fold-change	 p	value	 q	value	PA0865	 hpd	 4-hydroxyphenylpyruvate	dioxygenase	 0.28	 4.15E-03	 0.035	PA4268	 rpsL	 30S	ribosomal	protein	S12	 0.29	 4.62E-03	 0.035	PA5036	 gltB	 glutamate	synthase	large	chain	precursor	 0.31	 2.34E-02	 0.086	PA4241	 rpsM	 30S	ribosomal	protein	S13	 0.32	 2.99E-03	 0.035	PA4563	 rpsT	 30S	ribosomal	protein	S20	 0.32	 6.23E-04	 0.021	PA1580	 gltA	 citrate	synthase	 0.37	 5.05E-03	 0.036	PA4253	 rplN	 50S	ribosomal	protein	L14	 0.37	 6.07E-03	 0.039	PA4274	 rplK	 50S	ribosomal	protein	L11	 0.38	 1.89E-03	 0.032	PA4244	 rplO	 50S	ribosomal	protein	L15	 0.39	 5.29E-03	 0.036	PA0782	 putA	 proline	dehydrogenase	PutA	 0.4	 5.48E-03	 0.036	PA3645	 fabZ	 (3R)-hydroxymyristoyl-[acyl	carrier	protein]	dehydratase	 0.41	 3.83E-03	 0.035	PA4240	 rpsK	 30S	ribosomal	protein	S11	 0.41	 2.76E-03	 0.035	PA4246	 rpsE	 30S	ribosomal	protein	S5	 0.41	 1.06E-03	 0.027	PA4262	 rplD	 50S	ribosomal	protein	L4	 0.43	 1.81E-02	 0.074	PA4249	 rpsH	 30S	ribosomal	protein	S8	 0.49	 1.58E-04	 0.01	PA4465	 	 conserved	hypothetical	protein	 0.49	 7.90E-03	 0.045	PA5054	 hslU	 heat	shock	protein	HslU	 0.5	 7.60E-04	 0.023	PA4247	 rplR	 50S	ribosomal	protein	L18	 0.51	 3.37E-05	 0.007	PA1583	 sdhA	 succinate	dehydrogenase	(A	subunit)	 0.55	 4.65E-03	 0.035	PA0579	 rpsU	 30S	ribosomal	protein	S21	 0.56	 2.70E-03	 0.035	
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…Cont.	PA	No.	 Gene	name	 Protein	description	 Fold-change	 p	value	 q	value	PA2967	 fabG	 3-oxoacyl-[acyl-carrier-protein]	reductase	 0.56	 2.03E-02	 0.079	PA3068	 gdhB	 NAD-dependent	glutamate	dehydrogenase	 0.56	 4.98E-03	 0.036	PA4756	 carB	 carbamoylphosphate	synthetase	large	subunit	 0.56	 2.11E-03	 0.032	PA3742	 rplS	 50S	ribosomal	protein	L19	 0.57	 4.43E-03	 0.035	PA2624	 idh	 isocitrate	dehydrogenase	 0.58	 3.15E-03	 0.035	PA5263	 argH	 argininosuccinate	lyase	 0.58	 1.13E-02	 0.055	PA4744	 infB	 translation	initiation	factor	IF-2	 0.59	 4.54E-03	 0.035	PA5552	 glmU	 glucosamine-1-phosphate	acetyltransferase/N-acetylglucosamine-1-phosphate	uridyltransferase	 0.59	 6.08E-05	 0.007	PA2619	 infA	 initiation	factor	 0.6	 3.50E-03	 0.035	PA2976	 rne	 ribonuclease	E	 0.6	 8.34E-03	 0.045	PA4252	 rplX	 50S	ribosomal	protein	L24	 0.6	 2.40E-03	 0.033	PA4258	 rplV	 50S	ribosomal	protein	L22	 0.6	 2.07E-04	 0.01	PA4269	 rpoC	 DNA-directed	RNA	polymerase	beta	chain	 0.6	 1.47E-03	 0.032	PA2740	 pheS	 phenylalanyl-tRNA	synthetase,	alpha-subunit	 0.61	 9.39E-04	 0.026	PA4996	 rfaE	 LPS	biosynthesis	protein	RfaE	 0.64	 6.38E-03	 0.039	PA4568	 rplU	 50S	ribosomal	protein	L21	 0.65	 3.21E-03	 0.035	PA4257	 rpsC	 30S	ribosomal	protein	S3	 0.66	 4.13E-03	 0.035	PA4266	 fusA1	 elongation	factor	G	 0.66	 2.35E-03	 0.033	PA0008	 glyS	 glycyl-tRNA	synthetase	beta	chain	 0.68	 2.84E-02	 0.096	
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…Cont.	PA	No.	 Gene	name	 Protein	description	 Fold-change	 p	value	 q	value	PA0576	 rpoD	 sigma	factor	RpoD	 0.69	 1.34E-02	 0.063	PA2742	 rpmI	 50S	ribosomal	protein	L35	 0.69	 3.86E-02	 0.099	PA3655	 tsf	 elongation	factor	Ts	 0.69	 3.25E-03	 0.035	PA5117	 typA	 regulatory	protein	TypA	 0.69	 7.52E-03	 0.044	PA4481	 mreB	 rod	shape-determining	protein	MreB	 0.71	 9.65E-03	 0.05	PA4686	 	 hypothetical	protein	 0.72	 2.72E-02	 0.094	PA4760	 dnaJ	 DnaJ	protein	 0.74	 6.51E-03	 0.039	PA4670	 prs	 ribose-phosphate	pyrophosphokinase	 0.75	 2.48E-02	 0.087	PA4263	 rplC	 50S	ribosomal	protein	L3	 0.76	 1.61E-02	 0.067	PA3637	 pyrG	 CTP	synthase	 0.77	 4.34E-03	 0.035	PA1794	 glnS	 glutaminyl-tRNA	synthetase	 0.78	 1.91E-02	 0.076	PA0555	 fda	 fructose-1,6-bisphosphate	aldolase	 0.79	 2.48E-02	 0.087	PA1544	 anr	 transcriptional	regulator	Anr	 0.8	 2.34E-02	 0.086	PA3001	 	 probable	glyceraldehyde-3-phosphate	dehydrogenase	 0.85	 2.36E-02	 0.086	
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Chapter	5 		Focused	metabolic	profiling	of	fatty	acids	
5.1 Introduction	
Experiments	described	in	Chapter	4	indicate	that	fatty	acid	metabolism	is	perturbed	in	a	
lasI	 rhlI	 double	 mutant	 during	 early	 post-exponential	 growth:	 a)	 several	 fatty	 acid	metabolites	were	differentially	modulated	in	aqueous	cellular	extracts,	b)	although	only	a	few	fatty	acid	genes	were	identified	by	mass	spectrometric	proteomic	analysis,	two	(FabG	and	FabZ)	were	downregulated	in	the	lasI	rhlI	mutant.	Previously	reported	transcriptomic	data	acquired	across	a	number	of	growth	conditions	shows	that	transcripts	involved	fatty	acid/phospholipid	metabolism	are	highly	represented	in	the	“core”	QS	regulon,	though	it	is	not	obvious	what	impact	these	changes	to	gene	expression	might	have	on	membrane	FA	composition	(Schuster	and	Peter	Greenberg	2006).	Prompted	by	 these	observations,	 the	present	 chapter	 describes	 experiments	 designed	 to	 provide	 a	 targeted,	 more	comprehensive	analysis	of	the	effects	of	AHL	QS	on	fatty	acid	metabolism.		
Aims	and	objectives:	To	characterise	the	impact	of	las	and	rhl	QS	on	fatty	acid	metabolism	in	batch	culture	by	comparing	the	FA	profiles	of	wild-type	PAO1	and	a	lasI	rhlI	mutant.	FA	profiles	were	assessed	using	fatty	acid	methyl	ester	(FAME)	GC-MS	to	analyse	the	total	fatty	acid	content	of	organic-phase	cell	extracts.	This	approach	will	enable	measurement	of	the	total	fatty	acid	pool	including	both	free	fatty	acids	and	fatty	acid	residues	from	lipids.	The	roles	of	the	las	and	rhl	systems	were	compared	by	complementing	the	signal-null	lasI	rhlI	mutant	with	exogenous	AHLs.	
Data	presented	here	has	been	published	 in	the	 Journal	of	Bacteriology	(Davenport	et	al.	2015).	
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5.2 Results	
5.2.1 AHL-complementation	of	the	lasI	rhlI	mutant	growth	
advantage		
Planktonic	 cultures	 of	 P.	 aeruginosa	 were	 grown	 in	 AGSY	 medium.	 The	 growth	characteristics	of	the	wild-type	PAO1	strain	and	the	las	rhlI	mutant	were	similar	to	those	reported	in	Chapter	3,	with	the	mutant	beginning	to	achieve	higher	optical	density	as	the	bacterial	growth	rate	decelerated	around	4	hours.	The	lasI	rhlI	mutant	was	also	grown	with	exogenously	supplemented	AHLs:	either	BHL	(10	µM),	OdDHL	(15µM)	or	both.	The	AHL-complemented	cultures	had	growth	phenotypes	intermediate	to	the	wild-type	and	the	lasI	
rhlI	mutant,	 indicating	 that	 the	 activities	 of	 both	 the	 rhl	 and	 las	 systems	 influences	 the	growth	rate	of	P.	aeruginosa	(Figure	5.1).		
Complementation	of	the	lasI	rhlI	mutant	with	BHL,	OdDHL	or	both	resulted	in	a	decrease	in	optical	density	relative	to	the	mutant	alone	(P<=0.01	in	each	case).	For	ANCOVA	analyses,	the	 optical	 density	 of	 cultures	 between	 5	 and	 10	hours	were	 treated	 as	 the	 dependent	variable,	time	as	a	covariate	and	the	growth	conditions	(strain	and	AHL	complementation)	as	the	independent	variable;	Tukey’s	“Honest	Significant	Difference”	method	was	used	to	calculate	p	values.	Data	represent	four	biological	replicates.	
5.2.2 	Evaluation	of	FAME-GCMS	analysis	of	P.	aeruginosa	cell	
extracts	
In	order	 to	 assess	 fatty	 acid	profiles,	 dried	aliquots	of	 the	organic	phase	of	 chloroform-methanol	cell	extracts	were	incubated	with	boron	trifluoride	in	methanol.	This	results	in	esterification	of	the	free	fatty	acids	to	fatty	acid	methyl	esters	(FAMEs)	by	methylation	of	the	carboxyl	group,	thereby	enabling	chromatographic	separation	and	analysis	by	GCMS.	Fatty	acid	lipid	esters	of	acyl-lipids	are	also	converted	to	FAME	by	direct	transesterification	(alcoholysis)	during	this	 incubation	(Eder	1995).	Thirteen	 fatty	acids	were	 identified	by	analysis	 of	 organic	 phase	 extracts	 of	 wild-type	 PAO1.	 These	 included	 saturated	 (SFA),	unsaturated	(UFA)	and	cyclopropane	(CPFA)	fatty	acids.	Although	the	full	complement	of	expected	 phospholipid-linked	 fatty	 acids	 was	 observed,	 no	 hydroxyl	 fatty	 acids	 were	detected.	 This	 consisted	 with	 previous	 observations	 that	 the	 boron	 trifluoride	derivatisation	method	is	inefficient	at	releasing	hydroxy	fatty	acids	from	lipid	A.		
Metabolic	profiling	of	fatty	acids	
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Figure	5.1	Cell	growth	of	lasI	rhlI	and	AHL-complemented	cultures.		Growth	phenotypes	of	wild-type	PAO1,	the	lasI	rhlI	mutant	and	the	mutant	complemented	with	exogenous	BHL	(10	µM),	OdDHL	(15	µM)	or	both,	plotted	with	optical	density	on	log10	(a)	or	linear	(b)	scales.	All	cultures	were	grown	in	AGSY	medium.	No	significant	differences	in	 optical	 density	 were	 found	 during	 exponential	 phase	 growth	 (1-3	 hours,	 p<=0.05,	Student’s	 t-test	 or	 ANCOVA).	 As	 per	 chapter	 2,	 small	 but	 significant	 differences	 growth	between	the	wild-type	and	lasI	rhlI	mutant	were	evident	following	a	deceleration	in	growth	between	3	and	4	hours:	this	was	evident	when	assessed	by	Student’s	t	tests	(indicated	by	asterisks	 in	 (a),	 *	 p<=0.05,	 **	 P<=0.01)	 and	 by	 ANCOVA	 (p<=0.001,	 Tukey’s	 HSD,	considering	data	between	5	and	10	hours).	
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Table	5.1	Fatty	acid	profiles	of	bacterial	cells	as	determined	by	FAME	GCMS	analysis.		Fatty	acid	profiles	of	bacterial	cells	as	determined	by	FAME	GCMS	analysis.	Percent	complementation	was	calculated	as	the	percentage	return	towards	the	wild-type	phenotype	(values	are	shown	only	where	P<=0.05).	Student’s	t-tests	were	calculated	relative	to	the	wild-type	(WT,	for	mean	percentages)	or	to	the	lasI	rhlI	mutant	(LIRI,	for	percent	complementation).	Asterisks	indicate	significant	differences	(*P<=0.05,	**	P<=0.01,	two-tailed	Student’s	t	test).	Upwards	(↑)	and	downwards	(↓)	arrows	indicate	an	increase	or	decrease	in	response	to	chemical	complementation,	respectively	(relative	to	the	lasI	rhlI	mutant).	Abbreviations:	SFA	=	saturated	fatty	acid,	CUFA	=	cis-unsaturated	fatty	acid,	CPFA	=	cyclopropane	fatty	acid,	ACCL	=	average	carbon	chain	length.	Individual	fatty	acids	are	indicated	according	to	the	carboxyl-reference	system,	for	example	“9Z-16:1”	indicates	a	fatty	acid	with	a	16	carbon	acyl	chain	containing	a	cis	C=C	double	bond	at	the	ninth	position	from	the	carboxyl	carbon	(hexadec-9-enoic	acid,	or	palmitoleic	acid).	“⎯”	=	not	significant.		
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Fatty acids PAO1 LIRI PAO1 LIRI PAO1 LIRI PAO1 LIRI BHL OdDHL BHL+OdDHL BHL OdDHL BHL+OdDHL
12:0 0 0 0 0.1 0.1 0 0.4 0.2** - - - 97**(↓) 35**(↓) 109**(↓)
15:0 1.5 1.7** 1.5 1.8** 1.2 2.2** 2.3 3.5** - - 128*(↓) 76**(↓) 43**(↓) 102**(↓)
7Z-14:1 0.1 0.1 0 0 0 0 0.1 0.1** - - - 84**(↓) 53**(↓) 92*(↓)
9Z-14:1 0.2 0.1 0.2 0.2 0.2 0.1 0.6 0.5 - - - - - -
15:0 0.2 0.3 0.3 0.3 0.2 0.2 0.2 0.2 - - -287*(↑) - 86*(↑) 203*(↑)
16:0 39 39 39 38.8 40.2 41.6** 38.3 41.7** - - - - - 135*(↓)
9Z-16:1 18 18.7** 18 19** 14.4 18.4** 10.1 15.7** - - - 69**(↓) 28**(↓) 82**(↓)
17:0 0.1 0.1 0.1 0.1** 0.1 0.1** 0.3 0.3 - - 19353*(↑) 46**(↑) 29**(↑) 126*(↑)
9cyc-17:0 0.3 0.3 0.3 0.3 1.6 1** 3.5 2.1** 46**(↑) - 116*(↑) 64**(↑) 24**(↑) 44**(↑)
18:0 5.2 5.1 5.6 5.2 4.9 4** 14 10.7** - - 132**(↑) 57**(↑) - 73*(↑)
11Z-18:1 35.2 34.5** 34.6 34 35.6 31.9** 26.7 24.1** - - 172*(↑) 62**(↑) 34**(↑) 111**(↑)
11cyc-19:0 0.1 0.1** 0.1 0.1 1.2 0.4** 3.5 0.7** 2**(↑) - 112*(↑) 54**(↑) 16**(↑) 52**(↑)
13Z-22:1 0.1 0.1 0.1 0.1 0.1 0** 0.2 0.2 - - - - - -
Sum SFA 46 46.2 46.6 46.3 46.8 48.1** 55.5 56.6 67*(↓) - 245*(↓) 43**(↓) 36**(↓) 128**(↓)
Sum CUFA 53.5 53.4 53 53.3 50.4 50.5 37.6 40.5** - - - - - 314*(↑)
Sum CPFA 0.5 0.3** 0.4 0.4 2.9 1.4** 7 2.8** 27**(↑) - 115*(↑) 59**(↑) 20**(↑) 48**(↑)
ACCL 16.8 16.8** 16.8 16.7 16.8 16.7** 16.8 16.6** - - 166*(↑) 62**(↑) 32**(↑) 101**(↑)
All 0.7 0.7** 0.7 0.7 0.7 0.6** 0.9 0.6** - - 173**(↑) 57**(↑) 28**(↑) 102**(↑)
SFA 0.1 0.1 0.1 0.1 0.1 0.1** 0.4 0.3** - - 148**(↑) 52**(↑) - 80*(↑)
CUFA 2 1.8** 1.9 1.8** 2.5 1.7** 2.7 1.5** - - 144*(↑) 60**(↑) 26**(↑) 90**(↑)
CPFA 0.4 0.3** 0.4 0.3 0.8 0.4** 1 0.4** - - - 56**(↑) 16**(↑) 80**(↑)
CUFA+CPFA 1.9 1.8** 1.9 1.8** 2.3 1.7** 2.2 1.4** - - 145*(↑) 61**(↑) 27**(↑) 95**(↑)
% Complementation
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5.2.3 Wild-type	fatty	acid	profiles	show	increased	saturation	and	
cyclopropanation	during	transition	to	stationary	phase	growth		
Wild-type	 fatty	 acid	 profiles	 were	 similar	 to	 those	 measured	 in	 other	 studies	 of	 P.	
aeruginosa	(Hancock	and	Meadow	1969;	Baysse	et	al.	2005;	Zhu	et	al.	2006).	Hexadecanoic	acid	(39%),	(Z)-11-octadecenoic	acid	(35%)	and	(Z)-9-hexadecanoic	acid	(18%)	were	the	predominant	species,	together	accounting	for	92%	of	measured	fatty	acids	(Table	5.1).	The	wild-type	 saturated	 fatty	 acid	 (SFA)	 content	 increased	 from	 46%	 to	 55%	 during	 the	transition	to	stationary	phase	growth,	paralleled	by	a	decrease	in	cis-unsaturated	fatty	acids	from	53.5%	to	37.6%	(Figure	5.2	and	Figure	5.3).	This	change	in	degree	of	saturation	was	driven	by	an	increase	in	18:0	octadecanoic	acid	(5%	to	14%),	a	decrease	in	9Z-16:1	(18%	to	10%)	and	a	decrease	in	11Z-18:1	(35.2%	to	26.7%).	P.	aeruginosa	can	synthesise	CUFAs	via	 both	 FASII	 and	 aerobic	 desaturases,	 but	 11Z-18:1	 is	 understood	 to	 be	 produced	exclusively	via	FASII	(Zhu	et	al.	2006).	The	overall	0.85-fold	decrease	(35.4	to	31.2%)	in	11Z-18:1	and	11cyc-19:0	(derived	from	11Z-18:1)	implies	that	a	large	fraction	of	the	change	in	SFA:CUFA	ratio	is	determined	by	FASII.		
The	 average	 carbon	 chain	 length	 (ACCL)	 of	 wild-type	 fatty	 acids	 increased	 on	 entry	 to	stationary	phase,	during	growth	(Figure	5.4).	The	degree	and	timing	of	this	change	in	chain	length	 differed	 between	 SFAs	 and	 CUFAs:	 the	 length	 of	 CUFAs	 increased	 during	 early	stationary	phase	between	OD2.5	and	OD4.5,	whereas	the	length	of	SFAs	increased	between	early	(OD4.5)	and	mid	(OD6.5)	stationary	phase.	
The	cyclopropanated	fatty	acid	(CPFA)	content	of	was	almost	undetectable	at	OD1.5	and	OD2.5,	then	increased	during	stationary	phase	to	7%	at	OD6.5	(Figure	5.5).	Over	the	same	time	period,	16:0	and	18:0	were	cyclopropanated	to	9cyc-17:0	and	11cyc-19:0,	respectively.	The	35-fold	increase	in	cis-11,12-methyleneoctadecadonic	acid	(11cyc19:0,	0.1%	to	3.5%)	and	11.7-fold	 increase	 in	cis-9,10-methylenehexadecanoic	acid	(9cyc17:0,	0.3%	to	3.5%)	together	accounted	for	41%	of	the	decrease	in	CUFAs.		
These	changes	are	similar	 to	 those	reported	previously	 to	be	associated	with	stationary	phase	adaptation	(Dubois-Brissonnet	et	al.	2000,	2001;	Härtig	et	al.	2005).	
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Figure	5.2	Saturated,	cis-unsaturated	and	cyclopropane	fatty	acids	in	wild-type	P.	aeruginosa	
PAO1.		The	percentage	of	saturated	fatty	acids	(SFA)	and	cyclopropane	fatty	acids	(CPFA)	in	P.	aeruginosa	increase	as	cultures	enter	stationary	phase	growth,	while	percentage	of	cis-unsaturated	fatty	acids	(CUFA)	decrease.	Samples	of	bacterial	cultures	were	analysed	by	FAME-GCMS	at	OD600	readings	of	1.5	 ( ),	2.5	 ( ),	4.5	( )	and	6.5	 ( ).	Error	bars	 represent	one	standard	deviation.	Asterisks	indicate	significant	differences	(**	P<=0.01,	two-tailed	Student’s	t	test).	Data	are	calculated	from	6	biological	replicates.			 	
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Figure	5.3	Stationary	phase	fatty	acid	saturation	is	repressed	by	QS.	Error	bars	represent	one	standard	deviation.	Asterisks	indicate	significant	differences	(*	P<=0.05,	**	
P<=0.01,	two-tailed	Student’s	t	test).	A)	lasI	rhlI	mutant	(white	bars)	compared	to	wild-type	PAO1	(black	bars).	B)	Complementation	of	lasI	rhlI	mutant	with	10	µM	BHL	(vertical	stripes),	15	µM	OdDHL	(horizontal	stripes)	or	both	(chequered).	
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Figure	5.4	AHL	Quorum	Sensing	induces	a	reduction	in	fatty	acid	chain	length.		The	 average	 carbon	 chain	 length	 (ACCL)	 of	 fatty	 acids	 in	 the	 wild-type	 shortens	 during	 post-exponential	growth,	in	contrast	to	the	lasI	rhlI	mutant.	Error	bars	represent	one	standard	deviation.	Asterisks	indicate	significant	differences	(*	P<=0.05,	**	P<=0.01,	two-tailed	Student’s	t	test).	A)	lasI	
rhlI	mutant	(white	bars)	compared	to	wild-type	PAO1	(black	bars).	B)	Complementation	of	lasI	rhlI	mutant	with	10	µM	BHL	(vertical	stripes),	15	µM	OdDHL	(horizontal	stripes)	or	both	(chequered).		
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Figure	5.5	AHL	Quorum	Sensing	increases	cyclopropanation	of	fatty	acids.		Error	bars	represent	one	standard	deviation.	Asterisks	indicate	significant	differences	(*	P<=0.05,	**	
P<=0.01,	two-tailed	Student’s	t	test).	A)	lasI	rhlI	mutant	(white	bars)	compared	to	wild-type	PAO1	(black	bars).	B)	Complementation	of	lasI	rhlI	mutant	with	10	µM	BHL	(vertical	stripes),	15	µM	OdDHL	(horizontal	stripes)	or	both	(chequered).	
5.2.4 The	lasI	rhlI	mutant	fatty	acid	profiles	reveal	reduced	
cyclopropanation	and	shorter	acyl	chain	lengths	
Consistent	with	data	presented	in	Chapter	3,	the	wild-type	and	QS	mutant	fatty	acid	proﬁles	were	nearly	identical	during	exponential	growth,	before	diverging	at	the	onset	of	stationary	phase.	From	early	stationary	phase,	there	were	differences	in	levels	of	11	of	13	of	the	FAs	detected	 (Table	 5.1).	 In	 general,	 the	 lasI	 rhlI	 mutant	 showed	 a	 pattern	 of	 fatty	 acid	saturation	similar	to	that	of	the	wild	type,	with	the	SFA:CUFA	ratio	increasing	during	early	stationary	phase.	However,	the	degree	of	fatty	acid	cyclopropanation	was	less	than	half	that	of	the	wild	type	(Figure	5.4).	The	chain	length	of	fatty	acids	in	the	mutant	also	differed	from	the	wild-type:	where	FA	 chain	 length	 increased	 in	 the	wild-type	during	 early	stationary	phase	growth,	chain	length	of	fatty	acids	in	the	QS	mutant	decreased.	This	shortening	of	FA	length	is	driven	by	changes	to	the	cis-unsaturated	FA	pool	(principally	a	lower	18:1/16:1)	
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ratio;	the	length	of	saturated	FAs	increases	in	the	mutant,	albeit	to	a	lesser	degree	than	in	the	wild-type.	
Chemical	 complementation	 of	 the	 lasI	 rhlI	 mutant	 with	 synthetic	 OdDHL	 and	 BHL	was	performed	 in	 order	 to	 examine	 the	 dependence	 of	 the	 observed	 phenotypes	 on	 AHL	signalling	 (Table	 5.1).	 Addition	 of	 both	 OdDHL	 and	 BHL	 returned	 levels	 of	 all	 11	 FAs	modulated	 in	 the	QS	mutant	 towards	or	beyond	wild-type	 levels.	The	 same	was	 true	of	composite	variables	including	SFA	levels	and	ACCL.	In	most	cases,	addition	of	the	two	AHLs	in	 combination	 had	 a	 larger	 effect	 than	 either	 alone,	 with	 the	 notable	 exception	 of	cyclopropanation,	 in	which	 BHL	alone	 had	 the	 greatest	 effect.	More	 generally,	 BHL	 had	greater	 effects	 than	 OdDHL	 on	 the	 FA	 profiles,	 suggesting	 that	 the	 rhl	 system	 is	 more	intimately	linked	to	fatty	acid	and	membrane	adaptation	than	is	the	las	system.		
5.3 Discussion	
The	lipid	bilayers	of	bacterial	membranes	are	crucial	for	cell	integrity	and	survival	as	they	act	as	partially-selective	permeability	barriers	and	house	systems	responsible	for	processes	including	nutrient	acquisition,	waste	elimination,	energy	transduction	and	environmental	sensing.	Bacteria	tune	the	properties	of	their	lipid	bilayers	in	order	to	maintain	and	adjust	their	function	across	diverse	environments	and	physiological	states.	A	key	means	by	which	bacteria	achieve	this	is	by	controlling	the	fatty	acid	composition	of	their	lipids.		
Fatty	acids	are	synthesised	 in	 the	cytosol	by	FASII	and	 though	there	are	 free	FAs	 in	 the	membrane	envelope,	they	are	for	the	most	part	incorporated	into	lipids.	In	Gram-negative	bacteria	 such	 as	Pseudomonas	 spp.	 the	majority	 of	 fatty	 acyl	 chains	 are	 ester-linked	 to	phospholipid	head	groups	in	the	inner	membrane	bilayer	and	the	inner	leaflet	of	the	outer	membrane.	These	lipid	acyl	chains	are	major	determinants	of	membrane	physicochemistry,	influencing	bilayer	fluidity,	permeability	and	the	activities	of	membrane	proteins	including	nutrient	permeases	(Nikaido	2003;	Vitrac	et	al.	2013).		
The	results	presented	here	illustrate	the	fatty	acid	composition	of	wild-type	PAO1	grown	in	AGSY	medium	changes	during	the	transition	from	exponential	to	stationary	phase	growth,	shifting	towards	higher	levels	of	saturation,	longer	acyl	chain	lengths	and	higher	levels	of	cyclopropanation.	 These	 trends	 are	 similar	 to	 those	 reported	 in	 other	 growth	 media	(Hancock	and	Meadow	1969;	Dubois-Brissonnet	et	al.	2000,	2001).	Longer	SFA	fatty	acyl	chain	lengths	generally	increase	the	rigidity	of	lipid	bilayers,	as	longer	chains	have	larger	
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non-polar	surfaces	in	contact	with	adjacent	acyl	chains	and	also	penetrate	deeper	into	the	membrane,	increasing	interactions	between	layers	(Baysse	and	O’Gara	2007).	By	contrast	cis	 C=C	 double	 bonds	 introduce	 a	 30°	 kink	 into	 the	 acyl	 chain,	 disrupting	 the	 ordered	packing	of	SFAs,	thereby	increasing	bilayer	fluidity.	In	addition,	the	cis	double	bond	renders	adjacent	methylene	(-CH2-)	groups	vulnerable	to	peroxidation.	By	increasing	the	length	and	saturation	of	 lipid	 acyl	 chains,	 bacteria	 increase	 their	 resistance	 to	membrane	 stressors	such	as	lipophilic	solvents,	acids,	high	temperatures	and	reactive	oxygen	species	(Massa	et	al.	1988;	Keweloh	et	al.	1991;	Sikkema	et	al.	1995;	Denich	et	al.	2003;	Pesakhov	et	al.	2007).	
Like	other	Gram-negative	bacteria,	P.	aeruginosa	can	cyclopropanate	cis-monounsaturated	lipid	acyl	chains	by	inserting	methylene	groups	across	their	C=C	double	bonds;	this	allows	rapid	adaptation	of	membrane	properties	without	metabolically	costly	de	novo	fatty	acid	synthesis	 (Hancock	 and	Meadow	1969;	Grogan	and	Cronan	1997).	 In	P.	 aeruginosa	 this	cyclopropane-fatty-acyl-phospholipid	 synthase	 activity	 is	 likely	 encoded	by	hypothetical	protein	PA5546,	which	has	68%	amino	acid	sequence	identity	to	cfaB	of	P.	putida	KT2240	(Muñoz-Rojas	et	al.	2006).	Wild-type	PAO1	grown	in	AGSY	showed	35-fold	higher	levels	of	cyclopropane	 fatty	 acids	 in	 mid-stationary	 compared	 to	 exponential	 phase	 growth.	Cyclopropane	fatty	acids	are	thought	to	have	effects	on	membrane	fluidity	intermediate	to	SFAs	and	CUFAs:	they	maintain	the	kink	of	CUFAs,	but	the	introduction	of	a	methylene	group	across	 the	 double	 bond	 is	 thought	 to	 enhance	 van	 der	 Waals	 interactions	 (Silvius	 and	McElhaney	1979;	 Loffhagen	et	 al.	 2007).	 In	 addition,	 the	 absence	of	 a	C=C	double	bond	reduces	the	vulnerability	of	the	acyl	chain	to	peroxidation.	Cyclopropanation	of	unsaturated	fatty	acyl	chains	is	especially	associated	with	slowing	growth	rates	in	response	to	nutrient	deprivation	(Guckert	et	al.	1986;	Dubois-Brissonnet	et	al.	2001;	Loffhagen	et	al.	2007)	and	has	been	 found	 to	 increase	 resistance	 to	membrane	 stressors	 including	 reactive	oxygen	species	 and	 low	pH	(Grogan	and	Cronan	1997;	Chang	 and	Cronan	1999;	Pradenas	 et	al.	2013).	
The	 transition	 to	 post-exponential	 growth	 corresponds	 to	 limitation	 of	 nutrients	 in	 the	growth	medium	and	a	consequent	reduction	in	growth	rate.	The	consequences	of	growth	rate	perturbations	on	membrane	metabolism	of	gram	negative	bacteria	is	best	understood	in	 E.	 coli,	 in	 which	 the	 reduction	 in	 growth	 rate	 at	 the	 onset	 of	 stationary	 phase	 is	accompanied	by	inhibition	of	phospholipid	synthesis.	This	is	understood	to	be	triggered	by	RelA-	and	SpoT-	dependent	increases	in	(p)ppGpp	(Hengge	2011;	Kanjee	et	al.	2012),	which	inhibits	 glycerol-3-phosphate	 acetyl	 transferase	 activity	 (PlsB)	 (Heath	 et	 al.	 1994).	Continued	fatty	acid	synthesis	results	in	accumulation	of	long	chain	acyl-ACP,	which	inhibits	FASII	via	FabH,	the	type	III	beta-ketoacyl-ACP	synthase	responsible	for	initiating	FASII	by	
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condensation	 of	 acetyl-CoA	 with	 malonyl-ACP	 (Heath	 and	 Rock	 1996a).	 ppGpp	 also	modulates	 fatty	 acid	 metabolism	 by	 inhibiting	 expression	 of	 accA,	 accB,	 fabB	 and	 fabZ	(Kanjee	et	al.	2012).	The	increase	in	ppGpp	at	the	onset	of	stationary	phase	is	a	key	inducer	of	 the	 stationary	 phase	 sigma	 factor	 and	 general	 stress	 response	 regulator,	 RpoS.	 The	regulatory	 scheme	 in	 P.	 aeruginosa	 is	 thought	 to	 be	 broadly	 similar	 to	 that	 in	 E.	 coli,	including	induction	of	RpoS	expression	by	(p)ppGpp.	As	in	E.	coli,	levels	of	RpoS	increase	at	the	onset	of	stationary	phase	growth	of	P.	aeruginosa,	conferring	resistance	to	a	number	of	stressors	including	heat,	low	pH,	high	osmolarity,	H2O2	and	ethanol	(Jørgensen	et	al.	1999;	Suh	et	al.	1999).	This	stationary-phase	stress	tolerance	is	conferred	in	part	by	modifications	to	 the	 bacterial	 membranes	 such	 as	 those	 observed	 in	 the	 wildtype	 FA	 profiles	 in	 the	present	experiments.		
The	present	FAME-GCMS	analyses	of	the	mutant	and	AHL-complemented	mutants	indicate	that	AHL	 signalling	 plays	 a	 significant	 role	 in	 increasing	 acyl-chain	 length	 and	 levels	 of	cyclopropane	 fatty	 acids	 during	 entry	 to	 stationary	 phase.	 The	 mass	 spectrometric	proteomic	 analysis	 described	 in	 Chapter	 3	 detected	 six	 proteins	 involved	 in	 fatty	 acid	biosynthesis,	 of	which	 two	were	downregulated	 in	 the	wild-type	 relative	 to	 the	 lasI	 rhlI	mutant	 during	 stationary	 phase:	 levels	 of	 FabG	 beta-ketoacyl-ACP	 reductase	were	 45%	lower,	 levels	 of	 FabZ	 beta-hydroxyacyl-ACP	 dehydratase	 were	 60%	 lower.	 Previous	transcriptomic	analyses	have	also	identified	genes	involved	in	fatty	acid	and	phospholipid	metabolism	to	be	modulated	by	AHL	QS:	across	three	independent	microarray	analyses,	26	genes	were	identified	as	modulated	by	AHL	QS	(Table	5.2)	(Hentzer	et	al.	2003;	Schuster	et	al.	2003;	Wagner	et	al.	2003).	It	is	striking	that	all	26	genes	in	Table	5.2	were	identified	as	QS-modulated	by	Wagner	et	al.,	whereas	Hentzer	et	al.	and	Schuster	et	al.	identified	only	6	of	these	genes.	This	suggests	that	the	impact	of	fatty	acid	and	phospholipid	metabolism	can	vary	widely	and	is	sensitive	to	the	prevailing	growth	conditions.	The	six	genes	modulated	in	all	 three	 transcriptomic	studies	 include	 fabH2	 (PA3333,	a	beta-ketoacyl-ACP	synthase	III),	pqsD	(PA0999,	a	beta-ketoacyl-ACP	synthase	III,	also	called	fabH1),	PA1869	(a	probable	acyl	carrier	protein),	PA3334	(probable	acyl	carrier	protein)	and	PA3330	(probable	short	chain	dehydrogenase).		
FabG	catalyses	the	first	reductive	step	in	the	elongation	cycle	of	fatty	acid	biosynthesis	and	is	essential	for	fatty	acid	biosynthesis	and	cell	growth	(Zhang	and	Cronan	1998;	Kutchma	et	al.	1999).	Depressed	levels	of	FabG	therefore	likely	reflect	a	general	slowing	in	fatty	acid	biosynthesis	in	the	wild-type.	Neither	of	the	three	transcriptomic	studies	found	differences	in	fabG	gene	expression,	suggesting	that	this	is	specific	to	our	growth	conditions	and/or	the	timing	of	sampling.	
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Control	of	carbon	chain	length	is	exerted	at	multiple	points	in	FASII.	The	only	gene	in	Table	5.2	that	is	directly	involved	in	FASII	is	fabZ,	which	was	found	to	be	downregulated	45%	by	QS	in	early	stationary	phase	by	(Wagner	et	al.	2003).	Under	the	present	condition	of	growth	in	 AGSY,	 levels	 of	 the	 gene	 product	 FabZ	 beta-hydroxyacyl-ACP	 dehydratase	were	 60%	lower	in	the	wild-type	than	the	lasI	rhlI	mutant	during	early	post-exponential	growth	(Table	4.3).	The	influence	of	FabZ	over	the	control	of	flux	through	FASII	is	not	yet	well-defined.	The	roles	of	FabA	and	FabZ	beta-hydroxyacyl-ACP	dehydratases	have	best	been	characterised	in	E.	coli,	in	which	both	FabA	and	FabZ	use	saturated	beta-hydroxyacyl-ACPs	as	substrates	but	only	FabZ	shows	high	dehydratase	activity	with	unsaturated	beta-hydroxyacyl-ACPs	and	so	is	considered	the	primary	dehydratase	for	the	CUFA	branch	of	FASII.	A	reduction	in	FabZ	 activity	 might	 therefore	 be	 expected	 to	 decrease	 the	 overall	 rate	 of	 fatty	 acid	biosynthesis	and	to	increase	the	proportion	of	FA	intermediates	entering	the	SFA	branch	(Heath	 and	 Rock	 1996b).	 However	 more	 recently	 researchers	 have	 observed	 that	overexpression	of	FabZ	can	result	in	elevated	proportions	of	SFAs	(16:0	and	18:0)	and	an	increase	 in	 the	 carbon	 chain	 length	 of	 SFAs	 in	 E.	 coli	 (Jeon	 2012).	 It	 therefore	 seems	plausible	that	depressed	levels	of	FabZ	in	the	present	study	contributed	to	the	observed	difference	in	chain	length.		
Wagner	et	al.	also	reported	that	levels	of	plsY	transcripts,	encoding	a	glycerol-3-phosphate	acyltransferase,	are	two-fold	repressed	by	las-rhl	QS,	implying	that	QS	represses	the	rate	of	glycerolipid	synthesis4.	A	QS-dependent	decrease	in	PlsY	activity	would	be	consistent	with	the	lower	growth	rate	of	the	wild-type	observed	in	the	present	conditions,	though	Wagner	et	al.	did	not	report	a	QS-dependent	growth	effect	under	their	growth	conditions.		
Interestingly	fabH2,	encoding	the	FabH2	beta-ketoacyl-ACP	synthase	III,	was	observed	to	be	upregulated	~30-fold	by	QS	in	all	three	microarray	studies	(Table	5.2).	(FabH2	was	not	detected	in	the	proteomic	analysis	described	in	Chapter	4.)	The	physiological	function	of	FabH2	is	unknown.	Whereas	E.	coli	FASII	is	initiated	with	the	condensation	of	acetyl-CoA	with	 malonyl-ACP	 by	 the	 FabH	 beta-ketoacyl-ACP	 synthase	 III,	 the	 dominant	 FASII-initiating	KAS	in	P.	aeruginosa	is	FabY,	a	KASI/II	enzyme	(Yuan	et	al.	2012).	fabH2	is	part	of	a	predicted	eight-gene	operon	all	of	whose	members	are	predicted	to	be	metabolic	enzymes	but	whose	 physiological	 role	 is	 unknown.	 This	 suggests	 that	 FabH2	 likely	 has	 a	 role	 in	secondary	metabolism	rather	than	FASII.		
																																																													
4	PlsY	is	thought	to	be	the	principle	glycerol-3-phosphate	acyltransferase	in	P.	aeruginosa.	PlsB	is	not	essential	(Yao	and	Rock	2013).		
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The	 genetic	 basis	 for	 cyclopropanation	 of	 fatty	 acid	 is	 well	 understood.	 PA5546	 is	 a	probable	 cyclopropane-fatty-acid-phospholipid	 synthase	 gene	 and	 was	 found	 to	 be	upregulated	3.2-fold	by	AHL	QS	during	early	stationary	phase	by	Wagner	et	al.	(Table	5.2).	PA5546	 has	 a	 potential	 las-rhl	 box	 like	 sequence	 gaCtaggAGgTTTGGCAtG	 immediately	upstream	of	its	translational	start	site.	This	sequence	has	11/19	sequence	identity	with	the	acCtgccAGaTTTGGCAgG	putative	rhl	consensus	sequence	(uppercase	letters	match	the	rhl	consensus,	 underlined	 letters	 are	 considered	 important	 in	 distinguishing	 rhl	 vs	 las	regulation)	 (Schuster	 et	 al.	 2004a;	 Schuster	 and	 Greenberg	 2007).	 PA5546	 is	 3.7-fold	repressed	 in	 a	 rpoS	 mutant	 during	 early	 stationary	 phase	 and	 has	 the	 likely	 RpoS	 -10	sequence	 CTATAgT	 (1	 nt	 difference	 from	 the	 consensus	 CTATAcT)	 positioned	 29	 bp	upstream	of	the	ATG	start	codon	(Schuster	et	al.	2004b).	It	therefore	seems	probable	that	transcription	of	PA5546	and	hence	cyclopropanation	is	directly	regulated	by	both	rhl	QS	and	 RpoS	 during	 the	 transition	 to	 early	 stationary	 phase.	 The	 present	 FAME	 analysis	confirms	that	AHL	QS	plays	a	significant	role	in	induction	of	FA	cyclopropanation	on	entry	to	stationary	phase	growth	and	also	indicates	the	rhl	system	has	a	greater	degree	of	control	than	the	las	system.	However,	neither	Hentzer	et	al.	nor	Schuster	et	al.	observed	changes	in	the	transcript	levels	of	PA5546	(Table	5.2).	This	could	be	due	to	differences	in	experimental	setup,	for	example	differences	in	growth	conditions	or	the	timing	of	sampling.	The	E.	coli	CFA	 synthase	 gene	 (also	 regulated	 by	 RpoS)	 is	 expressed	 transiently	 during	 entry	 to	stationary	phase,	if	the	expression	profile	of	PA5546	is	similar	then	the	power	of	microarray	analyses	to	detect	differential	regulation	will	be	highly	dependent	on	the	time	of	sampling	(Wang	and	Cronan	1994;	Chang	et	al.	2000).		
Why	 might	 QS	 influence	 FA	 metabolism?	 There	 are	 a	 several	 mutually	 compatible	explanations.	First,	changes	to	FA	metabolism	may	be	due	to	indirect	effects	of	the	global	impact	of	AHL	QS	on	P.	aeruginosa	physiology.	AHL	QS	can	modulate	the	expression	of	up	to	12%	of	the	P.	aeruginosa	genome	(Wagner	et	al.	2003).	As	described	in	previous	chapters,	the	 global	 effects	 of	 AHL	 QS	 on	 gene	 expression	 shifts	 the	 demands	 placed	 on	 central	metabolic	functions	and	this	could	be	expected	to	impinge	on	fatty	acid	metabolism.	Indeed,	a	high	proportion	of	these	QS-regulated	genes	are	involved	in	the	synthesis	of	secondary	metabolites	from	fatty	acid	metabolic	intermediates,	for	example	quinolones,	rhamnolipids	and	 AHLs	 themselves.	 QS-dependent	 changes	 to	 FA	 metabolism	 may	 therefore	 reflect	indirect	 responses	 to	 shifting	 metabolic	 demand.	 In	 a	 similar	 fashion,	 many	 AHL	 QS-regulated	 secreted	 factors—including	 the	 quinolones,	 rhamnolipids	 and	 AHLs—are	membrane-active	 and	 would	 be	 expected	 to	 trigger	 adaptive	 changes	 to	 membrane	composition,	including	via	fatty	acid	metabolism.	
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A	second	explanation	for	the	influence	of	AHL	QS	on	FA	metabolism	is	that—because	QS	infers	and	communicates	valuable	information	regarding	the	state	of	the	cellular	social	and	physical	 environment—P.	 aeruginosa	 AHL	 QS	 has	 evolved	 to	 directly	 regulate	 primary	metabolic	functions	including	FA	metabolism.	This	is	consistent	with	growing	evidence	that	QS	plays	a	role	in	stress	signalling	and	that	the	rhl	system	in	particular	integrates	metabolic	regulatory	cues	(Baysse	and	O’Gara	2007;	Mellbye	and	Schuster	2014).	Both	RelA	and	RpoS	expression	have	been	found	to	induce	AHL	QS	in	P.	aeruginosa	(Latifi	et	al.	1996;	Van	Delden	et	al.	2001;	Schuster	et	al.	2004b;	Khakimova	et	al.	2013).	Likewise	AHL	QS	induces	RpoS	expression,	principally	through	the	rhl	system	(Latifi	et	al.	1996;	Schuster	et	al.	2004b).	Like	RpoS	and	RelA,	AHL	QS	systems	can	confer	increased	resistance	to	oxidative,	osmotic	and	thermal	stressors	(Hassett	et	al.	1999;	García-Contreras	2016).	The	connectedness	of	these	global	regulators	is	illustrated	by	RpoS	expression	affecting	40%	of	the	las-rhl	regulon	and	18%	 of	 the	 RpoS	 regulon	 being	 QS-regulated	 (Schuster	 et	 al.	 2004b).	 This	 overlap	 has	perhaps	been	best	characterized	with	regard	to	resistance	to	oxidative	stress	by	induction	of	catalase	(CAT,	via	katA	expression)	and	superoxide	dismutase	(SOD,	via	sodA	expression)	activities	(Eichel	et	al.	1999;	Schuster	et	al.	2004b;	García-Contreras	et	al.	2014).	Less	 is	known	about	the	relation	of	QS	and	stress	signalling	with	regard	to	membrane	adaptation.	Previous	work	has	shown	that	QS	can	be	induced	in	response	to	membrane	perturbations	and	that	this	is	dependent	on	relA	(Baysse	et	al.	2005).	The	present	results	demonstrate	that	the	 reverse	 is	 also	 true—QS	 can	modulate	membrane	 composition—and	 indicates	QS	 is	involved	 in	development	of	 stationary	phase	membrane	 stress	 tolerance,	 probably	both	directly	 via	 rhl-dependent	 regulation	 action	 at	 the	PA5546	promoter,	 and	 indirectly	 via	RpoS.	
The	impact	of	AHL	QS	on	FA	and	membrane	metabolism	is	likely	a	function	of	direct	and	indirect	control	via	LuxR-type	transcriptional	regulators,	as	well	as	adaptive	responses	to	to	the	wider	regulatory	effects	of	QS.	Regardless	of	the	mechanisms	employed,	the	present	results	indicate	that	QS	induces	changes	to	FA	and	membrane	metabolism	consistent	with	stationary	 phase	 stress	 tolerance.	 Further	 experiments	 are	 needed	 to	 explore	 the	physiological	impact	of	these	changes	under	conditions	that	represent	the	diverse	ecology	of	 P.	 aeruginosa.	 This	 will	 be	 important	 in	 understanding	 the	 role	 AHL	 QS	 plays	 in	coordinating	stress	responses	and	in	“competition	sensing”	(Cornforth	and	Foster	2013).
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Table	5.2	QS-modulated	genes	involved	in	fatty	acid	and	phospholipid	metabolism.		Data	was	compiled	from	three	independent	studies:	(Hentzer	et	al.	2003;	Schuster	et	al.	2003;	Wagner	et	al.	2003).	a	Fold	change	was	reported	as	the	average	fold	induction	in	a	lasI	rhlI	mutant	when	supplemented	with	2	µM	OdDHL	and	5	µM	BHL	(average	of	samples	collect	at	OD600	of	0.5,	1.3,	1.6,	2.0,	2.7).	Bacteria	were	grown	aerobically	in	ABt	minimal	medium	with	0.5%	casamino	acids.		b	Fold	change	was	reported	as	the	maximum	fold	induction	in	a	lasI	rhlI	mutant	when	supplemented	with	2	µM	OdDHL	and	10	µM	BHL	(maximum	of	samples	collected	at	OD600	of	0.2,	0.4,	0.8,	1.4,	2.0,	3.0,	and	4.0).	Bacteria	were	grown	aerobically	in	buffered	Lysogeny	Broth.		c	Fold	change	was	reported	as	the	fold	induction	in	a	lasI	rhlI	mutant	when	supplemented	with	1	µM	OdDHL	and	2	µM	BHL.	Values	are	reported	for	samples	collected	during	early	mid-logarithmic	(ML)	or	stationary	phase	(ES)	growth.	The	values	are	reported	for	the	early	stationary	phase	when	differential	expression	was	observed	in	both	growth	phases	(B).	Bacteria	were	grown	aerobically	in	modified	FAB	medium.	…Cont.	 	 Fold	modulation	in	lasI	rhlI	mutant	 	
PA	number	 Gene	Name,	synonyms	 Hentzer	et	al.	2003a	 Schuster	et	al.	2003b	 Wagner	et.	al	2003c	 Description	/	gene	product	PA0228		 pcaF	 	 	 3.8	(ES)	 beta-ketoadipyl	CoA	thiolase	PcaF	PA0447	 gcdH	 	 	 7.8	(ML)	 glutaryl-CoA	dehydrogenase	PA0581	 plsY	 	 	 -2	(ML)	 glycerol-3-phosphate	acyltransferase	PA1869	 	 57	 41	 79	(B)	 probable	acyl	carrier	protein	PA2001	 atoB	 	 	 23	(ML)	 acetyl-CoA	acetyltransferase	PA3300	 fadD2	 	 	 3.6	(ML)	 long-chain-fatty-acid--CoA	ligase	PA3333	 fabH2	 30	 32	 32	(B)	 3-oxoacyl-[acyl-carrier-protein]	synthase	III	PA3334	 	 30	 49	 23	(B)	 probable	acyl	carrier	protein	PA3645	 fabZ,	sefA	 	 	 -1.8	(ES)	 (3R)-hydroxymyristoyl-[acyl	carrier	protein]	dehydratase	
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…Cont.	 	 Fold	modulation	in	lasI	rhlI	mutant	 	
PA	number	 Gene	Name,	synonyms	 Hentzer	et	al.	2003a	 Schuster	et	al.	2003b	 Wagner	et.	al	2003c	 Description	/	gene	product	PA3924	 	 	 	 4.6	(ML)	 probable	medium-chain	acyl-CoA	ligase	PA4888	 desB		 	 	 -1.8	(B)	 acyl-CoA	delta-9-desaturase,	DesB	PA0744	 	 	 	 7	(ML)	 probable	enoyl-CoA	hydratase/isomerase	PA0745	 	 	 	 8.2	(ML)	 probable	enoyl-CoA	hydratase/isomerase	PA0996	 pqsA	 9	 90	 4.7	(B)	 probable	coenzyme	A	ligase	PA0999	 pqsD,	fabH1	 9	 25	 5.1	(B)	 3-oxoacyl-[acyl-carrier-protein]	synthase	III	PA2552	 acdB	 	 	 10	(ML)	 probable	acyl-CoA	dehydrogenase	PA2553	 	 	 	 14	(ML)	 probable	acyl-CoA	thiolase	PA2554	 	 	 	 11	(ML)	 probable	short-chain	dehydrogenase	PA2862	 lipA	 	 	 4	(ML)	 lactonising	lipase	precursor	PA2889	 atuD	 	 	 2.8	(ML)	 putative	citronellyl-CoA	dehydrogenase	involved	in	catabolism	of	citronellol	PA3330	 	 149	 120	 38	(ML)	 probable	short	chain	dehydrogenase	PA3924	 	 	 	 4.6	(ML)	 probable	medium-chain	acyl-CoA	ligase	PA4907	 ydfG	 	 	 1.7	(ES)	 probable	short-chain	dehydrogenase	PA4979	 	 	 	 2.4	(ML)	 probable	acyl-CoA	dehydrogenase	PA5521	 	 	 	 1.9	(ML)	 probable	short-chain	dehydrogenase	PA5546	 		 	 	 3.2	(ES)	 probable	cyclopropane-fatty-acid-phospholipid	synthase	
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Chapter	6 		Focused	metabolic	profiling	of	amino	acids	and	polyamines	
6.1 Introduction	
Experiments	described	in	Chapter	4	found	that	the	concentrations	of	several	amino	acids	were	perturbed	in	a	lasI	rhlI	mutant.	However,	in	many	cases	the	detected	levels	of	many	of	these	 metabolites	 was	 close	 to	 the	 limits	 of	 detection.	 Moreover,	 the	 GC-MS	 analysis	performed	in	Chapter	4	was	semi-quantitative,	enabling	comparison	of	the	concentrations	of	individual	analytes	across	conditions,	but	does	not	permit	comparison	of	contributions	to	total	metabolite	pools	by	different	component	metabolites,	or	of	changes	to	the	size	of	such	pools.	Amino	acids	pools	are	known	to	change	on	entry	to	stationary	phase	and	to	be	influenced	by	environmental	factors.		
A	quantitative	and	more	comprehensive	analysis	of	amino	acid	metabolites	will	be	valuable	in	 evaluating	 QS-dependent	 changes	 to	 amino	 acid	metabolism.	 This	 chapter	 describes	efforts	 towards	 these	 aims,	 both	 developing	 and	 applying	 a	 liquid	 chromatography—tandem	 mass	 spectrometry	 (LC-MS/MS)	 method	 for	 the	 analysis	 of	 amino	 acids	 and	polyamines.		
A	quantitative	LC-MS/MS	method	was	validated	 for	 the	quantitative	measurement	of	40	compounds	 involved	 in	 amino	 acid	 and	 polyamines.	 This	 validated	 method	 was	 then	applied	 to	 analysis	 of	 extracts	 from	 P.	 aeruginosa	 batch	 cultures	 to	 provide	 a	 more	comprehensive	 and	quantitative	 analysis	 of	 the	 impact	 of	AHL	QS	on	 these	branches	 of	metabolism.	
	
Aims	and	objectives:		
• To	establish	and	validate	a	quantitative	LC-MS/MS	method	 for	analysis	of	amino	acids	and	polyamines.	
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• To	 characterise	 the	 impact	 of	 las	 and	 rhl	 QS	 on	 amino	 acid	 and	 polyamine	metabolites	by	comparing	the	profiles	of	amino	acid	and	polyamine	metabolites	in	wild-type	PAO1	and	a	lasI	rhlI	mutant.		
Outcomes:	
• An	LCMS-based	method	was	validated	for	quantitative	analysis	of	polyamines	and	agmatine.	
• Quantitative	 measurements	 of	 all	 39	 metabolites	 were	 achieved	 with	 a	 15	 min	runtime	per	sample.	
• Lower	 limits	 of	 quantitation	 (LOQ)	 were	 20–150	 nM	 for	 putrescine,	 spermine,	spermidine,	cadaverine,	agmatine,	and	below	5	µM	for	all	analytes.	
• Responses	were	linear	for	all	analytes	between	0.5	and	50	µM.		
• The	 impact	 of	 AHL	 QS	 on	 amino	 acid	 and	 polyamines	 metabolism	 is	 discussed	below.	
Work	presented	here	has	been	published	in	the	Journal	of	Chromatography	B	(Ubhi	et	al.	2013).	 Development	 and	 validation	 of	 the	 EZ:faast	 LCMS	 method	 was	 conducted	 in	collaboration	 with	 Baljit	 Ubhi.	 Peter	 Davenport	 was	 responsible	 for	 development	 of	methods	for	measurement	of	analytes	not	previously	validated	for	analysis	using	EZ:faast	(personal	communication	with	Phenomenex):	agmatine,	putrescine,	spermidine,	spermine,	cadaverine.	 Baljit	 Ubhi	 was	 responsible	 for	 development	 of	 the	 methods	 for	 all	 other	analytes.		 	
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6.2 Results 
6.2.1 Development	and	validation	of	EZ:faast	LC-MS	method	for	
analysis	of	amino	acid	and	polyamine	metabolites	
Several	 methods	 have	 been	 reported	 that	 use	 MS	 in	 tandem	 with	 chromatographic	separation	to	quantitate	amino	acids	(Fonteh	et	al.	2006;	Kaspar	et	al.	2008)	or	polyamines	(Häkkinen	 et	 al.	 2007)	 separately,	 or	 basic	 amino	acids	 and	 polyamines	 simultaneously	(Feistner	1994).	Commercial	kits	provide	convenient,	high-throughput	bioanalysis	of	amino	acids	 and	 related	metabolites	 (for	 example,	 Phenomenex	 EZ:faast,	Waters	Masstrak,	AB	Sciex	aTRAQ,	Perkin	Elmer	neogram	AAAC	kit).		
	
Figure	6.1	Reaction	 scheme	 for	 the	derivatisation	of	 amino	acids	 to	 alkyl	 esters	 and	alkyl	
carbamate	esters	by	reaction	with	alkyl	chloroformates	and	alcohols.	The	esterification	of	carboxylic	acids	proceeds	via	either	exchange	with	the	dominant	alcohol	(A,	the	favoured	pathway),	exchange	with	alcohol	derived	from	hydrolysis	of	the	alkyl	chloroformate	(B),	or	decarboxylation	 of	 the	 intermediate	 carboxylic	 anhydride	 (C)	 (Wang	 et	 al.	 1994);	 the	 EZ:faast	(Phenomenex	Inc.,	Torrence,	CA,	USA)	derivitisation	uses	n-propyl	chloroformate	and	n-propanol,	thereby	ensuring	that	all	three	pathways	yield	n-propyl	esters.	The	EZ:faast	LC-MS	and	GC-MS	methods	(Phenomenex	Inc.,	Torrence,	CA,	USA)	comprise	solid	 phase	 extraction	 and	 chloroformate	 derivatisation	 prior	 to	 chromatographic	separation	and	MS	analysis,	and	are	notable	for	quick	and	quantitative	measurement	of	over	40	amino	acids	and	related	metabolites	in	complex	biological	matrices	(Fonteh	et	al.	2006;	Kaspar	et	al.	2008).	The	EZ:faast	preparation	method	involves	i)	a	solid	phase	extraction,	in	which	analytes	are	concentrated	onto	a	cation	exchange	sorbent	before	wash	and	elution	steps	separate	analytes	from	salts,	proteins	and	other	interfering	matrix	components,	ii)	a	liquid	phase	derivatisation	step	with	n-propyl	chloroformate	and	n-propanol,	using	picoline	as	a	catalyst,	which	converts	carboxylic	groups	to	n-propyl	esters	and	amine	groups	to	n-
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propyl	 carbamate	 esters	 (see	 Figure	 6.1),	 iii)	 a	 liquid/liquid	 aqueous/organic	 phase	extraction	step.	Derivatisation	improves	separation	of	analystes	by	reverse-phase	HPLC	as	well	as	aiding	their	purification.	
The	 EZ:faast	 method	 was	 selected	 for	 evaluation	 due	 to	 its	 reported	 quick	 sample	preparation	(11	minutes)	and	analysis	(15	mins),	robustness	to	a	variety	of	sample	matrices	and	use	of	validated	internal	standards	to	account	for	absolute	quantitation	and	to	account	for	sample	matrix	effects.	LC-MS/MS	was	chosen	for	the	MS	step	on	account	of	the	relative	ease	of	method	development	and	validation,	including	unambiguous	analyte	identification,	compared	to	typical	GC-MS	approaches.	The	EZ:faast	method	had	been	internally	validated	by	 Phenomenex	 for	 measurement	 of	 >40	 amino	 acid	 metabolites,	 and	 the	 precision,	linearity	and	other	metrics	have	been	independently	assessed	(data	from	a	GCMS	specific	version	of	the	kit)	(Badawy	et	al.	2007).		
The	EZ:faast	LC-MS/MS	method	used	in	this	chapter	was	optimized	and	validated	for	use	with	 the	 instrumentation	described	 in	 the	methods	 section.	This	 involved	assessing	 the	analytical	 precision,	 recovery,	 linearity	 and	 stability	 in	 sample	 preparation	 and	measurement	of	all	analytes	reported	here.	A	calibration	solution	was	prepared	consisting	of	a	mixture	of	all	derivatised	target	analytes	at	10	µM	and	internal	standards	homoarginine	(HARG),	methionine-d3	 (MET-d3)	 and	 homophenylalanine	 (HPHE)	 at	2	 µM.	 The	 10	 µM	calibration	solution	was	supplied	to	the	mass	spectrometer	by	continuous	infusion	driven	by	a	syringe	pump.	For	each	analyte,	the	parent	mass	was	detected	to	two	decimal	places,	daughter	 ions	 were	 identified	 following	 fragmentation	 with	 collision	 gas	 and	 collision	energies	were	optimised.	Although	the	standard	Phenomenex	protocol	recommends	using	internal	 standards	 (HARG,	 MET-d3	 and	 HPHE)	 at	 200	 µM,	 this	 resulted	 in	 responses	saturating	the	MS	detector	and	so	internal	standards	were	subsequently	used	at	2	µM	in	all	assays.	Daughter	 scan	 experiments	were	 then	used	 to	 identify	unique	daughter	 ions	 for	quantification	 of	 each	 amino	 acid,	while	 additional	 daughter	 ions	were	 used	 to	 confirm	identification	 of	 analytes	 with	 reference	 with	 chemical	 standards.	 This	 process	 was	repeated	for	each	analyte	and	used	to	define	a	multiple	reaction	monitoring	(MRM)	method	that	 specified	 transitions	 for	 each	 analyte	 and	 its	 unique	 fragment(s)	 across	 a	chromatographic	separation.	The	transitions	specified	in	this	MRM	method	are	detailed	in	Table	6.1.	The	MRM	method	was	divided	into	three	time	segments	to	increase	the	dwell	time	and	decrease	the	cycle	time	per	MRM	scan,	resulting	high	sensitivity	and	at	least	15	data	points	per	chromatographic	peak	of	each	analyte.	Extracted	ion	chromatograms	(XICs)	based	on	this	method	are	illustrated	in	Figure	6.2.	
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	The	linearity	of	each	analyte	response	curve	was	assessed	by	measurement	of	calibration	curves	in	which	internal	standards	were	constant	at	2	µM	whereas	all	target	analytes	were	varied	by	serial	dilution	across	a	concentration	range	of	500	pM	to	50	µM.	Measurement	of	all	analytes	was	linear	within	the	range	500	nM	to	50	µM,	with	R2	values	of	>99.6%.	The	linearity	 of	 response	 across	 this	 range	 and	 the	 improvement	 in	 analytical	 precision	following	 normalisation	 to	 the	 homophenylalanine	 internal	 standard	 is	 illustrated	 for	analysis	of	spermidine	in	Figure	6.3.		
Using	 linear	 models	 fitted	 to	 calibration	 curves	 of	 each	 analyte,	 measurements	 were	assessed	 for	precision	 across	 the	 full	 linear	 range	 for	 that	 analyte.	Assay	 precision	was	assessed	by	intra-assay	and	inter-assay	coefficients	of	variation	(CVs).	For	each	analyte,	CVs	were	calculated	for	each	concentration	of	the	calibration	standards	within	the	linear	range	for	that	analyte.	Intra-assay	CVs	were	measured	by	injection	of	the	derivatised	sample	of	the	10	µM	calibration	solution	ten	times	in	succession	and	CVs	were	all	below	15%,	with	a	mean	of	9%.	Inter-assay	CVs	were	calculated	from	four	independent	calibration	solutions,	prepared	and	analysed	on	separate	days.	Using	raw	response	values,	the	mean	inter-assay	CV	was	~30%.	After	normalisation	to	the	internal	homophenylalanine	standard,	all	inter-assay	CVs	were	>15%	with	a	mean	of	8%.	This	is	illustrated	for	spermidine	in	Figure	6.3.		
The	lower	limit	of	detection	(LOD)	for	each	analyte	was	calculated	as	the	mean	plus	three	times	the	standard	deviation	of	signal	in	QC	samples	(Table	6.1).	In	accordance	with	the	United	States	Federal	Drug	Administration	guidance	for	quantitative	biochemical	assays	the	lower	limit	of	quantitation	was	calculated	as	the	lowest	standard	on	the	calibration	curve	that	was	i)	greater	than	the	LOD,	ii)	within	the	linear	range	of	the	calibration	curve,	iii)	had	a	response	CV	of	<15%	(Food	and	Drug	Administration	2001).	LLOQ	values	were	<=15	nM	for	putrescine,	spermine,	spermidine,	cadaverine,	agmatine,	and	<=500	nM	for	all	analytes.	Responses	were	linear	for	all	analytes	between	0.5µM	and	50	µM.	Repeat	measurements	of	calibration	curves	over	three	days	demonstrated	that	derivatised	analytes	were	stable	for	at	least	24	hours	at	25	°C	and	3	days	at	4	°C:	LLOQs	were	unchanged	and	inter-assay	CVs	were	<15%.	
Analyte	recovery	was	assessed	by	first	analysing	five	P.	aeruginosa	cell	extracts	both	with	and	without	addition	of	15	µM	calibration	solutions.	Recovery	of	all	analytes	was	>96%	and	CVs	 of	 all	 target	 analytes	 after	 normalization	 to	HPHE	were	 all	 <7%.	 The	 only	 analyte	measured	with	>7%	precision	was	MET-d3,	for	which	a	CV	of	40%	was	calculated.	This	is	indicative	of	matrix	effects	interfering	with	measurement	of	MET-d3	(in	the	absence	of	cell	extract	the	CV	for	MET-d3	was	7%).		
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This	process	of	method	development	and	optimization	validated	use	of	the	EZ:faast	method	for	quantitation	of	amino	acid	metabolites	in	P.	aeruginosa	cell	extracts	by	LC-MS/MS	and	also	 validated	 the	 extended	 use	 of	 the	method	 to	 quantify	 concentrations	 of	 agmatine,	cadaverine,	putrescine,	spermidine	and	spermine:	analytes	not	previously	reported	to	have	been	measured	using	the	EZ:faast	method.		 	
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Table	6.1	Analytical	parameters	of	the	optimised	LC-MS/MS	method.	
Analyte	 Abbreviated	name	 Parent	ion	(m/z)	 Product	ion	(m/z)	 LOD	(nM)	 LLOQ	(nM)	 R2	Arginine	 ARG	 303.23	 156.04	 11.2	 15	 0.989	Glutamine	 GLN	 275.27	 172.1	 13	 15	 0.987	Citrulline	 CIT	 304.8	 287.1	 3.4	 5	 0.99	Serine	 SER	 234.12	 146.32	 467.3	 500	 0.996	Asparagine	 ASN	 243.23	 157.06	 65.1	 150	 0.988	4-Hydroxyproline	 HYP	 260.02	 171.97	 74.7	 150	 0.9	3-Methylhistidine	 3MIS	 298.11	 214.06	 38.8	 500	 0.993	1-Methylhistidine	 1MIS	 298.11	 210.08	 1.9	 5	 0.998	Glycine	 GLY	 204.21	 171.83	 133.5	 500	 0.986	Glycine-proline	 GPR	 301.22	 240.84	 4.9	 5	 0.998	Threonine	 THR	 248.16	 188	 210.8	 500	 0.984	Alanine	 ALA	 217.98	 130.4	 21.9	 500	 0.983	Hydroxylysine	 HYL	 262.19	 174.26	 13.7	 150	 0.996	γ-Aminoisobutyric	acid	 GABA	 232.02	 172.03	 5.7	 15	 0.997	Sarcosine	 SAR	 217.98	 115.96	 15.6	 50	 0.987	β-Aminoisobutyric	acid	 BAIBA	 232.02	 130	 2.1	 5	 0.995	α-Aminobutyric	acid	 AABA	 232.02	 144.1	 4.2	 15	 0.983	Ornithine	 ORN	 347.2	 287.24	 3.9	 5	 0.996	Methionine	 MET	 278.1	 189.84	 39.9	 50	 0.993	
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Proline	 PRO	 244.2	 156.13	 70.7	 500	 0.98	Lysine	 LYS	 361.21	 170.07	 10.3	 50	 0.992	Aspartic	acid	 ASP	 304.08	 216.21	 124.4	 150	 0.989	Histidine	 HIS	 370.16	 195.91	 1.7	 5	 0.985	Thiaproline	 TPR	 262.19	 174.26	 216.5	 500	 0.972	Valine	 VAL	 256.13	 115.94	 330.5	 500	 0.988	Glutamic	acid	 GLU	 318.25	 172.16	 62.9	 150	 0.995	Tryptophan	 TRP	 333.25	 245.02	 1.6	 5	 0.997	Aminoadipic	acid	 AAA	 332.11	 244.48	 9.9	 15	 0.992	Leucine	 LEU	 260.7	 172.07	 0.8	 5	 0.983	Phenylalanine	 PHE	 294.18	 206.16	 16.4	 50	 0.994	Isoleucine	 ILE	 260.7	 129.91	 11.2	 15	 0.981	Aminopimelic	acid	 APA	 346.2	 286.06	 0.6	 5	 0.998	Cystathionine	 CTH	 479.03	 229.2	 0.1	 0.5	 0.998	Cysteine	 CYS	 497	 248.02	 0.2	 5	 0.994	Tyrosine	 TYR	 396.17	 308.15	 6.2	 15	 0.995	Agmatine	 AGM	 303.44	 243.31	 15	 15	 0.987	Cadaverine	 CAD	 275.45	 215.25	 8.9	 15	 0.996	Putrescine	 PUT	 261.39	 201.21	 8.9	 15	 0.998	Spermine	 SPM	 461.53	 155.31	 0.8	 15	 0.996	Spermidine	 SPD	 461.52	 284.29	 0.2	 1.5	 0.998	
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Figure	6.2	Total	and	extracted	 ion	chromatograms	 from	analysis	of	a	standard	mixture	of	
amino	acids,	polyamines	and	dipeptides.		a)	Total	 ion	chromatograms	(TICs):	the	MS/MS	Multiple	Reaction	Monitoring	(MRM)	method	was	split	into	3	three	time	segments	to	increase	dwell	time	per	analyte.	b)	Extracted	ion	chromatograms	(XICs)	of	agmatine,	spermine,	putrescine,	cadaverine	and	spermidine.	
Spermidine
Cadaverine
Putrescine
Spermine
Agmatine
Time (min) Time (min)
a) b)
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Figure	6.3	LC-MS/MS	assays	for	spermidine	show	linear	responses	over	a	range	of	1.5	nM	to	
15	µM.		The	 linearity	 of	 analyte	 responses	 of	 the	 optimised	 MRM	method	was	 evaluated	 by	 analysis	 of	calibration	standards	in	which	internal	standards	(HARG,	MET-d3	and	HPHE)	were	kept	constant	at	2	µM	while	all	target	analytes	were	varied	by	serial	dilution	across	a	concentration	range	of	500	pM	to	50	µM.	Illustrative	data	for	spermidine	is	shown	in	(a–e).	Four	calibration	curves	were	prepared	and	analysed	independently	on	different	days,	then	analysed	as	either.raw	response	values	(a–b)	or	homophenylalanine-normalised	 response	 values	 (c–d).	 Normalisation	 to	 the	 homophenylalanine	internal	standard	improved	inter-assay	variability	(compare	a–b	to	c–d).	Log-transformed	data	(b	and	d)	was	used	to	assess	linearity.	(e)	illustrates	homophenylalanine-normalised	response	values	for	spermidine	in	a	typical	LC-MS/MS	run	are	depicted	in	(e):	biological	samples	(black)	are	run	in	sets	of	<10,	separated	by	blanks	(green)	and	pooled	QC	(orange)	samples;	calibration	curves	(blue)	are	run	before	and	after	each	run.		
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Figure	6.4	Global	impression	of	impact	of	quorum	sensing	on	amino	acid	metabolism.		Principle	 Components	 Analysis	 was	 used	 to	 analyse	 EZ:faast	 LC-MS/MS	 data.	 At	 a	 global	 level,	addition	of	AHLs	complements	the	lasI	rhlI	mutant	towards	a	wild-type	metabotype.	Data	was	Pareto	scaled	prior	to	PCA	analysis.			
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Figure	6.5	Concentrations	of	selected	analytes	as	measured	by	EZ:faast	LC-MS/MS.		Wild-type	PAO1	(black	bars),	lasI	rhlI	mutant	(white	bars),	lasI	rhlI	mutant	complemented	with	10	µM	 BHL	 (vertical	 stripes),	 15	 µM	 OdDHL	 (horizontal	 stripes)	 or	 both	 (chequered).	 Error	 bars	represent	one	standard	deviation.	Asterisks	indicate	significant	differences	between	lasI	rhlI	mutant	and	complementation	with	BHL,	OdDHL	or	both	(*	P<=0.05,	**	P<=0.01,	two-tailed	Student’s	t	test).	Daggers	 indicate	significant	differences	between	samples	harvested	at	OD1.5	and	OD4.5	for	each	growth	condition	(†	P<=0.05,	‡	P<=0.01,	two-tailed	Student’s	t	test).	
	
Figure	6.6	Total	amino	acid	pools	decline	on	entry	to	stationary	phase.		Sum	of	analyte	 concentrations	measured	 in	cell	 extracts	 by	 LC-MS/MS.	 Component	 analytes	are:	arginine,	 aspartic	 acid,	 cysteine,	 glutamic	 acid,	 glutamine,	 glycine,	 histidine,	 isoleucine,	 leucine,	lysine,	methionine,	 ornithine,	 phenylalanine,	 proline,	 serine,	 threonine,	 tryptophan,	 tyrosine	 and	valine.	Wild-type	PAO1	(black	bars),	 lasI	rhlI	mutant	(white	bars),	 lasI	rhlI	mutant	complemented	with	10	µM	BHL	(vertical	stripes),	15	µM	OdDHL	(horizontal	stripes)	or	both	(chequered).	Error	bars	represent	one	standard	deviation.	Asterisks	indicate	significant	differences	between	lasI	rhlI	mutant	and	complementation	with	BHL,	OdDHL	or	both	(*	P<=0.05,	**	P<=0.01,	two-tailed	Student’s	t	test).	Daggers	 indicate	significant	differences	between	samples	harvested	at	OD1.5	and	OD4.5	for	each	growth	condition	(†	P<=0.05,	‡	P<=0.01,	two-tailed	Student’s	t	test).		 	
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6.2.2 QS-dependent	impacts	on	amino	acid	and	polyamine	
metabolism		
Cell	 extracts	 were	 prepared	 from	 samples	 of	 the	 bacterial	 cultures	 using	 a	 methanol-chloroform	 method.	 Samples	 were	 collected	 at	 OD600	 1.5	 and	 4.5	 in	 order	 bracket	 the	divergence	in	cellular	metabolism	identified	in	Chapter	2.	The	validated	EZ:faast	LC-MS/MS	method	was	then	used	to	quantify	amino	acid	and	polyamine	metabolites	in	the	cell	extracts.		
Estimates	of	the	cellular	concentrations	of	amino	acids,	assuming	a	cytoplasmic	volume	of	2.2	 fL	 (Cohen	 et	 al.	 2015),	 indicate	 cellular	 concentrations	 similar	 to	 values	 previously	reported	 for	 Gammaproteobacteria	 (Table	 6.2).	 These	 estimated	 cellular	 concentrations	offer	 reassurance	 that	measurements	are	within	 expected	 ranges,	 but	 should	be	 treated	with	caution	since	they	assume	a	cell	volume	measured	under	different	growth	conditions.	For	 example,	 estimated	 cellular	 concentrations	at	OD600=1.5	 for	 the	 two	most	 abundant	amino	acids,	glutamate	and	aspartate,	were	100	mM	and	3.4	mM	respectively,	similar	to	values	 of	 96	mM	 and	4.3	mM	 reported	 for	E.	 coli	 grown	 in	 a	 glucose	minimal	medium	(Bennett	 et	 al.	 2009).	 Estimated	 cellular	 concentrations	 of	 putrescine	 and	 spermidine	during	exponential	growth	are	8.8	mM	and	1.3	mM,	respectively,	lower	but	within	an	order	of	magnitude	of	values	reported	for	E.	coli	grown	in	nutrient	broth	(32.2	mM	for	putrescine	and	6.88	mM	for	spermidine)	(Miyamoto	et	al.	1993).		
The	PCA	scores	depicted	in	Figure	6.4	provides	an	overview	of	the	relationships	between	the	samples:	in	general,	the	concentrations	of	analytes	in	the	wild-type	and	lasI	rhlI	mutant	were	similar	at	OD1.5,	but	became	distinct	by	OD4.5.	The	PCA	also	illustrates	that	addition	of	exogenous	OdDHL	or	BHL	drives	the	analyte	profiles	of	the	lasI	rhlI	mutant	towards	those	of	the	wild-type,	confirming	that	both	the	las	and	rhl	systems	are	involved	in	this	composite	metabolic	phenotype.		
Some	of	the	more	striking	differences	between	the	wild-type	and	mutant	were	in	arginine	and	polyamine	metabolism	(Figure	6.5).	Concentrations	of	putrescine,	spermidine	and	their	precursor	ornithine	were	all	lower	in	wild-type	than	in	mutant	cells	during	stationary	phase	(by	4,	 5	 and	1.8	 fold,	 respectively):	whereas	wild-type	 concentrations	decreased	during	post-exponential	growth,	the	concentrations	in	lasI	rhlI	cells	were	more	stable.	Addition	of	BHL	and	to	a	lesser	degree	OdDHL	decreased	stationary	phase	concentrations	of	putrescine	and	spermidine	towards	wild-type	levels.	Surprisingly,	supplementation	of	the	mutant	with	BHL	 and	 OdDHL	 together	 resulted	 in	 higher	 in	 ornithine	 levels	 rather	 than	complementation	towards	lower	wild-type	levels.	Levels	of	a	third	polyamine,	cadaverine,	decreased	from	around	300	µM	at	OD	1.5	to	negligible	concentrations	at	OD	4.5	and	parallel	
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a	5-fold	drop	 in	concentrations	of	 lysine.	Utilisation	of	L-lysine	by	P.	aeruginosa	PAO1	is	dependent	on	the	lysine	decarboxylase	pathway	with	cadaverine	as	an	intermediate	(Chou	et	 al.	 2010).	 This	 suggests	 that	decreasing	 cadaverine	 concentrations	 reflect	decreasing	uptake	and	catabolism	of	lysine	from	the	growth	medium.		
The	size	of	free	amino	acid	pools	in	bacteria	(the	combined	concentration	of	proteinogenic	amino	acids)	has	long	been	observed	to	correlate	strongly	with	bacterial	growth	rate.	Under	the	present	conditions,	the	size	of	the	amino	acid	pool	halved	between	OD	1.5	and	OD	4.5	in	both	 the	 wild-type	 and	 lasI	 rhlI	 mutant,	 consistent	 with	 studies	 in	 E.	 coli	 (Figure	 6.6)	(Mandelstam	1958).	Despite	marked	shifts	in	the	relative	levels	of	amino	acid	analytes,	the	size	of	 the	amino	acid	pools	of	 the	wild-type	and	mutant	were	 indistinguishable	at	both	sampling	points.	However,	the	size	of	the	amino	acid	pool	in	the	lasI	rhlI	mutant	at	OD4.5	increased	when	cultures	were	supplemented	with	AHLs	(p<0.01	for	OdDHL,	p=0.051	for	BHL,	 Student’s	 t-test).	 This	 was	 driven	 principally	 by	 higher	 levels	 of	 glycine	 and	methionine	 in	 AHL-supplemented	 cultures.	 Despite	 the	 demand	 for	 SAM	 for	 AHL	biosynthesis	 in	 the	wild-type,	 levels	 of	methionine	were	 similar	 to	 those	 in	 the	 lasI	 rhlI	mutant.	 Levels	 of	 methionine	 in	 the	 mutant	 were	 elevated	 >5-fold	 in	 response	 to	supplementation	 with	 BHL	 and	 >3-fold	 in	 response	 to	 OdDHL.	 These	 low-micromolar	increases	in	methionine	may	be	due	to	metabolic	assimilation	of	AHLs	via	SAM	and	suggest	higher	 rates	 of	 assimilation	 of	 BHL	 than	 OdDHL.	 The	 millimolar	 increases	 in	 glycine	concentrations	in	response	to	exogenous	AHLs	cannot	be	explained	by	assimilation	of	AHLs:	a)	 there	 is	 no	 simple	metabolic	pathway	 or	 regulatory	 link	 that	 ties	 AHL	 catabolism	 to	glycine	 concentrations,	 b)	 the	 concentrations	 of	 supplemented	 AHLs	 are	 insufficient	 to	explain	the	increases	in	glycine	(~1	µmole	of	AHL	added	to	cultures	compared	to	~10	µmole	increases	in	glycine,	c)	glycine	concentrations	responded	only	to	OdDHL	and	not	BHL.	
Levels	of	several	other	amino	acid	metabolites	were	modulated	in	the	mutant	relative	to	the	wild-type	(Figure	6.5).	Concentrations	of	lysine	in	the	mutant	during	early	post-exponential	growth	(OD	4.5)	were	twice	those	in	the	wild-type	and	this	difference	was	complemented	with	 exogenous	 BHL,	 suggesting	 that	 lysine	metabolism	 is	 impacted	 by	 the	 rhl	 system.	Glutamate	concentrations	were	depressed	by	40%	in	the	mutant	were	increased	to	wild-type	by	addition	of	AHLs.	Although	measurements	of	γ-aminoisobutyric	acid	were	noisy,	they	mirrored	those	of	glutamate,	suggesting	that	glutamate	decarboxylase	(GAD)	activity	is	perturbed	by	QS.	GAD	activity	is	involved	in	several	bacterial	stress	responses	including	acid	 shock,	 salt	 stress	 and	 stationary	 phase	 growth	 (De	 Biase	 et	 al.	 1999;	 Feehily	 and	Karatzas	2013).		
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Tyrosine	concentrations	in	the	lasI	rhlI	mutant	were	60%	lower	than	the	wild-type	in	early	post-exponential	growth	and	increased	to	near	wild-type	levels	in	response	to	BHL.	This	may	 reflect	 diversion	 of	 flux	 from	 the	 shikimic	 acid	 pathway	 toward	 QS-induced	exometabolites	 such	 as	 phenazines,	 however	 tyrosine	 concentrations	 correlated	 poorly	with	those	of	other	aromatic	amino	acids.		
	
Table	6.2	Estimated	cellular	concentrations	of	amino	acid	and	polyamine	metabolites.	Cellular	concentrations	are	calculated	based	on	data	from	Table	2,	assuming	a	cell	volume	of	2.2	fL.	Student’s	t-tests	were	calculated	relative	to	the	wild-type	(WT,	for	the	lasI	rhlI	mutant)	or	relative	to	the	 lasI	rhlI	mutant	(LIRI,	 for	chemical	complementation(s)).	Complementation	values	are	shown	where	significant	(p<=0.05).	Asterisks	indicate	significant	differences	(*P<=0.05,	**	P<=0.01,	two-tailed	Student’s	t	test).	“⎯”	indicates	no	significant	change	relative	to	the	non-complemented	culture.		
	
Metabolite PAO1 lasI	rhlI	 BHL OdDHL BHL+OdDHL PAO1 lasI	rhlI	 BHL OdDHL BHL+OdDHL
1‐methyl	histidine 2.20E‐06 6.71E‐07 ⎯ ⎯ ⎯ 8.35E‐07 1.56E‐06 ⎯ ⎯ ⎯
3‐methyl	histidine 2.19E‐06 7.35E‐07 ⎯ ⎯ ⎯ 1.49E‐05 5.07E‐06 ⎯ ⎯ ⎯
4‐aminobutryic	acid 2.61E‐03 6.07E‐03** ⎯ 4.58E‐03** ⎯ 2.93E‐03 3.98E‐03 ⎯ ⎯ ⎯
4‐hydroxyproline 3.70E‐04 3.43E‐04 ⎯ ⎯ ⎯ 4.10E‐04 1.64E‐04 ⎯ ⎯ ⎯
α‐aminoadipic	acid 3.50E‐05 1.78E‐05 ⎯ ⎯ ⎯ 7.34E‐06 1.05E‐05 ⎯ ⎯ ⎯
α‐aminobutyric	acid 5.80E‐04 5.41E‐04 ⎯ ⎯ ⎯ 4.15E‐04 6.04E‐04 ⎯ ⎯ ⎯
agmatine 3.07E‐04 2.28E‐04 ⎯ ⎯ ⎯ 3.57E‐04 2.40E‐04 ⎯ ⎯ ⎯
aminopimelic	acid 4.65E‐06 2.12E‐06 ⎯ ⎯ ⎯ 1.48E‐06 1.90E‐06 ⎯ ⎯ ⎯
arginine 2.54E‐04 2.17E‐04 ⎯ ⎯ ⎯ 2.93E‐04 2.30E‐04 ⎯ ⎯ ⎯
aspartic	acid 3.39E‐03 3.31E‐03 ⎯ ⎯ ⎯ 2.20E‐03 1.75E‐03 ⎯ ⎯ 2.77E‐03*
β‐aminoisobutyric	acid 8.70E‐06 9.67E‐06 ⎯ ⎯ ⎯ 7.08E‐06 1.05E‐05 ⎯ ⎯ ⎯
cadaverine 1.30E‐03 6.38E‐04* ⎯ ⎯ ⎯ 3.23E‐06 1.68E‐06 ⎯ ⎯ ⎯
citrulline 3.90E‐03 2.87E‐03 ⎯ ⎯ ⎯ 1.49E‐03 1.86E‐03 ⎯ ⎯ ⎯
cystathionine 8.73E‐05 8.36E‐05 3.58E‐05* 2.88E‐05** ⎯ 2.56E‐05 4.42E‐05 ⎯ ⎯ ⎯
cysteine 2.19E‐05 2.51E‐05* 1.89E‐05** ⎯ ⎯ 2.00E‐05 2.75E‐05 ⎯ ⎯ ⎯
glutamic	acid 9.97E‐02 7.39E‐02 ⎯ ⎯ ⎯ 5.35E‐02 3.51E‐02* 6.45E‐02** 5.76E‐02* 5.63E‐02*
glutamine 6.47E‐04 5.22E‐04 ⎯ ⎯ ⎯ 5.19E‐04 4.00E‐04 ⎯ ⎯ ⎯
glycine 2.50E‐02 3.19E‐02 ⎯ ⎯ ⎯ 1.50E‐02 1.34E‐02 ⎯ 4.30E‐02** 4.12E‐02*
glycine‐proline 4.66E‐05 2.50E‐05 4.07E‐05* ⎯ 6.53E‐05** 4.31E‐05 2.81E‐05 ⎯ ⎯ ⎯
histidine 1.46E‐03 6.65E‐04 1.54E‐03* 1.64E‐03* ⎯ 5.65E‐04 1.04E‐03 ⎯ ⎯ ⎯
hydroxylysine 2.10E‐04 1.46E‐04 ⎯ ⎯ ⎯ 2.62E‐04 1.82E‐04 ⎯ ⎯ ⎯
isoleucine 4.68E‐03 4.30E‐03 ⎯ ⎯ ⎯ 9.36E‐04 1.03E‐03 ⎯ ⎯ ⎯
leucine 8.06E‐03 6.18E‐03 ⎯ ⎯ ⎯ 2.94E‐03 4.44E‐03 ⎯ ⎯ ⎯
lysine 1.04E‐02 1.17E‐02 ⎯ ⎯ ⎯ 1.20E‐03 2.47E‐03** 1.63E‐03** ⎯ 1.85E‐03*
methionine 2.47E‐04 2.58E‐04 ⎯ ⎯ ⎯ 3.59E‐05 2.52E‐05 ⎯ 8.58E‐05* ‐
ornithine 5.13E‐04 3.97E‐04 4.85E‐04* 6.01E‐04* 6.67E‐04** 2.73E‐04 4.25E‐04** ⎯ ⎯ 5.84E‐04*
phenylalanine 4.73E‐03 2.82E‐03* ⎯ ⎯ 5.01E‐03** 1.12E‐03 1.65E‐03* ⎯ 1.23E‐03** 1.27E‐03**
proline 2.86E‐03 2.86E‐03 ⎯ ⎯ ⎯ 1.56E‐03 1.29E‐03 ⎯ ⎯ ⎯
putrescine 8.82E‐03 8.83E‐03 ⎯ ⎯ ⎯ 2.10E‐03 1.04E‐02** 3.44E‐03** 4.90E‐03** 4.32E‐03**
sarcosine 3.95E‐05 5.63E‐05 ⎯ ⎯ ⎯ 5.84E‐04 4.00E‐04 ⎯ ⎯ ⎯
serine 1.45E‐02 1.66E‐02 9.70E‐03* ⎯ ⎯ 7.17E‐03 8.91E‐03 ⎯ ⎯ ⎯
spermidine 1.34E‐03 1.19E‐03 ⎯ ⎯ ⎯ 2.47E‐04 1.06E‐03** 4.41E‐04** 6.66E‐04* 4.25E‐04**
spermine 1.81E‐07 4.53E‐08 ⎯ ⎯ ⎯ 1.31E‐07 2.72E‐07 ⎯ ⎯ ⎯
thiaproline 4.30E‐04 1.09E‐03 ⎯ ⎯ ⎯ 7.17E‐04 7.36E‐04 ⎯ ⎯ ⎯
threonine 2.35E‐03 3.12E‐03 ⎯ 2.39E‐03* ⎯ 1.28E‐03 1.34E‐03 ⎯ ⎯ ⎯
tryptophan 5.38E‐05 3.36E‐05 ⎯ ⎯ 4.72E‐05** 3.26E‐05 3.13E‐05 ⎯ ⎯ 5.54E‐05*
tyrosine 1.24E‐03 5.83E‐04* 7.00E‐04* ⎯ 1.36E‐03** 6.31E‐04 2.31E‐04* 5.06E‐04** 3.24E‐04* 7.86E‐04**
valine 1.77E‐02 1.32E‐02 ⎯ ⎯ ⎯ 6.26E‐03 8.84E‐03 ⎯ ⎯ ⎯
Mean	concentration	(M)
OD600	=	1.5 OD600	=	4.5
Metabolic	profiling	of	amino	acids	and	polyamines	
	132	
6.3 Discussion	
A	 rapid,	 reliable,	 high-throughput	 method	 was	 developed	 to	 simultaneously	 measure	polyamine	and	amino	acid	metabolites	with	a	large	dynamic	range.	Detection	limits	were	in	the	nM	range	for	each	analyte	and	responses	were	linear	across	the	0.5-50	µM	range	tested.	Using	 this	 LC-MS/MS	method,	 it	was	 shown	 that	P.	 aeruginosa	has	 a	marked	 impact	 on	cellular	concentrations	of	polyamine	and	amino	acid	metabolism.		
Polyamines	are	multifunctional	molecules	 associated	with	 a	 variety	of	 stress	 responses,	notably	against	oxidative	stress	(Yoshida	et	al.	2004;	Rhee	et	al.	2007).	Polyamines	execute	these	 functions	 by	 diverse	means,	 including	modulating	 gene	 expression,	modifying	 the	activities	of	cell	membrane	components,	and	by	scavenging	free	radicals.	By	sequestering	free	 radicals,	 polyamines	 can	 protect	 cell	 components	 (especially	 GC-rich	 DNA)	 against	reactive	 oxygen	 species	 (ROS)-induced	 stress.	 In	 the	 wild	 type,	 QS	 is	 known	 to	 elicit	increased	 expression	 of	 enzymes	 involved	 in	 ROS	 detoxiﬁcation,	 such	 as	 superoxide	dismutases	 (Mn-SOD	 and	 Fe-SOD),	 the	 major	 catalase	 KatA	 (Hassett	 et	 al.	 1999),	 and	NADPH-generating	 glucose-6-phosphate	 dehydrogenase	 (NADPH	 is	 required	 for	 the	synthesis	 of	 glutathione).	 Indeed,	 it	 has	 been	 suggested	 recently	 that	 because	 they	 are	“private	 goods,”	 the	 expression	 of	 these	 detoxiﬁcation	 enzymes	 is	 another	 key	 factor	suppressing	 the	 appearance	 of	 “social	 cheats”	 in	 the	 population	 (García-Contreras	 et	 al.	2014).	Since	 these	enzymes	would	no	 longer	be	upregulated	in	the	 lasI	rhlI	mutant,	 it	 is	possible	 that	 the	 elevated	 levels	 of	 putrescine	 and	 spermidine	 reﬂect	 an	 alternative	metabolic	response	to	increased	ROS-induced	stress	as	the	culture	enters	stationary	phase.	
The	 total	 concentration	 of	 free	 amino	 acids	 is	 closely	 linked	 to	 energy	 metabolism.	Investigations	in	the	1950’s	demonstrated	that	inhibition	of	oxidative	phosphorylation	with	azide,	or	dissipation	of	 the	proton	motive	 force	both	 lead	 to	reductions	 in	 the	 total	 free	amino	acid	pools.	Similarly,	the	pool	of	free	amino	acids	decreases	as	growth	rate	slows	for	example	 during	 the	 transition	 to	 stationary	 phase	 growth	 in	 batch	 culture,	 as	 rates	 of	protein	synthesis	decrease	(Mandelstam	1958;	Tempest	et	al.	1970).	The	size	and	makeup	of	 the	 free	 amino	acids	 pool	 has	 long	 been	 known	 to	 vary	with	 changes	 to	 a	 variety	 of	environment	 conditions,	 for	 example	 rapid	 changes	 to	 amino	 acid	 pools	 in	 response	 to	stresses	 such	 as	mild	 changes	 in	 osmolarity.	 However,	 it	 is	 not	 clear	why	 exogenously	supplied	AHLs	should	affect	the	total	amino	acid	pool	size	and	levels	of	glycine	in	particular,	particularly	 as	 no	 difference	 was	 evident	 between	 the	 wild-type	 and	 lasI	 rhlI	 mutant	cultures.		
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The	QS-induced	changes	to	amino	acids	suggest	several	avenues	for	further	investigation.	For	example,	aromatic	amino	acids	including	tyrosine	are	present	at	high	concentrations	in	CF	sputum	and	induce	P.	aeruginosa	anti-microbial	activity	and	synthesis	of	Pseudomonas	quinolone	signal	(PQS)	(Palmer	et	al.	2007,	2010).	Tyrosine	and	tryptophan	metabolism	is	also	 implicated	 in	metabolic	 adaptation	of	P.	 aeruginosa	 to	 the	CF	 lung	(Behrends	 et	 al.	2013).	Several	gene	products	involved	in	aromatic	amino	acid	metabolism	have	previously	been	shown	to	be	induced	by	QS,	including	the	anthranilate	synthase	genes	phnAB	(Table	4).	 The	 present	 data	 confirms	 that	 AHL	 QS	 can	 have	 a	 marked	 impact	 on	 cellular	concentrations	of	free	tyrosine.	
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Table	6.3	QS-modulated	genes	involved	in	amino	acid	metabolism.		Data	was	compiled	from	three	independent	studies:	(Hentzer	et	al.	2003;	Schuster	et	al.	2003;	Wagner	et	al.	2003).	a	Fold	change	was	reported	as	the	average	fold	induction	in	a	lasI	rhlI	mutant	when	supplemented	with	2	µM	OdDHL	and	5	µM	BHL	(average	of	samples	collect	at	OD600	of	0.5,	1.3,	1.6,	2.0,	2.7).	Bacteria	were	grown	aerobically	in	ABt	minimal	medium	with	0.5%	casamino	acids.		b	Fold	change	was	reported	as	the	maximum	fold	induction	in	a	lasI	rhlI	mutant	when	supplemented	with	2	µM	OdDHL	and	10	µM	BHL	(maximum	of	samples	collected	at	OD600	of	0.2,	0.4,	0.8,	1.4,	2.0,	3.0,	and	4.0).	Bacteria	were	grown	aerobically	in	buffered	Lysogeny	Broth.		c	Fold	change	was	reported	as	the	fold	induction	in	a	lasI	rhlI	mutant	when	supplemented	with	1	µM	OdDHL	and	2	µM	BHL.	Values	are	reported	for	samples	collected	during	early	mid-logarithmic	(ML)	or	stationary	phase	(ES)	growth.	The	values	are	reported	for	the	early	stationary	phase	when	differential	expression	was	observed	in	both	growth	phases	(B).	Bacteria	were	grown	aerobically	in	modified	FAB	medium.		 	 	 Fold	modulation	in	lasI	rhlI	mutant	 	PA	number	 Gene	Name,	synonyms	 Hentzer	et	al.	2003a	 Schuster	et	al.	2003b	 Wagner	et.	al	2003c	 Description	PA0228	 pcaF	 	 	 3.8	(ES)	 beta-ketoadipyl	CoA	thiolase	PcaF	PA0447	 gcdH	 	 	 7.8	(ML)	 glutaryl-CoA	dehydrogenase	PA0581	 plsY	 	 	 -2	(ML)	 glycerol-3-phosphate	acyltransferase	PA1869	 	 57	 41	 79	(B)	 probable	acyl	carrier	protein	PA2001	 atoB	 	 	 23	(ML)	 acetyl-CoA	acetyltransferase	PA3300	 fadD2	 	 	 3.6	(ML)	 long-chain-fatty-acid--CoA	ligase	PA3333	 fabH2	 30	 32	 32	(B)	 3-oxoacyl-[acyl-carrier-protein]	synthase	III	PA3334	 	 30	 49	 23	(B)	 probable	acyl	carrier	protein	PA3645	 fabZ,	sefA	 	 	 -1.8	(ES)	 (3R)-hydroxymyristoyl-[acyl	carrier	protein]	dehydratase	PA3924	 	 	 	 4.6	(ML)	 probable	medium-chain	acyl-CoA	ligase	
		
135		
PA4888	 desB,	desB		 	 	 -1.8	(B)	 acyl-CoA	delta-9-desaturase,	DesB	PA0744	 	 	 	 7	(ML)	 probable	enoyl-CoA	hydratase/isomerase	PA0745	 	 	 	 8.2	(ML)	 probable	enoyl-CoA	hydratase/isomerase	PA0996	 pqsA	 9	 90	 4.7	(B)	 probable	coenzyme	A	ligase	PA0999	 pqsD,	fabH1	 9	 25	 5.1	(B)	 3-oxoacyl-[acyl-carrier-protein]	synthase	III	PA2552	 acdB	 	 	 10	(ML)	 probable	acyl-CoA	dehydrogenase	PA2553	 	 	 	 14	(ML)	 probable	acyl-CoA	thiolase	PA2554	 	 	 	 11	(ML)	 probable	short-chain	dehydrogenase	PA2862	 lipA	 	 	 4	(ML)	 lactonizing	lipase	precursor	PA2889	 atuD	 	 	 2.8	(ML)	 putative	citronellyl-CoA	dehydrogenase	involved	in	catabolism	of	citronellol	PA3330	 	 149	 120	 38	(ML)	 probable	short	chain	dehydrogenase	PA3924	 	 	 	 4.6	(ML)	 probable	medium-chain	acyl-CoA	ligase	PA4907	 ydfG	 	 	 1.7	(ES)	 probable	short-chain	dehydrogenase	PA4979	 	 	 	 2.4	(ML)	 probable	acyl-CoA	dehydrogenase	PA5521	 	 	 	 1.9	(ML)	 probable	short-chain	dehydrogenase	PA5546	 		 	 	 3.2	(ES)	 conserved	hypothetical	protein	
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Chapter	7 		Summary	and	General	Discussion	
AHL	QS	systems	infer	and	convey	valuable	information	about	P.	aeruginosa’s	physical	and	social	 environment.	 They	 are	 intimately	 connected	 to	 a	 wider	 regulatory	 network	 that	integrates	cellular	and	environmental	cues	to	determine	the	bacterium’s	growth	strategy.	Moreover,	AHL	regulatory	systems	regulate	a	large	portion	of	 the	P.	aeruginosa	genome,	including	metabolically	costly	secreted	factors.	There	is	therefore	good	reason	to	expect	QS	systems	to	exert	significant	influence	over	primary	metabolic	functions.	Indeed	several	lines	of	evidence	from	previous	studies,	including	multiple	independent	transcriptomic	studies,	have	suggested	this	might	be	the	case	(Hentzer	et	al.	2003;	Schuster	et	al.	2003;	Wagner	et	al.	2003).	However,	to	my	knowledge	there	has	been	no	previous	study	of	the	global	impact	of	AHL	QS	on	the	metabolome	of	P.	aeruginosa,	and	so	an	important	biochemical	perspective	on	this	relationship	has	been	missing.	The	central	aim	of	work	presented	in	this	dissertation	was	 to	 conduct	 a	 systematic	 metabolomic	 investigation	 of	 the	 extent	 to	 which	 P.	
aeruginosa’s	primary	metabolism	is	coupled	to	AHL	QS	activity.	This	study	has	established	that	 AHL	 QS	 has	 widespread	 effects	 on	 the	 small	 molecule	 primary	 metabolism	 of	 P.	
aeruginosa	and	that	many	of	these	changes	are	consistent	with	QS	coordinating	metabolic	adaptation	to	stationary	phase	stresses.	
Work	described	in	Chapter	3	established	that	the	rhl,	las	and	PQS	systems	do	indeed	induce	marked	 changes	 to	 the	 small	 molecule	metabolism	 of	 P.	 aeruginosa	 and	 that	 these	 are	apparent	via	1H-NMR	metabolic	footprinting.	Mutants	deficient	in	lasI,	rhlI	and	pqsR	were	readily	differentiated	from	wild-type	P.	aeruginosa	PAO1.	Fatty	acid	and	amino	acid	profiles	in	 particular	 were	 altered	 in	 all	 three	 QS	mutants.	 The	metabolic	 footprint	 of	 the	 pqsR	mutant	showed	similar	effects	to	the	AHL	QS	mutants,	although	effect	sizes	were	larger	for	the	lasI	and	rhl	mutants.	This	suggests	that	AHL	signalling	has	a	larger	impact	on	primary	metabolism	than	does	alkyl	quinolone	signaling	via	pqsR,	however	further	investigation	is	necessary	to	establish	whether	this	holds	true	under	other	growth	conditions	and	to	assess	the	roles	of	the	several	AQ	signals	in	modulating	primary	metabolism.		
The	pilot	study	prompted	a	systematic	investigation	of	the	impact	of	the	las	and	rhl	systems	on	primary	metabolism,	based	on	comparison	of	an	“AHL	signal-null”	 lasI	rhlI	mutant	to	wild-type	P.	aeruginosa	PAO1.	Time-resolved	1H-NMR	metabolic	footprinting	described	in	Chapter	4	proved	valuable	in	identifying	the	timing	of	shifts	in	primary	metabolism	in	the	
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mutant,	revealing	that	rates	of	nutrient	uptake	and	acetogenesis	of	the	mutant	diverge	from	that	of	wild-type	P.	aeruginosa	during	late	exponential	phase	growth	in	AGSY	medium.	This	divergence	coincided	with	AHL	accumulation	in	wild-type	cultures,	induction	of	rhl-	and	las-regulated	gene	expression	and	a	small	growth	defect	relative	to	the	mutant.	Complementary	MS	metabolomic	and	proteomic	analyses	were	used	to	more	precisely	detail	QS-dependent	cellular	metabolic	changes	during	this	transition	to	stationary	phase	growth,	as	described	in	Chapter	4,	 Chapter	5	and	Chapter	6.	These	 analyses	 revealed	 that	AHL	signalling	has	widespread	effects	on	primary	metabolism,	including	substantial	impacts	on	central	carbon	metabolism,	amino	acid	metabolism	and	fatty	acid	metabolism.	Of	the	many	QS-dependent	effects	on	primary	small	molecule	metabolism,	perhaps	the	most	compelling	trend	is	that	QS	activity	seems	to	induce	metabolic	adaptations	to	stationary	phase	stresses,	particularly	to	oxidative	stress	and	growth	in	oxygen-depleted	environments.	The	slower	growth	of	the	wild-type	was	accompanied	by	repression	of	the	oxidative	CO2-evolving	portion	of	the	TCA	cycle,	decreased	acetogenesis	and	induction	of	the	glyoxylate	bypass.	The	glyoxylate	shunt	is	has	previously	been	shown	to	be	induced	in	response	to	oxidative	and	antibiotic	stress	(Dunn	et	al.	2009;	Ahn	et	al.	2016).	Proteomic	data	indicated	QS-induction	of	several	other	factors	 involved	 in	 adaptation	 to	microaerobiosis,	 including	 arginine	 deiminase	 (ArcA),	nitrite	 reductase	 (NirS,	 cytochrome	 cd1)	 and	azurin	 (a	 nitrite	 reductase	 redox	 partner)	(Schreiber	et	al.	2006;	Trunk	et	al.	2010).	Similarly,	 the	 fatty	acid	profiling	revealed	QS-dependent	 increases	 in	 cyclopropanation	 and	 longer	 acyl	 chain	 lengths,	 consistent	with	defense	 against	 stationary	 phase	 membrane	 stressors	 (including	 oxidative	 damage).	 In	contrast,	the	lasI	rhlI	mutant—i.e.	in	the	absence	of	AHL	signalling—expressed	lower	levels	of	a	variety	of	factors	linked	to	protection	against	oxidative	stress	including	catalase	(KatA)	and	 the	 siderophores	 pyoverdine	 and	 pyochelin.	 This	 may	 explain	 the	 elevated	concentrations	of	the	general	stress-response	molecules	putrescine	and	spermidine	seen	in	the	mutant.		
AHL	QS	has	previously	been	shown	to	enhance	the	oxidative	stress	response:	catalase	and	superoxide	 dismutase	 activities	 in	 lasI,	 rhlI	 and	 lasI	 rhlI	 mutants	 have	 been	 linked	 to	increased	sensitivity	to	oxidative	stress	(Hassett	et	al.	1999).	More	recently,	a	study	of	a	lasR	
rhlR	QS-deficient	mutant	demonstrated	that	QS	confers	resistance	to	osmotic,	thermal	and	heavy	metal	stresses	and	exposure	to	oxidative	stress	(H2O2)	can	select	for	cells	with	active	QS	systems	(García-Contreras	et	al.	2014).	The	present	results	suggest	that	QS-control	of	resistance	to	oxidative	stress	extends	to	protective	modulation	of	primary	metabolism.	This	implies	there	may	be	more	general	validity	than	realised	to	earlier	hints	that	QS-dependent	induction	of	primary	metabolic	processes	serves	protective	roles,	 for	example	 that	AHL-induction	 of	 glucose-6-dehydrogenase	 in	 early	 stationary	 phase	 protects	 the	 cell	 from	oxidative	stress	by	supporting	glutathione	synthesis	(Ma	et	al.	1998;	Schuster	et	al.	2003).		
Discussion	
	139	
The	control	of	protective	primary	metabolic	functions	by	QS	in	P.	aeruginosa	in	the	present	study	 is	 consistent	 with	 growing	 evidence	 for	 similar	 functions	 in	 other	 bacteria.	Environmental	correlation	between	QS	autoinducer	concentrations,	population	cell	density	and	resource	competition	means	that	QS	may	be	used	 to	 infer	 the	strength	of	ecological	competition,	and	do	so	earlier	than	a	stress	responses	system	could	allow	(Cornforth	and	Foster	2013).	More	generally,	stresses	associated	with	crowded	environments	can	be	self-inflicted,	 for	 example	 via	 accumulation	 of	 toxic	 excretions.	 Work	 by	 (Goo	 et	 al.	 2012)	suggests	that	Burkholderia	species	use	QS	to	perform	“anticipatory”	adaptation	by	inducing	the	excretion	of	oxalate	as	cultures	approach	carrying	capacity,	thereby	protecting	against	ammonia-mediated	 alkaline	 toxicity	 in	 stationary	 phase.	 Similarly,	 QS-dependent	repression	 of	 primary	 metabolic	 processes—including	 nutrient	 uptake	 and	 oxidative	phosphorylation—in	the	rice	pathogen	Burkholderia	glumae	has	been	interpreted	as	a	QS-controlled	 metabolic	 brake	 that	 supports	 metabolic	 homeostasis	 under	 crowded	 but	cooperative	 conditions	(An	et	 al.	 2014).	QS-dependent	 induction	of	 the	 glyoxylate	 cycle,	arginine	 fermentation	and	protective	 fatty	acid	metabolism—as	observed	 in	 the	present	study—suggest	 that	 QS	 may	 perform	 analagous	 anticipatory	 regulation	 of	 the	 primary	metabolism	of	P.	aeruginosa.		
QS	is	one	of	several	interlinked	regulatory	mechanisms	determining	stress	responses	in	P.	
aeruginosa.	QS-induced	stress	responses	are	mediated	in	part	via	regulators	such	as	RpoS.	The	presence	of	putative	RpoS	and	rhl	boxes	in	the	promoter	region	of	PA5546	(a	probable	cyclopropane-fatty-acid-phospholipid	 synthase	 gene)	 suggests	 coordinate	 regulation	 of	cyclopropanation.	 This	 expands	 the	 already	 extensive	 overlap	 in	 the	 RpoS	 and	 AHL	 QS	regulons	 (Schuster	 et	 al.	 2004b).	 The	 las-rhl	 box	 upstream	 of	 PA5546	 points	 to	 direct	regulation	by	QS,	however	it	is	likely	that	QS	modulation	of	central	metabolic	processes	is	also	 a	 consequence	 of	 indirect	 regulation	 (via	 global	 regulators	 including	 RpoS)	 and	adaptation	to	QS-induced	perturbations	to	the	cellular	environment.	AHL	QS	influences	the	cellular	 and	 environmental	 oxidative	 potential	 via	 expression	 of	 factors	 including	rhamnolipid	surfactants,	phenazine	redox	shuttles,	siderophores	and	catalase.	For	example	oxygen	 availability	 can	 be	 modulated	 via	 secretion	 of	 rhamnolipid	 surfactants,	 as	demonstrated	by	Sabra	et	al.	(2002)	and	Kim	et	al.	(2003).	In	a	similar	vein,	AHL	QS	activity	may	 increase	 the	 capacity	 for	 cellular	 oxidative	 phosphorylation	 via	 induction	 of	 AHL-regulated	 redox	 shuttles	 such	 as	 phenazines:	 pyocyanin	 regulates	 primary	 metabolism	during	 stationary	 phase	 under	 conditions	 of	 low	 oxygen	 availability	 and	 lowers	 the	intracellular	NADH/NAD	ratio	(Price-Whelan	et	al.	2007).	Such	QS-mediated	manipulations	of	the	cellular	and	external	environment	could	contribute	to	the	changes	in	central	carbon	metabolism	 observed	 in	 the	 present	 study.	 Another	 consideration	 is	 that	 redirection	 of	metabolic	resources	away	from	central	metabolism	and	toward	QS-dependent	biosynthesis	
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public	goods	will	itself	result	in	adaptive	metabolic	responses,	independent	of	any	direct	QS	regulatory	 control.	Metabolic	 supply-demand	analysis	 illustrates	 that	 the	 control	 of	 flux	through	 a	 supply	 pathway	 may	 reside	 outside	 that	 pathway,	 in	 downstream	 demand	reactions	 (Hofmeyr	 and	 Cornish-Bowden	 2000;	 Oliver	 2002).	 This	 may	 contribute	 to	depletion	of	TCA	intermediates	and	amino	acid	precursors	of	secondary	metabolites	as	well	as	the	lower	growth	yield	of	the	wild-type	compared	to	the	lasI	rhlI	mutant.	
Defenses	against	biotic	and	abiotic	stress	play	key	roles	in	environmental	persistance	and	virulence	and,	given	the	role	of	QS	in	stress	tolerance,	are	probably	also	important	in	the	evolution	 of	 QS	 systems.	 For	 example	 several	 of	 the	 QS-induced	 primary	 metabolic	phenotypes	are	thought	to	play	roles	in	host	colonisation	and	disease.	A	recent	analysis	of	genome-wide	 gene	 expression	 and	mutant	 fitness	 profiles	 found	metabolic	 phenotypes	similar	to	those	described	here	are	implicated	in	fitness	in	a	mouse	acute	wound	model	of	infection:	downregulation	of	 the	decarboxylating	 steps	of	 the	TCA	 cycle,	 upregulation	of	isocitrate	 lyase,	 and	 upregulation	 of	 a	 number	 of	 genes	 associated	 with	 growth	 under	oxygen-limitation	(Turner	et	al.	2014).	The	glyoxylate	cycle	and	arginine	deiminase	are	also	induced	in	chronic	lung	infections	(Son	et	al.	2007;	Dunn	et	al.	2009).		
To	 better	 understand	 the	mechanisms	 connecting	 QS	 and	metabolic	 changes,	 it	 will	 be	important	 to	 distinguish	 the	 direct	 from	 the	 indirect	 consequences	 of	 QS,	 for	 example	between	 direct	 regulation	 of	 primary	 metabolic	 enzymes	 and	 indirect	 regulation	 of	metabolism	via	modulation	of	metabolic	demand	(synthesis	of	secondary	metabolites	and	secreted	 factors),	 cellular	 physiology	 (membrane	 composition)	 and	 environmental	conditions	(environmental	oxidative	potential).	Using	chromatin	 immunoprecipitation	 in	conjunction	with	DNA	microarray	analysis	(ChIP-chip),	Gilbert	et	al.	(2009)	assessed	direct	transcriptional	regulation,	observing	that	only	a	small	fraction	of	las-induced	transciptional	regulation	 could	 be	 ascribed	 to	 direct	 promoter-binding	 by	 LasR.	 Given	 the	 apparent	interdependency	of	multiple	regulators	 in	mediating	QS	responses,	 it	would	be	useful	to	extend	 this	 line	 of	 investigation	 to	 examine	 coordination	 between	 LasR,	 RhlR	 and	 their	regulatory	 partners,	 using	 metabolomic,	 gene	 expression	 and	 ChIP-chip	 data	 obtained	under	common	conditions.		
Understanding	the	various	indirect	mechanisms	by	which	QS	controls	primary	metabolism	will	require	careful	experimental	control	of	nutrient	composition,	environmental	conditions	and	QS-dependent	gene	expression	(ideally	exogenous,	QS-indpendent	control).	Chemostat	fermentation	would	be	a	particularly	attactive	approach,	affording	independent	control	of	environmental	conditions,	bacterial	cell	density	and	exogenous	inducers	of	gene	expression.	Ideally,	 such	 experiments	 would	 be	 desinged	 to	 allow	 for	 analysis	 of	 population	
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heterogeneity,	 for	 example	 using	 single-cell	 measurement	 of	 gene	 expression	 using	fluorescent	reporters	and	high-resolution	microscopy.	Such	approaches	offer	the	exciting	prospect	of	unravelling	the	fundamental	metabolic	adaptive	functions	of	QS	in	terms	of	true	quorum	 sensing	 (population	 density),	 diffusion	 sensing	 (mass	 transfer	 environment),	competition	sensing	(ecological	competition)	and	metabolic	prudence.		
It	is	important	to	note	that	only	a	portion	of	the	P.	aeruginosa	metabolome	was	assayed	in	the	present	study	and	so	 the	data	 inevitably	provides	a	partial	view	of	 the	role	of	QS	 in	regulating	 small	molecules	metabolism.	Moreover,	 the	 analyses	were	 conducted	on	 cells	grown	in	batch	culture	in	rich	medium	at	a	single	temperature,	with	an	emphasis	on	the	transition	from	exponential	to	stationary	phase	growth.	It	is	certainly	the	case	that	QS	has	many	effects	on	primary	metabolism	not	yet	identified	and	that	these	are	highly	dependent	on	prevailing	growth	conditions.	There	is	also	scope	for	optimising	the	sampling	protocols	used.	For	example	the	sampling	protocol	used	for	cellular	metabolic	profiling	in	Chapters	4–6	 consisted	 of	 quenching	 by	 cooling	 and	washing	with	 cold	 saline,	 following	 by	 snap	freezing	 and	 methanol-chloroform	 extraction.	 Quenching	 with	 cold	 saline	 and	centrifugation	was	performed	so	as	to	avoid	the	high	rates	of	cell	 leakage	observed	with	direct	injection	into	solvents	(Bolten	et	al.	2007).	However,	some	reactions	will	continue	at	significant	rates	for	several	minutes	prior	to	snap	freezing	in	liquid	nitrogen.	This	could	be	addressed	by	applying	rapid	sampling	techniques,	 for	example	 fast	 filtration	methods	or	direct	 injection	 techniques	 optimised	 so	 as	 to	minimise	 cell	 leakage	 (Faijes	 et	 al.	 2007;	Canelas	et	al.	2009).	Stable	isotope	labelling	for	metabolic	flux	analysis	would	be	valuable	in	 supplementing	 the	 present	 current	 metabolite	 concentation	 data,	 particularly	 in	examining	the	effects	of	QS	on	central	carbon	metabolism.	
To	conclude,	the	present	work	provides	a	missing	perspective	on	the	relationship	between	QS	 and	 small	 molecule	 metabolism—that	 of	 a	 broad	 analysis	 of	 the	 QS-modulated	metabolome—and	 in	 doing	 so	 identifies	 QS-regulated	 primary	 metabolic	 traits	 with	implications	for	the	evolutionary	stability	of	P.	aeruginosa	QS	systems	and	their	adaptive	functions	in	the	environment	and	during	infection.	
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